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1. Summary 
Eukaryotic genomes make use of nucleosomes to considerably reduce their packaging volumes. As a 
consequence, the underlying DNA is rendered inaccessible. Cells make use of ATP-dependent 
remodeling factors to disrupt histone-DNA contacts and bring about access to the DNA. ACF1 is the 
largest regulatory subunit of two nucleosome remodeling factors, namely ACF and CHRAC. These 
complexes assemble, slide or evenly space nucleosomes on DNA with an ability to sense the linker 
lengths. However, roles of ACF1 in organizing nucleosomes in vivo and their physiological consequences 
are largely unclear. To understand the roles of ACF1 on chromatin organization, I compared nucleosome 
occupancy and transcription profiles in wild-type and ACF1-deficient Drosophila embryos. To further 
investigate and corroborate these chromatin changes, I performed genomewide mapping of ACF1 using 
chromatin immunoprecipitation.    
Nucleosome occupancy was mapped by subjecting DNA obtained from MNase-digested chromatin to 
deep sequencing and the occupancies were analyzed using advanced analog signal processing methods. 
We found discontinuous and discrete patches of regularly positioned nucleosomes in wild-type tissue, 
referred to as ‘regularity regions’. These regions span actively transcribing and silent chromatin domains 
and show associated variation in the linker lengths across them. A subset of these regions located at sides 
remote from the transcriptional start sites loses regularity upon ACF1 deletion and show presence of a 
novel DNA sequence motif. Analyzing nucleosome periodicity by autocorrelation function revealed that 
nucleosome linker length is longer in ACF1-deficient embryos. Despite profound quantifiable changes in 
the chromatin organization the RNA expression analyses did not show any major changes.   
Genomewide localization of ACF1 was studied using by chromatin immunoprecipitation. We observed a 
strong enrichment of ACF1 along active promoter regions, coinciding strikingly well with another 
remodeling factor, RSF-1. However, careful analyses using mutant tissues for both proteins demonstrated 
that the observed enrichments were in fact false positive. We define 3100 genomic sites as false positive 
‘Phantom Peaks’ that tend to enrich in the ChIP-seq experiments. By comparing publicly accessible 
profiles and the Phantom regions, we showed that several ChIP-seq profiles of the epigenetic regulators 
show strong enrichment along the Phantom Peaks.  
In conclusion, we identify regions of regularly organized nucleosomes across the genome and show that a 
subset localized in silent chromatin regions is affected by ACF1 deletion. Moreover, we identified a class 
of false positive ChIP-seq peaks at active promoters. This list of Phantom Peaks can be used to assess 
potential false positive signal in a ChIP-seq profile, especially when mutant tissue is not available as a 
control. 
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Zusammenfassung 
Eukaryoten nutzen Nukleosomen um das Packvolumen ihres Genoms drastisch zu reduzieren. Dadurch 
wird die Zugänglichkeit der DNA stark eingeschränkt. Um bei Bedarf DNA-Abschnitte von 
Nukleosomen zu lösen nutzen eukaryotische Zellen ATP-abhängige Remodeling Faktoren. Zwei dieser 
Remodeling Faktoren, ACF und CHRAC, sind Multiproteinkomplexe und beinhalten als grösste 
Untereinheit das Protein ACF1. Beide Komplexe können Nukleosomen assemblieren, verschieben und 
mit gleichmässigen Abständen auf einem DNA-Strang anordnen. 
Es ist aber noch weitgehend unbekannt, was die genauen Funktionen dieser Komplexe in der lebenden 
Zelle sind, und wie sie dort die Nukleosomenorganisation beeinflussen. Um diese Fragen zu beantworten 
habe ich Nukleosomenverteilungen und Transkriptionsprofile in normalen und ACF1-mutanten 
Drosophilaembryonen bestimmt. Zusätzlich habe ich mit Hilfe der Chromatin-Immunopräzipitations-
Methode (ChIP) untersucht, wo auf dem Genome ACF1 bindet. 
Die Nuklesomenverteilung wurde bestimmt, indem Embryonenchromatin mit MNase verdaut wurde, und 
die resultierenden DNA-Fragmente sequenziert wurden. Dabei haben wir herausgefunden, dass es 
verschiedene Regionen auf dem Genom mit sehr gleichmässig angeordneten Nukleosomen gibt. Wir 
nennen diese Regionen “regularity regions”. Sie sind sowohl in transkribiertem wie auch inaktivem 
Chromatin zu finden und haben unterschiedliche Nukleosomenlinkerlängen. Viele dieser regulären 
Regionen sind nur in normalen, aber nicht in ACF1-mutanten Embryonen zu finden. Diese ACF1-
abhängigen regulären Chromatinabschnitte zeigen auch bislang unbekanntes DNA Motiv. Indem die 
Nukleosomenperiodizität mit einer Autokorrelationsfunktion bestimmt wurde, konnte gezeigt werden, 
dass der Nukleosomenlinker in ACF1-mutanten Embryonen länger als normal ist. Obwohl klare Defekte 
in der Chromatinorganisation in ACF1 Mutanten gefunden wurden, zeigte eine RNA-Expressionsanalyse 
keine grösseren Unterschiede zu normalen Embryonen. 
Die genomweite Verteilung von ACF1 wurde mit der ChIP-Methode untersucht. Wir haben dabei eine 
starke Anreicherung von ACF1 an aktiven Promotoren gefunden, sehr ähnlich wie beim verwandten 
Remodeling Faktor RSF-1. Nachdem wir aber die Experimente in ACF1 und RSF-1 mutanten 
Embryonen wiederholt hatten, und die Lokalisierung beider Faktoren an Promotoren immer noch zu 
sehen war, schlossen wir daraus, dass die beobachteten Anreicherungen falsch-positiv waren. Insgesamt 
haben wir in unseren ChIP-Experimenten an 3100 Stellen des Genoms falsch-positive “Phantom Peaks” 
gefunden. Indem wir verschiedene öffentlich zugängliche ChIP-Profile mit diesen “Phantom Peaks” 
verglichen haben, konnten wir zeigen, dass mehrere dieser Profile ein grosse Übereinstimmung mit den 
“Phantom Peaks” hatten. 
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Wir haben also einerseits innerhalb des Fliegengenoms Regionen mit sehr gleichmässig angeordneten 
Nukleosomen gefunden und gezeigt, dass ein Teil davon die Regularität in der Absenz von ACF1 verliert. 
Darüberhinaus haben wir eine Klasse von falsch-positiven ChIP-Anreicherungen an aktiven Promotoren 
identifiziert: Diese Liste von “Phantom Peaks” kann nun dazu benutzt werden, potentiell falsch-positive 
Signale in ChIP-Experimenten zu identifizieren, vor allem wenn keine Kontrolle mit einer Nullmutante 
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2. Introduction 
2.1 Challenges of DNA packaging 
Biomolecules and their functions have been a matter of curiosity in the life science field since long. 
Earliest report assessing the contents of cell nuclei comes from Walther Flemming. Using basic anilin 
dye, he could stain the contents of the Chironomus salivary gland nuclei and suggested acidic nature of 
the non-protein molecule, nuclein (now DNA) (1). Later on, a conceptual framework of ‘order from 
disorder’ was put forward by Erwin Schrödinger in his landmark book ‘What is life’. He reasoned that the 
master molecule carrying genetic information must consist of a large number of atoms for its stability (2). 
Indeed, now we know that DNA is a fairly long heteropolymer that contains key genetic information for 
cellular response and survival. For example, the length of an end-to-end stretched DNA from a single 
human cell comes to ~2 meters. Or, in case of Drosophila melanogaster whose genome (or genetic 
material) is 20 times smaller, the linear DNA length measures ~11 centimeters.  
An essential aspect of cell functioning is its ability to organize and efficiently access the DNA molecule 
inside the nuclei. From mathematical standpoint, a 2 m long fiber can potentially be packaged in 
following three ways, assuming that it is flexible and non-interacting. First, the molecule can be 
considered to float freely in the 3D space where its diffusion is governed by square root of its length. 




 (3). Second, 
the molecule can adopt supercoiled structure to minimize the volume. In this case, the effective packaging 




. And third way of packaging is a condensate, where the fiber is 
arranged in a compact ball, by reducing the space between folds to a bare minimum. Considering the 
diameter of the fiber as 2 nm, the effective packaging volume comes to about 35 µm
3
(4). Cell nucleus 
offers a volume of 250 µm
3
 for storing their DNA. The space constrains rule out first two ways while the 
third way of packaging confers substantial limitations on DNA access. Moreover, DNA is a highly 
charged molecule with linear charge density of one elementary charge per 0.17 nm. Conceivably, 
compact organization demands neutralization or substantial reduction of electrostatic interactions which 
may be facilitated by solvents of low dielectric constants or polyvalent cations, further risking phasing out 
of the molecule from solution. Nonetheless, cells amazingly compact the DNA ~ 150,000 times and at the 
same time keep it accessible.  
2.2 DNA packaging as a condensate 
Access to the DNA molecule is fundamental and overarching theme that orchestrates different ways of 
packaging the genome. DNA is a stiff molecule with a persistence length of 50 nm, a hypothetical 
segment length required for the molecule to bend it by thermal fluctuations (5). As a result, beyond 50 nm 
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DNA behaves as a flexible fiber which can pack itself in solution with the help of counter-ions. In-
solution packaging can be facilitated by two ways. First, presence of the crowding agents effectively 
reduce the diffusion volume while, the counter-ions in the solution facilitate charge neutralization and 
condensate formation. Polyamines or neutral polymers act as crowding agents (6, 7). And second, 
multivalent cations neutralize the negative charge on DNA phosphodiester backbone, thereby reducing 
repulsion between DNA supercoiled segments and promoting condensation. It is estimated that 
neutralization of 89-90% DNA backbone charge can effectively lead to its condensation (8). Sufficiently 
high concentrations of the counter-ions or crowding agents lead to formation of DNA condensates that 
can phase out of the solution by adopting crystalline structures.  
Condensate based packaging offers extremely poor accessibility to the DNA, which viruses use to stash-
away their genomes. Viral capsid carries genomic condensates that need to be accessible only upon host 
cell infection. Cryo-electron microscopy and other biophysical experiments reveal that, with the help of 
multivalent cations and crowding agents (polyamines like spermine and spermidine), the DNA is 
organized in the form of a spool or highly concentrated hexagonal-defect structures where the local DNA 
concentrations can reach staggering 534 mg/ml (9–11). During the host-cell infection, these structures are 
relaxed into cholesteric and subsequently isotropic forms.  
2.3 Accessible DNA packaging using architectural proteins– prokaryotes  
The genome sizes of prokaryotes and eukaryotes are substantially larger as compared to viruses. It is easy 
to form linearized condensates on large genomic DNA, however non-viral genomes need to remain 
accessible during cell functioning, hence necessitating a fluid-state packaging. To cope with the 
accessibility part, evolution has devised a range of architectural proteins that bind and package the DNA 
molecule. As a consequence, architectural proteins create a regulated access to the underlying DNA 
molecule. DNA bending, wrapping and bridging of the DNA-loops are the three principle ways by which 
architectural proteins package the genome [summarized in (3, 7)].  
DNA bending proteins (i.e. HMGB, Sul7/Cren7, HU/Fis in eukaryotes, archea and bacteria) interact with 
the minor groove and bring about a bend of up to a maximum of 160° (Figure 2.1A). The HU/ HU-like 
proteins in bacteria may further exhibit cooperative or sequence-specific binding to the DNA (12–15). On 
the other hand, DNA bridging proteins (i.e. H1, Alba/SMC or H-NS/H1-like in eukaryotes, archea and 
bacteria) establish dynamic crosslinks between DNA duplexes, or DNA complexes and other architectural 
proteins. Such interaction leads to the formation of DNA loops and promote high level of compaction. 
Architecturally these proteins contain a DNA binding domain and a bridging domain (16–18). DNA-
wrapping proteins are highly specialized architectural proteins whose positively charged surfaces help 
Page | 13 
 
neutralizing the DNA charge and wrap the molecule around them, like a spool (19) (Figure 2.1A). The 
so-formed nucleoprotein structures not only reduce diffusion volume of DNA but the winding around a 
protein core further induces writhe in the fiber leading to an enhanced supercoiling. Histones are a typical 
example of DNA wrappers in all the eukaryotes and effectively cope with packaging challenges for large 
genome. Even though they are not present across all kingdoms, their evolutionary relatives such as 
HMfA/HMfB are present in archea (20). Archeal DNA-wrapping proteins are considerably smaller than 
the histones that lack both N- and C- terminal tails to allow wrapping of up to 60 bp DNA (3, 20, 21). In 
nutshell, wrappers allow left-handed DNA packaging (toroidal form), unlike the right handed plectonemic 
supercoiled form (22) (Figure 2.1B, C).    
 
Figure2.1. Variety of architectural proteins in DNA packaging. (A) Wrapping, bending and bridging are principle modes of 
packaging DNA. (B) Prokaryotic genomes are packaged preferentially using benders and bridgers from plectonemic form to 
partially supercoiled form. (C) DNA wrapping is an advanced form of packaging predominantly seen in eukaryotes along histone 
proteins. Removal of histones renders the DNA in supercoiled state - similar to plectonemic form. [Adopted from (3)]    
 
DNA is a helically twisted molecule. When it interacts with proteins by binding, wrapping around or 
bending over them, an additional strain is generated in the molecule –provided that the ends are fixed. To 
relieve the strain, the duplex writhes around itself and introduces supercoiling, an energetically favorable 
state. Negative form of supercoiling has two distinct outcomes. First, it considerably reduces the 
packaging volume by arborizing supercoils within the DNA molecule. Such forms are referred to as 
‘plectoneme’(negatively supercoiled DNA with right handed inter-wound) (Figure 2.1B). And second, 
supercoiling may lead to partial DNA strand separation. DNA access brings about dynamic DNA-protein 
interactions that in turn alter the helicity in the molecule. If the helicity is not constrained, the DNA 
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molecule is likely to phase out of the solution. Prokaryotes alter DNA supercoiling by employing 
enzymes like gyrase, or binding of architectural proteins that compartmentalize it.  
Bacterial genomes are folded predominantly using DNA bending and bridging proteins. DNA-wrapping 
proteins are largely absent in prokaryotes, while the in vivo concentrations of benders and bridgers are not 
sufficient to package the entire genomes. It is estimated that roughly 50% of the prokaryotic genome is 
organized with nucleoproteins while the rest is kept in supercoiled state. Macromolecules such as 
polyelectrolytes, amines or biomolecules like RNA and protein further act as crowding agents to force the 
interactions between DNA segments and their successive volume reduction  (16, 23, 24). The partial 
occupancy by architectural proteins suggests that overall bacterial genome packaging is largely governed 
by abundance of architectural proteins. Indeed, the starving or slow growing bacterial cells show more 
compact DNA organization that adopts partial cholesteric forms (like viruses) when compared to rapidly 
growing bacterial cells  (25–27).  
2.4 Advanced stage of DNA packaging in eukaryotes  
Eukaryotic genomes impose additional challenges during packaging. The DNA concentrations in 
eukaryotic nuclei are staggeringly high (200-220 mg/ml) as compared to prokaryotes (80-100 mg/ml) 
(28). And the estimated concentrations of biomolecules and multivalent ionic species within the nuclei 
can reach up to 400 mg/ml. Under these elevated concentrations, phase separation into cholesteric or 
liquid crystalline form is the most energetically favorable state. However, wrapping of the DNA along 
histones can effectively prevent thermodynamically dictated DNA phase separation to extremely inactive 
form (29).  
A ‘nucleosome’ is a repeating unit of DNA organization inside the eukaryotic nucleus. DNA wraps 
around octameric core of histone to form a ‘nucleosome’. The structure encompasses 147 bp long DNA 
wrapped around the histone cores in 1.67 turns which in effect reduces 50 nm long DNA to an 11 nm 
diameter structure. The protein core of nucleosomes is composed of 4 canonical histones H2A, H2B, H3 
and H4, each carrying 3 hydrophobic α-helices long histone-fold. The arginine residues form the core 
interact with DNA minor groove establishing total 14 weak contact points between the core histones and 
DNA (19). The histone octameric core of nucleosomes is assembled in succession by first assembling two 
dimers of H3-H4, which in turn associates with a dimer of H2A-H2B on the either side. Hydrophobic 
core of histone-folds forms a composite core, while N- terminal tails of the histones protrude out to 
remain available for post-translational modification (Figure 2.2).  
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Figure2.2. Crystallographic structure of nucleosome core particle. 147 bp DNA double helix is wrapped around dimers of 
H3-H4 and H2A-H2B. The view is along the DNA superhelix axis. N-terminal tails protrude from the core particle and are 
accessible to other nuclear proteins, while C-terminal adopts globular structure forming the core. There is a two-fold symmetry n 
the structure along the vertical dyad axis that passes in the plane of current view. [Adopted from (19)] 
DNA fiber organized along histone octamer is called as nucleosome and such repeating structures can be 
visualized as ‘beads on string’ where two nucleosome particles are separated by a linker region. 
Depending on the species, the lengths of linker regions vary from 10-60 bp (30). The linker histone binds 
nucleosomes on DNA entry-exit sides to further compact the loosely organized nucleosomes into a dense 
structure which is resistant to thermal fluctuations, unwrapping or sliding of nucleosomes (4, 31). It is 
suggested (and widely debated in the field) that beads-on-string structure further adopts a 30 nm fiber 
geometry which is stabilized by biding of a linker histone. This form subsequently organized into higher 
order folds that are stabilized by presence of scaffold proteins to ultimately form few micron long highly 
condensed mitotic chromosomes (4, 31) (Figure 2.3).   
Existence of 30 nm fiber as a potential substrate for higher order folding was initially demonstrated from 
in vitro experiments. Two competing models describe ‘one start helix’ (solenoid) versus ‘two start helix’ 
model for the formation of 30 nm fiber. First model assumes that nucleosomes are organized in a helical 
trajectory where they interact with their neighbors and accommodate 6 to 8 nucleosomes per turn (32). By 
contrast, the ‘two start helix model describes an arrangement where the linker DNA remains straight and 
alternate nucleosomes interact by forming two rows of helically arranged nucleosome cores (33). 
However, the existence of 30 nm higher order fold in in vivo conditions is strongly debated. Cryo-EM 
studies from echinoderm sperm and chicken erythrocytes support existence of 30 nm fiber (34, 35).  
However, it is important to note that the studied cell types represent a highly specialized chromatin 
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condensation state which is assisted by presence of unusual H1 linker variants. Subsequent studies 
involving different cell types, such as mitotic HeLa cells, could not identify the 30 nm fibers in vivo (36–
39). Instead, Nishino et al propose a polymer melt model, where the high concentration of the 
nucleosomes drives the nucleosome fibers to interdigitate, in trans. According to the new model, 30 nm 
fiber may exist in the nuclei during the transitions where chromatin states are perturbed.   
 
Figure2.3. Suggested organizational schematics for eukaryotic DNA inside the cells. First level of compaction is wrapping of 
DNA along the histone octamer. This structure further compacted by association with linker histones. The array subsequently 
folds into 30 nm fiber which successively adopts higher compactions. [Adopted from (40)] 
 
Another twist in explaining linear genomic organization comes from Fussner et al. Employing electron 
spectroscopic imaging with tomography on mouse somatic cells (MEFs, lymphocytes, liver cells) the 
authors conclude that both open (eu-) and closed (hetero-) chromatin consists of 10 nm fibers with 
absence of 30 nm folding (41, 42). There are independent corroborative findings for the observation. 
First, 3-C studies in yeast conclude that chromatin 3-dimensional interactions can be best modeled by 
assuming a single chromatin fiber type rather than hierarchical organization of chromatin fiber (43). 
Second, cryo-EM and small angle X-ray scattering studies on mitotic chromosomes suggest 10 nm 
chromatin fibers (39, 44). Taken together, the alternate line of evidences propose pronounced 10 nm fiber 
whose bending and shortening of the spacing between them can  lead to volume reduction and packaging 
of the chromatin fiber. 
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Interestingly, increasing the length of linker DNA by a single basepair can change the orientation of a 
nucleosome with respect to the preceding by as much as 36°. Under physiological conditions, linker 
lengths are highly dynamic which in turn offers substantial fiber heterogeneity. Recent computational 
approaches that accommodate variable linker lengths suggest a uniform to heteromorphic to polymorphic 
fiber geometry as a result of linker lengths variation. These states consist of uniformly compacted DNA, 
bent fibers, zigzag structures and loops (45, 46). Moreover, it is suggested that polymorphic states can 
achieve 30% more DNA compaction than the uniform packaging, while keeping the chromatin structure 
in a functional form.  
On a more physiological level, Deep sequencing and microscopy based studies identify non-random 
organization of the DNA. It has been suggested that the DNA is organized in the form of ‘topologically 
associated domains’ that show conserved, discrete 3-D organization of the underlying DNA (47–50). 
Genome organization and its determinants are discussed in Section 2.7 and 2.8.  
2.5 Accessing the DNA  
The process of DNA compaction makes use of variety of structural proteins and supercoiling. This may 
be optimal in terms of shielding the DNA from environmental damaging cues; however, it imposes severe 
obstacles on using the DNA information. For instance, transcription needs access to the free DNA where 
transcription factors and RNA polymerase assemblies can bind. Once the transcription process is initiated, 
the passage of RNA polymerase along the DNA is further obstructed by nucleosomes leading to reduced 
rates of elongation (51). Similarly, DNA transaction processes like replication or repair need access to the 
DNA.  
Abrogation of DNA access as a result of packaging can be viewed as following. First, on linear 
organizational level, DNA wrapping or bending creates sharp turns on a molecule by contacting the DNA 
in its minor groove. Often, the protein machinery employed for DNA transactions use the same location 
to contact DNA. Second, the motor proteins in DNA transacting processes like replication or repair or 
transcription ‘run’ along the DNA. Presence of supercoils and architectural proteins obstruct their linear 
passage. Third, modification of the architectural proteins often leads to further compaction of 
nucleoproteins making them even less accessible. For example, modification of histone H3 by 
methylation in eukaryotes leads to recruitment of HP1 and subsequent compaction (52). Fourth, the 
bridging, looping and higher order structural folding leads to further compaction of the nucleoprotein 
structures rendering them inaccessible. Despite odds, the large nucleoprotein complex remains in solution 
and also accessible - provided that there are factors which can actively generate access by altering 
nucleosome structures. 
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Accessibility is largely governed by two aspects. First, the covalent modifications of the N-terminal 
histone tails can potentially earmarks the region for altering the access. For example, acetylation of 
histone H4 on lysine K16 by MOF is associated with transcriptional activation of the underlying DNA 
(53, 54). Second, ATP-dependent nucleosome remodeling reversibly organizes nucleosomes on DNA 
fiber to create access. Nucleosome structures in eukaryotes are stabilized by weak ionic interactions 
between DNA phosphate backbone and positively charged histone surface. Any attempts to mobilize the 
nucleosomes are therefore energy-intensive. As a result,  the remodeling activities are coupled with ATP 
hydrolysis where an ATPase subunit (or domain) plays a key role (30).  
2.6 Nucleosome remodeling factors are essential for the eukaryotes 
Nucleosome remodeling is an ATP-dependent process that reversibly alters the histone-DNA contacts. As 
a result, one of the three outcomes is possible - nucleosome assembly, sliding or exchange of canonical 
histones with variant forms (30). Nucleosome sliding is studied biochemically using the enzymes that cut 
free DNA. For instance, endonuclease DNase-1 or restriction endonucleases cut DNA in a sequence-
independent or -dependent manner. Activities of these enzymes are abrogated when nucleosome occludes 
the DNA sequence and can be used to assay remodeling activities of the protein complexes. Likewise, 
assembly/disassembly of histones on DNA is used to study factors generating nucleosome assemblies. 
These two assays have been employed in identifying several distinct multi-subunit nucleosome 
remodeling factors (30, 55–58).  
In order to be called as nucleosome remodeling factors, a factor (or protein complex) needs to have 
affinity towards the nucleosomes, an ATPase domain with DNA translocation activity and additional 
domains that carry regulatory features (30). All identified nucleosome remodeling factors (or remodelers) 
contain an ATPase domain belonging to Snf2 superfamily of helicases. The helicases are characterized by 
having both translocation and helicase activity along the DNA. However, ATPase domains in the 
remodeler only retain the translocation activity (59) which assists their passage along the DNA without 
strand-separation. Bioinformatics analysis of the ATPase domain of the remodelers across sequenced pro- 
and eukaryotic genomes identify 24 distinct ATPase/translocase families. Interestingly, the homologs 
identified in prokaryotes fall in a single exclusive SSO1653 family. The members of this family are not 
ubiquitously present across all sequenced bacterial species suggesting non-essential function of the 
translocases/ ATPases. By contrast, all sequenced eukaryote species contain at least one remodeler family 
suggesting that in the eukaryotes remodeling activities are not dispensable (60). Amongst the 24 families, 
four are prominently studied and widespread in eukaryotes -SWI/SNF, ISWI, CHD and (Swr1-like) 
INO80 (Figure 2.4). The protein complexes belonging to these families are referred to as remodelers in 
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current work, while their activities as remodeling activity. Taken together, the analyses suggest that 
remodelers have evolved and diversified from an ancient bacterial family.  
 
Figure2.4. Major nucleosome remodeling ATPase subfamilies. These families are distinguished based on additional domains 
besides DEAD-HELICc. [Adopted from (61)]  
 
Bacterial RapA ATPase is well-studied in prokaryotes and seems to catalyze non-histone substrate. 
Sequence comparison suggests that RapA is related to the eukaryotic SWI/SNF remodeler family and is 
non-essential for E.coli. Its roles become obvious only during salt stress conditions in bacteria. High salt 
concentrations strongly affect DNA supercoiling and thereby RNA polymerase recycling in E.coli leading 
to reduced levels of transcription cycles. In such cases, RapA facilitates release of the σ70 holoenzyme 
from the DNA-RNA-protein complex through its translocase activity on DNA (62–65). It is important to 
note that rarity of DNA-wrapping proteins in prokaryotes correlates with the absence of specialized 
remodeling factors. 
The four remodeler families are distinguished based on the structure of their ATPase domains and 
accessory functional domains alongside. For instance, SWI/SNF carries bromodomain, CHD carries a 
chromodomain or ISWI carries an HSS. Importantly, INO80 family differs from the rest by having a 
strikingly large (300 aa) insertion between the DExx and HELICc domains of ATPase (Figure 2.4). 
During the course of evolution SWI/SNF family has undergone an extensive diversification of the 
remodeling complexes by allowing combinatorial use of subunits. By contrast, ISWI family is observed 
to form large numbers of distinct molecular complexes (30, 66, 67).  Biochemical activities of these 
remodeling ATPases are largely similar - namely they slide nucleosomes on DNA, in vitro. However, it is 
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important to note that neither of the remodeler ATPase seems to substitutes the functions of others, in 
vivo. Lethality of complete null alleles for these remodeler ATPases argues for non-redundant functions 
(Table 2.1). 
 
ATPase Reported biochemical activities Knockout phenotype in Drosophila melanogaster 
Snf2 Nucleosome sliding, DNA 
unwrapping, octamer ejection 
Null allele is embryonic lethal (68) 
ISWI Nucleosome spacing and sliding, 
nucleosome assembly 
Late larval, early pupal lethal (69) 
Chd Nucleosome sliding, nucleosome 
assembly 
dChd1: Delayed development, wing notch-phenotype in adults, 
defects in male fertility (70) 
Kismet: Null allele is larval lethal (71) 
dMi-2: Larval lethal (72) 
Ino80 Nucleosome sliding, spacing dIno80: Late embryonic lethal (73) 
dDomino: Early pupal stage lethal (74), female germline clone 
shows loss of germ-stem-cells (75) 
Table 2.1. Phenotypes of remodeling ATPase knockout in flies. Nucleosome sliding and spacing are discussed separately in 
Section 2.7 
Remodeling ATPase often functions by engaging nucleosomal DNA at super-helical location (SHL) 2, 
where the strongest histone-DNA contact is found (76). This location is further characterized by 
emergence of H4 tail, which contributes to the overall remodeling activity (77, 78). The translocation 
activity of a remodeler creates relative displacement between DNA and the histone octamer. Different 
modes of DNA translocation and variation of the themes are discussed in details by (79). Interestingly, a 
zinc finger protein subunit Les2 of Ino80 complex can stimulate ATPase activity of the complex, while 
Les6 and Arp5 subunits coherently function to promote nucleosome binding of Ino80 (80). Notably, ISWI 
activities are also regulated by sequence motifs localized in the N- and C-terminal region of the protein  
(81). Both observations suggest that activities of remodeler ATPases are strongly regulated in presence of 
an accessory subunits and regulatory domains. 
2.7 In vivo nucleosome organization 
In vitro biochemical activities suggest that remodelers function to bring about nucleosome sliding, 
assembly or exchanges of histone variants. These reactions use mononucleosomal substrates to 
understand the mechanistic properties of remodelers. How the remodelers function in vivo and what 
effects do they have on overall nucleosome organization remains an active area of research. 
Page | 21 
 
Nucleosome remodeling factors are also known to contribute to nucleosome assembly pathways. In 
principle, association of a histone octamer with DNA does not require active remodeling, but placement 
of H3/H4 tetramer and H2A/H2B dimers onto the DNA by dedicated chaperons (82). However, 
Kadonaga lab describes that the ACF remodeler was able to convert histone-DNA ‘prenucleosomes’ into 
proper nucleosomes presumably by winding the DNA around the octamer in an ATP-dependent manner 
(83). This reaction is akin to some histone variant exchange reactions (84).  
 
Figure2.5 Outcomes of the nucleosome sliding reactions. (A) Nucleosome sliding activity mobilizes the nucleosomes in cis on 
DNA molecule to align them along a barrier, such as - promoter, transcription factor /insulator binding sites. In a population, 
sliding with respect to barrier produces nucleosome phasing, with distinct well-positioned +1 or -1 nucleosomes along the 
barriers. (B) In absence of barrier, sliding activity may space nucleosomes with respect to neighboring ones in a uniform manner 
with similar distances between them. In a population average, such spacing does not lead to well-positioned nucleosomes. Red 
arrows suggest spacing activity.    
 
Sliding of a nucleosome is defined as the translocation of histone octamers with respect to the associated 
DNA molecule in cis without disassembling them (85), which in effect has distinct outcomes. In vitro 
experiments suggest that sliding can bring about directional movement of nucleosomes on the DNA, as 
against simply moving them randomly. For instance, ACF and Ino80.com can move nucleosomes from 
the end position to the center of the DNA fragment unlike other remodeler families (86, 87). Sliding of 
nucleosomes can bring about access or abrogate access to the underlying DNA, which is usually referred 
as ‘chromatin accessibility’ (58, 86, 88). On a multi-nucleosomal DNA, sliding can potentially arrange 
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the nucleosomes in homogeneous or uniform manner such that the distance between altering nucleosomes 
remains consistent. This activity is generally referred to as nucleosome ‘spacing’. By assembling the 
nucleosomes on a DNA and subsequently analyzing the remodeled nucleosomes using restriction 
endonuclease or partial MNase digestion suggested that ISWI, CHD and INO80 family remodeling 
ATPases have spacing activity (87, 89–93). In vivo deep sequencing experiments identify genome-wide 
nucleosome locations and report another important aspect of the sliding theme. Often, it is observed that 
nucleosome-free region or a DNA sequence-specific factor serves as boundary along which nucleosomes 
are well-spaced to form arrays. In this case the regular arrangement of nucleosomes with respect to a 
defined DNA position is called ‘phasing’. Sliding against such barriers lead to phasing of nucleosomes, 
where nucleosome positions remain well-defined and homogeneous across the population. In absence of a 
barrier, the spacing reaction may produce regularly spaced nucleosomes however they are not 
homogeneous across the population. Consequently, ‘nucleosome positioning’ is defined with respect to 
the underlying DNA and in sequencing experiment often assumes well-defined signal. While, occupancy 
of a nucleosome refers local density of a nucleosome in a population, or simply put, sequencing signal 
density (Figure 2.5).  
DNA is not uniformly packaged inside the eukaryotic cells. Regions of chromatin, such as 5’ end of the 
genes, remain preferentially accessible to DNase-1 while heterochromatin regions show poor access (94), 
suggesting an underlying variation in nucleosome organization. Changes in chromatin structure have been 
probed by employing micrococcal nuclease (MNase) which preferentially cleaves linker DNA. Reporter 
transgene integration assays suggest that the heterochromatic region has more regular nucleosome arrays 
as compared to the euchromatic integration sites (95, 96) which correlates with increased accessibility in 
the latter. Recently, the nucleosome organizations were studied in live mammalian cells by following the 
dynamics of core histone H2B using STORM microscopy (97). The findings reveal that nucleosomes in 
the cell are organized in spatially discrete domains separated by nucleosome free regions (NFRs). The 
numbers of derived nucleosomes within the clusters were different in pluripotent v/s differentiated cell 
types, in a manner that differentiated cells have higher cluster densities and larger size. Heterochromatin 
structure also showed large density of nucleosome clusters. Both studies, using different approaches 
suggest that organization of nucleosomes differ considerably within the cells from eu- to heterochromatic 
regions.    
More detailed insights into nucleosome organization come from the experiments that define in vivo 
nucleosome positions. Such positions are identified by enriching the histone bound DNA fragments and 
subsequently hybridizing them on to chip or deep sequencing. In these assays, well-positioned 
nucleosomes are identified as the genomic regions carrying high sequence-tag density. Nucleosome maps, 
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so-obtained from yeast to mammals suggest few key similarities. First, for transcriptionally active 
promoters, a nucleosome free region (NFR) was observed close to the transcription start site (TSS). 
Second, the NFR is followed by regularly ‘phased’ nucleosomes in the direction of transcription whose 
phasing decreases away from TSS. Third, depending on the species, 5’ end of the NFR is also decorated 
by presence of a strong (-1) nucleosome, e.g. in Drosophila, yeast. And last, phasing of the nucleosomes 
can also be observed along sequence-specific DNA binding factors (98–101) (Figure 2.5).  
Bulk nucleosome organizations are further characterized by nucleosome repeat length (NRL). It can be 
inferred from spacing based assays, such as partial MNase digestion followed by gel separation of the 
nucleosomal ladder. Importantly, spacing-based NRL estimation is not affected by nucleosome position 
heterogeneity across the population, but is likely affected by preferential solubility of the DNA from 
different chromatin environments. Phasing-based assays can also be used to define NRLs. However an 
important caveat of such estimation is that NRLs are largely guided by well-positioned nucleosomes 
across the population. Mathematical functions such as spectral density estimation or autocorrelation can 
make use of the nucleosome occupancy values across the genome to identify periodicities in the data, 
where well-positioned nucleosomes contribute maximum to the estimated periods. Likewise, linker 
lengths can be estimated from NRLs by correcting them for 147 bp long nucleosome bound DNA (19).  
The spacing-based NRLs vary across different species and cell types. For instance, the shortest reported 
NRL was found to be 155 bp in S. pombe while the longest, 240 bp NRL was measured in echinoderm 
sperm (97, 102, 103). Curiously, the NRL seems to be determined by transcription activity of the cells 
where transcriptionally inactive sperms or fully differentiated erythrocytes have longer NRL (~190 – 204 
bp) compared to precursor erythrocytes (103, 104). Phasing-based NRL estimations also reveal their 
transcriptional correlation. For instance, nucleosome phasing in human and yeast cells correlate well with 
the gene activity mediated by RNA polymerase-II (102, 105). Reasonably, it seems that underlying 
prevalent genomic features, such as transcription or silent state govern overall NRL estimation. In case of 
S. pombe, most of the genome (2/3
rd
) encodes for transcripts and hence the NRL estimated either by 
spacing or phasing seems to correlate well to ~154 bp (102).  
Estimations of NRL in different cellular domains show variation. TSS is strong organizer of nucleosomes 
where the NFR creates distinct phasing. Similar phasing is also seen for insulator binding sites. For 
instance, nucleosome mapping in CD4+ T-cells suggest that CTCF binding sites can phase nucleosomes 
even strongly and for extended lengths as compared to TSS. The overall phasing-based NRL at insulator 
binding sites is higher (~187 bp) compared to TSS (101). In addition, similar study (106) observes that 
NRL estimations can vary across different epigenetic domains such as promoter/enhancers, gene-bodies 
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and heterochromatin from 178 bp to 205 bp. Taken together, the observations suggest that NRL 
estimation (phasing or spacing based) vary across the cell types and within the cells across different 
chromatin environments. 
How do the changes in NRLs affect the structure of chromatin fiber? Small variations in the NRLs can 
potentially alter the intra-nucleosomal rotation angle (β) with an estimate of 36° per basepair addition 
(45). This essentially means that such changes can potentially alter the so-formed fiber geometry. 
Corroboratively, modeling studies that allow alterations in NRL by 3 to 7 bp suggested that the predicted 
fibers start to show increasingly high discontinuities with an increase in NRLs (107). Corroborating study 
supported the findings when the geometries of reconstituted fibers with varying NRLs were observed 
using electron microscopy. It was observed that the variations in fiber geometry were predominantly 
caused by the rotational alterations of successive nucleosomes however, the fibers could fold completely. 
Strikingly, any increase in the NRL in a multiple of 10.5 bp introduced complete compaction only for 
shorter NRLs. For sufficiently large NRLs (above 190 bp) there was an incomplete compaction. 
Interestingly, such fibers could fold completely in presence of a linker-histone (108–110). These findings 
fall in line with the microscopic observations where unexpectedly open and irregularly shaped chromatin 
structures were found for silent/condensed chromatin (39, 42). Above studies suggest alternate forms of 
DNA compaction for regions carrying shorter NRLs (i.e. transcribing domains) and the ones carrying 
longer NRLs (i.e. silent epigenetic domains). It is only in the latter case, where linker histones are 
potentially employed.  
Taken together, it appears that nucleosome organization in vivo is dynamic and makes use of varying 
NRL organizations which in effect influences folding of the fiber.  
2.8 Remodelers are important determinants of the nucleosome organization  
Nucleosome positions are determined by either underlying sequence-determinants, the activity of 
remodeling factors or DNA- transaction process like transcription [summarized by (106, 111–114)].  
DNA sequences play an important role in formation of the nucleosomes. Bendable di-nucleotides like AT 
if repeated at every 10 bp (at a helical turn) and spaced ~5 bp away from the GC nucleotides can strongly 
favor nucleosome formation (115, 116). Likewise, a strong GC bias towards the nucleosome dyad axis 
has been observed for well-positioned nucleosomes in mammals. These GC rich regions are often flanked 
by nucleosome deterring sequences like AA or TT dinucleotides and can trap the nucleosomes locally. 
For example, T-cells contain such strongly positioned nucleosomes that are distinct from the well-
positioned +1 nucleosome at the TSS (106). These sequence features can be modeled for genome-wide 
prediction of the nucleosome formation sequences. Models that take into consideration 5-mer sequence 
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features and AT dinucleotide repeat distribution predict strong convergences with in vivo data, close to 
75% in yeast, while such attempts in flies are not reliable (98, 117), suggesting additional sequence 
features or cellular components are needed. Unlike AT, nucleosome disfavoring sequences are also 
known. For example, homo-polymeric stretches of poly dA:dT or poly dG:dC strongly disfavor 
nucleosomes due to their enhanced stiffness. Such stretches are predominantly found in promoters of 
several eukaryotic genomes (117–120). However, these sequence features alone are unable to explain in 
vivo like nucleosome positioning. In vitro reconstitution experiments in yeast can recapitulate formation 
of NFRs at the promoter/terminators regions carrying dA:dT tracts or at engineered dA:dT tracts (121, 
122). Nevertheless, several important features of the in vivo like assembly are missing. For instance, 
strong positioning of +1 nucleosomes and subsequent well phased array formation along the “barrier” 
promoter regions are not observed (123) ( Figure 2.5). Also, inducible genes do not have dA:dT rich 
NFRs. Usually, onset of signal creates an accessible region at the 5’ end of such genes, which otherwise 
remain occupied by nucleosomes. Overall, it appears that additional cellular components play a crucial 
role in positioning, spacing and phasing the nucleosomes in vivo.  
A potent nucleosome stabilizing ‘601 positioning’ sequence offer thermodynamically stable state for 
nucleosome formation (124). Despite, nucleosome remodelers bring about destabilization and movement 
of the nucleosomes formed at these sites (86, 87) suggesting that remodelers play a pivotal role in 
overcoming steric or free-energy barriers imposed by stable histone-DNA contacts.   
Studies from the Korber and Pugh lab have demonstrated that in vitro reconstituted nucleosome arrays on 
the yeast genomic DNA can be reorganized by ATP-dependent remodeling to resemble in vivo like 
organization. By using whole cell extract from yeast the authors show that in presence of ATP strong 
phasing and a +1 nucleosome around the TSS can be established. This activity is brought about by 
remodeling factors and remains independent of transcription or replication (123), arguing that the 
remodelers are important determinants of nucleosome positions. Different remodeling factors contribute 
to different aspects of nucleosome positioning. For instance, RSC remodeler in yeast is required for 
positioning nucleosomes along the select set of promoters – an activity not observed with ySwi/Snf or 
yIswi2 (125). Similarly, deletion of RSC leads to narrowing of the NFR and shifts of phased nucleosomes 
upstream to their original position (126). It is therefore possible that RSC plays a role in NFR formation 
and maintenance of +1 nucleosome. A complementary observation comes from nucleosome organization 
assessment after genetically deleting Isw1, Isw2, Chd1 remodelers in yeast. The study suggests that 
deletion of individual remodeler has minimal effects on nucleosome phasing and none on the +1 
nucleosome. However, combination of all three remodelers shows strong phasing effects, surprisingly 
keeping the +1 nucleosome unaffected (127). Taken together, the findings suggest that RSC plays an 
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important role in organizing +1 nucleosome, while Isw1, Isw2 and Chd contribute to the downstream 
nucleosome phasing.  
Contribution of remodelers in organizing in vivo nucleosomes became evidently clear from graft 
experiments performed on two evolutionarily distinct yeast species –S. cerevisiae and K. lactis. Transfer 
of K. lactis genomic-DNA in the S. cerevisiae organizes the nucleosomes on implanted DNA in host 
specific manner (shorter NRLs). And surprisingly, this activity is bought about by Chd1 type remodeler 
whose subsequent cloning from K. lactis into S. cerevisiae increases the NRLs in the latter (118, 128). 
Statistical positioning theory describes that nucleosomes are organized along the barrier purely due to 
statistical movement and inhibitions imposed by their stacking interactions. In such scenario, spacing 
becomes a function of nucleosome density. However, reconstituting chromatin in presence of lower 
histone density finds that ISWI and CHD1 remodelers can effectively and constantly space nucleosomes 
(90), arguing for roles of remodeling factors in nucleosome organization and clamping the nucleosomes. 
Transcription, on the other hand, recruits several remodeling factors and therefore it is speculated that 
strong phasing at actively transcribing genes in fact is a result of nucleosome remodeling action mediated 
by the remodeling factors [discussed in (111, 112, 129)]. 
2.9 Accessory subunits regulate remodeling outcomes 
Remodeling ATPases often work in combination with accessory factors that contribute additional 
functional domains. Functional distinction of remodeling complexes invariably comes from the accessory 
subunits. 
SWI/SNF remodeling complexes undergo extensive subunit combinations during evolution with distinct 
functional outcomes. For instance, it has been observed that activation of vitamin-D pathway requires a 
PBAF composition that includes BAF180/200 but excludes BAF250a/b (130). Similarly, differentiation 
of ES cells into neuronal lineage requires BAF170 subunit but at the same time repression of BAF60b 
subunit in PBAF complex. Interestingly, terminal differentiation of the intermediates further needs 
expression of BAF53a, but repression of BAF53b and BAF45b/c  subunits (131, 132). It is likely that 
such tissue specific functions of SWI/SNF complexes arise due to their distinct genomic targets (66, 133). 
Misexpression of these accessory subunits can further have pathological underpinnings. Carcinoma 
pathologies suggest that accessory factors BAF250a and BAF250b function antagonistically by exhibiting 
anti- and pro- proliferative functions. Or, in mice BAF47 subunit seems to function as tumor suppressor 
(134–138). Essentially, SWI/SNF family ATPases is suggested for their role in destabilizing the 
nucleosomes. However, the context of such function is dramatically altered in presence of accessory 
subunits.  
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Roles of accessory subunits in case of Ino80 family become obvious during their targeting to the DNA 
double strand repair. It is observed that Swr1 ATPase only influences non-homologous end joining 
(NHEJ) type of repair and is targeted by Arp4. By comparison, Ino80 participates in both NEHJ and 
homologous-repair pathway and requires Les3/Nph10 subunits for targeting (139–141).  Alterations in 
function are also evident for ISWI type remodelers when transcription is assessed. ISWI in context of 
NURF complex promotes transcription. By contrast, the outcome switches to repression when ISWI 
assembles to form CHRAC/ACF, RSF, ToRC/NoRC  (30, 142–146).  Effects of the ISWI remodeling are 
likely to be a consequence of alterations in the nucleosome positions in vivo.  
2.10 ACF1 is major subunit of two ISWI subfamily of remodeling complexes 
The ISWI ATPase was discovered in Drosophila because of its similarity to Swi/Snf2 remodeler 
(imitation Swi). However, replacing the ATPase domain of ISWI with that from Swi/Snf2 remodelers 
dBrm and ySwi2 are unable to compensate ISWI functions (147) supporting non-redundancy on a 
functional level.  
 
Figure2.6: ISWI subfamily of remodeling complex. (A) Composition of ISWI containing remodeling complexes in Drosophila 
melanogaster (57, 58, 143, 148, 149). (B) Domain architecture of ACF1 protein. 
 
 
ISWI family remodelers are amongst the best studied remodeling complexes, in vitro. There are 6 known 
ISWI containing complexes in Drosophila. ACF1 is a major subunit of 2 of these complexes, namely 
CHRAC and ACF (Figure 2.6). ACF was defined as a molecular activity that assembles nucleosomes in 
presence of histone chaperon NAP-1 by stabilizing the intermediates (83, 93, 150). On the other hand, 
CHRAC was purified as a molecular activity creating access to the chromatinized DNA in an in vitro 
reaction by sliding the nucleosomes (151). CHRAC complex differs from ACF in having two small 
histone-fold proteins Chrac14/Chrac16 associated with the ACF1-ISWI heterodimer. In vitro 
characterization of CHRAC/ACF involved utilization of sliding, spacing and assembly reactions (Section 
2.7). It is important to note that CHRAC/ACF also ‘spaces’ nucleosomes on an in vitro  DNA and the 
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activity remains conserved for their evolutionarily distant human homologs. Interestingly, the 
ACF/CHRAC complex further exclusively exhibit remodeling activities in presence of linker histone H1, 
(57, 85, 152, 153).  ISWI can slide the nucleosome by itself however addition of ACF1 modulates sliding 
in a directional manner by moving the nucleosomes from the end of the DNA to the center, while further 
addition of Chrac14/Chrac16 increases the efficiency of such remodeling reactions (86, 154–156). 
C-terminal region of ACF1 contains PHD and Bromodomains while, N-terminal appears to be largely 
unstructured (Figure 2.6). The PHD fingers interact with all four core histones with equal affinity 
suggesting that the interaction involves central histone-fold regions (156). While, N-terminal part of 
ACF1 interacts with Chrac14-16 heterodimer (155). This interaction further enhances remodeling activity 
of the CHRAC by several folds. It is interesting to note that the C-terminal part of Chrac16 is 
unstructured and negatively affects DNA binding of the CHRAC, but positively regulates the remodeling 
activity. Hence, upon its deletion, CHRAC exhibits strong DNA binding but less remodeling – an effect 
analogous to DNA chaperon HMGB1-mediated inhibition of nucleosomes sliding. The N-terminus WAC 
domain further exhibit strong DNA binding ability which remains independent of DNA sequence (154).  
ACF1 functions as a linker length sensor during the remodeling reactions. Changes in nucleosome 
positions on the underlying DNA in an in vitro remodeling reaction can be monitored quantitatively by 
FRET measurements. Employing this strategy, it was demonstrated that human ACF complex samples 
linker lengths and preferentially remodels longer linker lengths to equalize it on both sides of the 
nucleosomes (91). As a result, ACF dependent remodeling can generate 50-60 bp long linkers. This line 
of work was further followed up to identify contributions of different domains of ACF1 in linker-sensing 
mechanism of ACF. As a final picture, the intricate ACF dependent remodeling involves H4-tails on 
histone, Auto-N regulatory motif on ISWI and WAC domain of ACF1 (77, 157). Auto-N motif of ISWI 
negatively regulates remodeling reaction and mutations in this motif also abrogate linker length sensing of 
ACF. In a nutshell, the WAC domain of ACF1 engages with long linker DNA, which subsequently leads 
to Auto-N –H4 tail binding and alleviation of Auto-N mediated inhibition of remodeling, leading to 
productive nucleosome spacing activity by hACF. When the linker lengths are short, the WAC domain 
folds back onto the complex and engage with H4 tail, leaving Auto-N region to inhibit remodeling. Such 
intricate balance only allows for a productive remodeling of the nucleosomal substrate. 
Physiological context of ISWI remodeling factors changes from transcriptional activation in case of 
NURF to repressor in case of CHRAC/ACF, RSF, NoRC/ToRC. The activities of the transcriptional 
repressive factors largely depend on nucleosome spacing/phasing. For instance, Isw2 in yeast pushes 
nucleosomes towards the NFRs. Absence of such activity leads to generation of 3’ NFR in yeast genes 
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leading to transcription in the antisense direction (158). Similarly, NoRC complex brings about silencing 
and heterochromatin formation along the rDNA loci by actively spacing nucleosomes (145, 146).  
In vivo functions of the largest subunit of CHRAC/ACF were studied by creating knockouts in fly and 
mouse. Fly mutant allele for ACF1 leads to overall sloppy chromatin organization in the mutant 
background with associated decrease in the spacing-based NRLs. The flies exhibit partial lethality without 
any severe effects on the surviving progeny (159). Interestingly, moderately variegated expression of 
reporter constructs were also observed in adult fly eyes upon the deletion of ACF1. This observation 
suggested that ACF1 affects chromatin organization at all stages of development, and hence must be 
ubiquitous. However, subsequent analyses clarified that ACF1 is strongly localized in the undifferentiated 
cells (160). Immunofluorescence studies reveal that ACF1 is ubiquitously expressed in the early stages of 
embryonic development. But as the embryos start to differentiate, the expression is strongly observed in 
neuroblasts and primordial germ cells. The finding suggests that alterations in chromatin structure in later 
developmental stage pan out from the earlier stages and remain uncompensated. The effects of ACF1 are 
further seen on replication process, where the rapidly dividing cells that lack ACF1 show faster 
progression through the S-phase (159). Unscheduled expression of ACF1 is potentially harmful for the 
cells, as they show deranged chromatin and altered replication timings. The derangement of chromatin 
structure was further identified in mouse knockout for ACF1 homolog, BAZ1A (161). The deletion of 
BAZ1A specifically affects male testes leading to excessive derangement of chromatin structure and 
transcriptional misregulation. Curiously, the testes specific gene expression program remained unaffected 
upon BAZ1A deletion suggesting that the transcriptional changes arise due to underlying chromatin 
structure, and perhaps non-specifically. To summarize, ACF1 affects chromatin structure in vivo, which 
may have diverse underpinnings.  
Contributions of ACF1 towards replication and repair have been further evaluated. ACF containing 
complexes, hACF, are targeted to the heterochromatin loci during replication to facilitate the passage of 
replication foci (146). Members of replication licensing complex interact with SNF2H and recruit the 
complexes at the sites of replication origin (162, 163). Though SNF2H takes part in the replication, its 
effects are subtle and surface during the stress-conditions. Strikingly, ACF1 containing complexes 
identified in xenopus are not important for replication through euchromatic region of the genome (164). 
These observations corroborate with ACF1 deficiency phenotype where S-phase appeared to be shortened 
in rapidly dividing larval neuroblasts (159). In summary, ACF1 seems to affect heterochromatic 
replication process. 
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ACF1 also plays a role in the DNA repair. Deletion of ACF1 in human cell-line suggests increased 
susceptibility of the cells to DNA-damaging cues. These effects are apparently orchestrated by 
compromising the checkpoint signals that otherwise should monitor DNA breaks before letting the cells 
enter into M phase of cell cycle (165). ACF1 seems to interact with DNA double strand break (DSB) 
proteins and likely to get targeted to the lesion sites. For instance, interaction of ACF1 with Ku70/80 
heterodimer is reported and also its recruitment to the NHEJ/ HJ repair foci is observed in mammalian 
cells (166–168). Importantly, DSB analyses in the heterochromatic regions in human cells find that ACF 
plays an opposing role to Chd3.1 by widening the nucleosome spacing which Chd3.1 sets after replication  
(169). This remodeling action further facilitates DNA access and repair.  
Taken together, non-catalytic subunit ACF1 plays a role in chromatin organization and influences 
processes such as transcription, replication and repair. 
2.11 Mapping genomic targets of remodeling factors 
Molecular compositions of remodeling complexes determine their functional outcomes in vivo. To further 
understand and corroborate the functions, attempts have been made to map key subunits of the 
remodeling complexes. Chromatin Immunoprecipitation (ChIP) method is routinely used to enrich the 
protein of interest and identify its genomic target sites by quantitative-PCR (qPCR), hybridization or by 
deep sequencing of the factor bound DNA.  
Remodelers can be actively targeted to their sites of action by sequence specific factors. Isw2 or Swi/Snf2 
ATPases in yeast are observed to get recruited to the target loci with the help sequence specific factors. 
For instance, meiotic gene repressor Ume6 recruits Isw2 to the target gene bodies along with histone 
deacetylases to bring about gene repression repression (170). Likewise, interactions of Swi/Snf2 with 
Hir1/ Hir2 repressors target the remodeler to the histone gene loci HTA1-HTB1 (66, 171) leading to 
repression. Interestingly, human Brg1 interacts with Rb2, leading to functional targeting of the 
heterodimer by its interactions with E2F transcriptional activator. However, such targeting at the cell-
cycle related genes bring repression and cell cycle arrest (66, 171). Factor dependent recruitment of 
remodelers does not always bring about repression. In case of Swi/Snf remodelers, their interactions with 
RNA-polymerase II and recruitment on the transcribing genes seem to enhance transcription by 
destabilizing the nucleosomes. Variation in the theme is also observed for yeast Swr1 remodeler 
recruitment. It was observed that Swr1 can ‘sense’ nucleosome-free DNA at the promoter regions of the 
genes and is recruited specifically (172).  Such recruitment serves to deposit H2A.Z histone variant in an 
ATP-dependent manner, suggesting that sequence-features can also play a role in recruitment of 
remodelers.  
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Localization of remodeling factors to the genomic sites has been observed in replication and repair 
processes. Both microscopic and ChIP studies suggest that hACF1 and SNF2H (human homolog of 
ISWI) are targeted to the repair sites (166, 167), presumably by their interactions with repair pathway 
proteins or by the availability of the nucleosome substrates. Likewise, recruitment of Ino80 and Swr1 
complexes to the repair sites are observed in yeast where these complexes function in histone-exchange 
reactions, essentially replacing the H2A variant with H2A.Z (173). Roles of remodeling factors in repair 
process and their recruitment to the DSB sites are further discussed in details in (174–176). On the similar 
grounds, replication process seems to benefit from recruitment of the remodelers to the sites of catalysis. 
Pre-initiation complexes are formed during origin defining step of replication. It is been observed that 
SNF2H (ISWI homolog), interacts with the members of pre-initiation complex, likely creating access to 
the underlying DNA (162, 163). Replication through heretochromatin further needs recruitment of ISWI 
remodeling complexes. Concomitantly, human ACF1 and WSTF complexes are accumulated in these 
silent-domains (146, 177). These examples suggest targeting of the remodelers in the context of 
transcription, replication or repair where the recruiters of remodelers are largely speculated.  
Attempts to identify genome-wide targets of remodelers became possible with hybridization and 
sequencing technologies. Earlier attempts to map spacing remodeler Isw2 suggested that catalytically 
inactive mutant is required for identifying its target-specific enrichment at specific genomic loci. 
Interestingly, further monitoring of the selected candidate loci in ChIP-qPCR assays revealed that Isw2 
bind to the genomic target sites in two distinct modes. Target-specific binding involves contributions 
from the sequence-specific factors and H4 tails of the nucleosomes, by contrast general binding is 
independent of such cues (178–181). Microscopy based measurements of factor retention of the genomic 
sites (e.g. fluorescence correlation spectroscopy) further substantiated these findings. A large fraction (~ 
97%) of human SNF2H seems to remain freely-floating in nuclei, while a minor fraction actively engages 
the nucleosomes. Replication or repair processes increase the genome-bound fraction of the remodeler 
presumably due to the fact that more remodeling substrate nucleosomes become available (167, 182, 
183). These observations suggest that remodelers constantly sample the chromatin for its cognate 
substrates and bind the genome only transiently.  
Several genome-wide localization maps of remodeling factors have been described. An exemplary case of 
mapping ISWI and its orthologues suggest their localization close to the 5’end of the gene. Yeast Isw2 
and Drosophila ISWI are found to preferentially target +1 nucleosome closer to the TSS irrespective of 
the chromatin shearing methods. However, Isw1 orthologue seems to be targeted over gene-bodies like 
Chd1 remodeler  (184–186). This localization pattern potentially substantiates the effects observed on the 
nucleosome arrangement in ISWI remodeler mutants. On a broader sense, mapping of the remodeling 
Page | 32 
 
family ATPases suggested conflicting outcomes in non-yeast species. In hybridization based mapping, 
genome-wide targets of 4 ATPases were observed to be distinct. The inferred localization of the factors 
suggested that except for ISWI, other family ATPases such as NuRD, BAP, Ino80 promote formation of 
nucleosomes at the nucleosome-disfavoring sites. And moreover, subunits of the remodeling complexes 
play an important role in their targeting. However, sequencing based mapping in mouse cells suggested 
strikingly overlapping genomic binding sites of the Brg1, Chd4 and SNF2H remodelers along the 
accessible sites. The observation suggests high level of co-occupancy and shared activity in creating 
access to the underlying DNA (133, 187). It is possible that the differences may arise due to experimental 
methodologies, cell-type differences, underlying biological cues or they are simply the artifacts.  
Exonuclease based additional quality control step in the ChIP protocol potentially enhances signal and 
reduces noise in the ChIP-sequencing profiles. Such ChIP-exo method has been subsequently used for 
mapping targets of remodeling factors in yeast (188, 189). Comprehensive mapping for large number of 
remodeling ATPases and their subunits in yeast suggests complex-specific binding events along the gene 
body at a basepair resolution.  For example, Isw1a, Isw2 and Arp5 (Ino80 family) bind +1 nucleosome 
while Isw2b (loc4 subunit) binds +2 nucleosomes or SWI/SNF binds at the NFR or Ino80 binds across the 
gene body. Considering an exemplary case of Ino80 family, subsequent mapping of 20 different subunits 
of Ino80/Swr1 complex suggested that they preferentially are localized along the +1 nucleosomes, where 
their binding potentially affect H2A.Z deposition (172, 190). Overall, these observations suggest that in 
yeast, nucleosome positioning data can be interpreted to a certain extent by studying genome-wide 
organization of the remodelers.  
Taken together, the genome-wide maps of remodelers are potentially useful in understanding their 
functional underpinnings.   
2.12 Rationale behind the current work and aims 
ACF1 is a nucleosome spacing factor that is strongly enriched in undifferentiated cells during early fly 
development. Undifferentiated cells tend to have large proportions of open chromatin structures. Deletion 
of ACF1 leads to generation of defects in overall chromatin organization that remains uncompensated 
during later stages of development. It is likely that such altered chromatin structures potentially affect 
transcription, replication or repair processes (159, 161, 176, 191).   
Studies in yeast suggest that alterations on nucleosome phasing along the gene bodies are orchestrated by 
redundant activities of remodelers. However, there are examples in the multicellular eukaryotes where 
nucleosome positions along the gene bodies are definitively affected in absence of individual SWI/SNF 
remodelers (127, 192, 193). Besides the phasing along TSS, several genomic features can potentially 
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suffer by spacing and phasing activities of the remodelers. Incidentally, ACF1 deletion already shows 
sloppy chromatin structure in the context of an organism, when fly or mouse tissues are analyzed (159, 
161). ISWI type remodelers are abundant during the early embryogenesis. Being a major subunit of two 
prominent ISWI complexes, the study aims to understand how ACF1 influences nucleosome positions 
and their organization in developing embryos.   
Transcriptional underpinning of ISWI can potentially change depending on the tissue being analyzed. For 
instance, in S2 cells deletion of ISWI has no sizable effect but in embryos the deletion leads to lethality 
(69, 194). Contributions of ACF1 towards transcription are not systematically analyzed. Besides the 
earlier study in mouse testes, effects of ACF1 on non poly-A transcripts such as non-coding RNA are not 
analyzed. Defects in chromatin organization often lead to activation of transposable elements that run a 
risk of DNA DSB and genome instability. Thus this study tries to understand whether ACF1 influences 
developmental transcription program. 
In vivo sites of functions for a protein can often be inferred by their genomewide mapping. ACF1 forms 
stable complex with ISWI as a part of CHRAC/ACF. It is not clear how ACF1 contributes to the genomic 
target sites of ISWI and what are the functional underpinnings of these subsets ACF1 bound sites. So-far, 
ISWI profiles in Drosophila embryos are unavailable and moreover the reported profiles show poor 
agreement with one another, perhaps due to differences in analyzed tissues, antibodies, or protocols. To 
get a comprehensive understanding of ACF1’s function, the study aims to identify genomic target sites 
of ACF1 during embryonic development.  
Protein interaction studies using SILAC method previously identified several potential interactions for 
ISWI in Drosophila cells (194). In the screen, ACF1 and known subunits of CHRAC are pulled down as 
stoichiometric hits, while rest of the interactions appears to be sub-stoichiometric or transient. The 
identified interactions are insufficient to understand potential roles of ACF1 specific complexes in 
developing embryos. Furthermore, complex signaling, differences in cell types and dynamic transcription 
program of embryos demand an elaborate protein interaction mapping for ACF1 in the context of 
CHRAC/ACF. Hence, the study aims to identify potential interaction partners for ACF1 from 
embryonic tissue.  
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3. Materials and Methods 
3.1 General methods 
Routine lab methods, reagents and their providers, primers, plasmids and newly generated fly lines during 
the study are detailed in Appendix 1. Most relevant methods are outlined in this section.  
3.1.1 Embryo collection and fixation 
0-12 and 2-8 hr old embryos were used for chromatin immunoprecipitation (ChIP) (genotypes: Oregon-R 
WT, acf1
7
) and nucleosome positioning assays (genotypes: w1118, yw or acf1
7





(143) were generated by imprecise P-element excisions. Unstaged embryos (1 g) 
were dechorinated in 120 ml 1:5 diluted sodium hypochloride (VWR, Cat.no. 301696S) for 3 min. The 
embryos were thoroughly washed and fixed in the fixing solution for 15 min at 16-18°C on a rotating 
wheel. Fixation was quenched by adding 125 mM glycine. The embryos were subsequently washed with 
PBS (including 0.01% Triton-X100) for 10 min and stored at -80°C until further use.   
3.1.2 Embryo nuclei isolation 
For nuclei isolation, embryos were slowly thawed and dounced using a glass homogenizer (Schubert, 
Cat.no. 9164693) with 20 strokes each of the A and B pestles in ice-cold NX-I buffer. The lysate was 
filtered through Miracloth and nuclei were pelleted at 3,500 rpm, 10 min at 4°C. 
3.1.3 Fly ovary preparation  
Prior to ovary collection, the flies were transferred to food vials containing yeast paste. This feeding 
enlarges the ovary size and induces flies to produce large numbers of eggs. 4-8 day old flies were 
transferred to ice for 10 -15 min. The ovarian tissue was prepared by submerging the flies in PBS in a 
glass jar with the help of tweezers. Briefly, the abdominal segment was tweezed using forceps to pull out 
the ovarian tissue, largest abdominal structure. The leftover of the flies were euthanized in 70% ethanol. 
The ovaries so obtained were cleaned of lipids in a fresh glass-jar containing PBS. 
3.2 Recombinant DNA technology methods 
3.2.1 Transgenic fly line generation using remcombineering method 
Transgenic flies were generated in collaboration with Pavel Tomancak’s lab at MPI-CBG, Dresden. 
Previously outlined bacterial liquid culture method was used to manipulate genomic fosmid clones 
generated by (195). Briefly, clone pFlyFos021945 and pFlyFos016131 were used for tagging ACF1 and 
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Chrac16 genes respectively. The fosmids carry 10-15 kb long endogenous DNA around the genes of 
interests enhancing the chances that regulatory sequences are contained within the clones. 
Briefly, E. coli culture containing the fosmid clone was transformed with pRedFlp4 carrying an L-
rhamnose inducible recA operon rendering it competent for homologous recombination. Combinatorial 
tag cassettes 2X-TY1-EGFP-3XFLAG and 2X-TY1-mCherry-3X-FLAG were used to tag ACF1 and 
Chrac16 at both and N-terminal ends respectively. PCR product carrying 50 bp homology arms 
surrounding the tag cassette and FRT flanked resistance gene was electroporated into the cells. Successful 
homologous recombination was scored by selection markers. In the last step, the kanamycin selection 
marker from the tag cassette was flipped out by inducing flippase operon on pRedFlp4 plasmid using 
anhydrotetracyclin (Figure 3.1). Fosmids were verified by restriction digestion and sequencing the 
junctions of tagged genes. Subsequently, microinjections of the plasmids into blastoderm embryos were 
performed by Genetic Services Inc., Boston, MA. Landing lines carrying attp40 (yw;attP40, at locus 
25C7, chr2L) and attP2 (yw;attp2, at 68A4 ,chr3R) were used for site specific integration of the ACF1 and 
Chracr16 fosmid clones respectively carrying attB sites.  
 
The F0 mosaic generation was crossed with w1118
 
and progeny flies in F1 generation onwards were 
screened for dsRed phenotype (red eye fluorescence). Homozygous stocks were established by tracking 
eye fluorescence and balanced stocks were established using appropriate chromosome balancers. The 
acf1
7
 deficiency was complemented by both N- and C- terminal tagged version of ACF1. 
Recombineering method was further applied to generate deletions of ACF1 and Chrac16 genes from the 
fosmid clones where the respective genes were replaced by the EGFP and mCherry tag cassettes 
Figure 3.1: Outline of the recombineering 
protocol. The steps are discussed in the text. 
Figure adopted from (195).   
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(Appendix A1.4). This was achieved by spacing the homology primers to the either ends of the genes. 
Such fosmid clones would serve as control for the side-effects of the manipulations.  
In principle, designing the homology primer positions can enable a variety of gene tagging possibilities. 
For instance, Gal4-DNA binding domain (Gal4DBD) was used to generate a new tag cassette (2X-TY1-
Gal4DBD-3X-FLAG) and to tag ACF1 at both ends. Furthermore, domains of ACF1 were replaced by 
the 2X-TY1-EGFP-3X-FLAG tags to generate ∆N-terminal (aa 1056-1476) and ∆C-terminal (aa 1-1055) 
ACF1 fosmid clones where the fragments lacking domains if ACF1 were tagged at the N- and C-terminal 
respectively.  
3.2.2 CRISPR-mediated ACF1 knockout fly generation 
Predicted guide RNAs (sgRNA) targeting sequences for 5’ and 3’ end of ACF1 were obtained from the 
Zhang lab CRISPR resource (total 8 for 5’ end and 4 for 3’ end). The 20 bp targeting sequences were 
inserted into the framework of primer-1 [5’-TAATACGACTCACTATAG-(targeting sequence)- 
GTTTTAGAGCTAGAAATAGC-3’] in 5’ to 3’ direction.  Using scaffold primer [5’-AAAAGCACCGA 
CTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCT
AAAAC-3’] and universal reverse primer [5’-AAAAGCACCGACTCGGTGCC-3’], a final DNA was 
assembled for in vitro transcription in a PCR reaction [2 µl -10 mM dNTPs, 3 µl – 50 mM MgCl2, 2 µl -
10 µM primer 1, 1 µl - 1 µM scaffold primer, 2 µl -10 µM universal reverse primer, 1 µl Pfu polymerase, 
NEB, in 100 µl reaction volume. Cycling: 95°C -2 min, 95°C -20 sec, 50°C -20 sec, 68°C -20 sec; then 
(95°C -20 sec, 55°C -20 sec, 68°C -20 sec, 31 cycles), 68°C -2 min]. The PCR product was purified using 
GeneElute PCR cleanup kit (Sigma). In vitro transcription reaction was performed using T7 
MEGAshortscript kit (Ambion) and purified RNA was assessed on agarose gel.  
 
Efficiency of the RNA mediated cleavage was assessed by transfecting 1 µg sgRNA to 7 X 10
5
 /ml SL2 
cells (Hgr4 clone from Klaus Fostermann lab that stably expresses Cas9) in 2 ml final volume (24 well 
plate). The cells were harvested after 48 hr and gDNA was prepared. PCR reaction was performed to 
amplify ~600 bp region along the selected guide RNA sequence (Figure 3.2). The PCR product was 
melted subsequently at 95°C for 5 min and then cooled slowly with the ramp rate of 0.1°C/sec. The 
Figure 3.2. Cloning method the 
homology arm in CRISPR  mediated 
knockout. See text for details. 
gDNA represents genomic DNA. 
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product was cleaved by T7 endonuclease (0.5µ T7 endonuclease (M0302S, NEB) in 100µl total reaction 
volume) at 37°C for 30 min. The product was quickly loaded on 1% agarose gel and separated to assess 
for possible breaks manifested by sgRNA/Cas9. sgRNA samples showing expected band patterns were 
selected for fly injection.  
Left (1.3 kb upstream) and right (1.5 kb downstream) arm sequences to the guide RNA sequence sites for 
ACF1 were PCR amplified from gDNA using high fidelity PCR reaction, excluding sgRNA sites (Figure 
3.2). The homology arms and 3XP3-dsRed fly selection cassette (obtained from pCL1 plasmid clone, 
Schnorrer lab, MPI-Biochemistry, Martinsried, Germany) were assembled together in pJet1.1 vector 
using golden gate cloning strategy (196). The final clone was validated using sequencing and restriction 
digestion analysis.  
Purified plasmid and sgRNA for 5’ and 3’ end of ACF1 were co-injected in blastoderm stage embryos of 
yw, Cas9, lig4169 genotype (in collaboration with Schnorrer lab. Cas9 endonuclease expression is driven 
under vasa promoter). The F0 mosaic males were crossed with w1118 females and subsequent F1 
transformants were screened for red fluorescence eye-phenotype. Lateron, the flies were backcrossed in 
yw strain (stock from the Becker lab) for 4 subsequent generations and rendered homozygous. Deletion of 
the locus was screened by PCR and loss of protein was assessed on WB. Final deletion of ACF1 
encompasses ~4716 base pairs from 562
th
 base onwards removing most of the gene except its 5’ and 3’ 
UTRs. 
3.3 Biochemistry and analytical methods 
3.3.1 High salt embryo nuclear extract preparation (TRAX method) 
Embryos were collected on agar juice plates from small/large population cages. Staging was done if 
needed by incubating the embryos on the plates at 25°C for specified time. Embryos were subsequently 
washed off the apple juice agar plates under tap water and collected using 3 sieves system (0.71, 0.355, 
0.125 mm diameters). Embryos were dechorinated in 120 ml 1:5 diluted sodium hypochloride (VWR, 
Cat.no. 301696S) for 3 min and washed under tap water to remove traces of bleach followed by drying 
them using paper towels. All subsequent steps of extract preparation were carried out at 4°C in the cold 
room.  
Embryos were weighed and resuspended in Buffer NX-1 (2 ml/g embryos). The suspension was 
homogenized in Yamato LH-21 homogenizer 1,000 rpm in 5 passes. The lysate was filtered through a 
single layer of Miracloth. Final lysate volume was adjusted to 5 ml/g embryos by Buffer NX-1. Nuclei 
were pelleted using precooled GSA rotor at 8,000 rpm for 15 min. Supernatant was decanted, lipids from 
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the tube walls were wiped out and the brown colored pellet was resuspended in Buffer NX-2 (1 ml/g of 
starting embryos).  
The nuclei were further dounced using a glass homogenizer (Schubert, Cat.no. 9164693) with 20 strokes 
each of the A and B pestles. The lysate was transferred to 4 to 6 45Ti tubes and 1/10
th
 volume of 4 M, 
(NH4)2SO4, pH 7.9 (RT) was added and mixed by rapid inversions. The mix was spun in precooled Ti45 
rotor (Beckman Coulter) at 35,000 rpm for 2 hr in precooled centrifuge. The colorless supernatant was 
removed and for each ml of the solution 0.3 g of finely ground (NH4)2SO4 was added slowly under 
stirring condition. The mix was spun in pre-cooled SS34 rotor (Sorvall) at 15.000 rpm for 20 min. The 
pellet was collected and resuspended in Buffer NX-3 (0.2 ml/g of starting embryos) by douncing. The 
extract so obtained was dialyzed for 4 hr against 2 L of Buffer NX-3. The extract was subsequently spun 
at 10,000 rpm in SS34 for 5 min and protein amount was estimated using Bradford assay on Nanodrop 
(Thermo Scientific, Inc.). Aliquots were frozen down at -80°C.  
3.3.2 Low salt embryo nuclear extract preparation (KCl extraction method) 
Embryos were collected and nuclei were prepared as described in Section 3.3.1. The nuclei were re-
suspended in buffer NX-2, gently dounced and subsequently pelleted at 8,000 rpm, 10 min at 4°C in a 
pre-weighted GSA rotor tube. The nuclei were resuspended in NX-4 buffer (0.5 ml/g nuclei) with gentle 
douncing. The suspension was allowed to incubate for 60 min at 4°C on ice. Next, the mix was spun at 
24,000 rpm at 4°C in SW28 rotors (Beckman Coulter). A clear yellow-tinted liquid layer (2
nd
 from top) 
was carefully collected. The nuclear extract was aliquoted and stored at -80°C.    
3.3.3 Low salt embryo nuclear extract preparation (ActiveMotif method) 
Embryo collection and nuclei isolation was performed as described in Section 3.3.1. Roughly 80 mg 
nuclei were digested in complete-digestion buffer with addition of enzymatic cocktail as described in the 
manufacturer’s protocol (Active Motif, Cat.no. 54001). The protein concentration of the extract was 
measured by Bradford assay and the aliquots were stored at -80°C. 
3.3.4 Extract preparation from small amounts of embryos 
Protocol outlined in Section 3.3.1 was used for 1-10 g of embryos by downscaling the volumes. For < 0.5 
g embryos, the nuclei were prepared by shearing dechorionated embryos in 1.7 ml Eppendorf tubes with 
an electric pestle (Kontes glass company, Cat.749540). Nuclei were subsequently collected by spinning 
down the tube at 3,000 rpm, 5 min, and 4°C, transferred to 1 X Laemmlie buffer and boiled at 95°C for 5 
min. Lateron, this crude extract was used in WB analysis.    
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3.3.5 Ovary extract preparation and Western Blot analysis 
For WB, 5-10 fly ovaries were collected in PBS and quickly transferred to 1 X Laemmli buffer. The 
tissue was homogenized with an electric homogenizer and heated at 95°C for 5 min. The crude extract 
from the same numbers of ovaries from different genotypes was used for WB and quantitative WB.  
3.3.6 Immunoprecipitation (IP) 
Protein extract was spun at 12,000 rpm for 10 min at 4°C. Following IP buffers were used: NX-3 (without 
Glycerol), RIPA and 1X PBS. 
3.3.6.1 GFP- and RFP-trap IP 
350 µl of extract was incubated with 35 µl GFP or RFP- agarose beads in 1 ml reaction using appropriate 
IP buffer for 1 hr at 4°C on rotating wheel. The beads were subsequently washed 3 times in 1 ml of IP 
buffer for 5 min each and boiled in 1X Laemmli buffer at 85°C for 5 min. The reactions were frozen 
down at -20°C until further use.  
3.3.6.2 IPs using antibodies 
Protein-G or Protein-A:G (1:1) bead-mix were presorbed with appropriate antibodies in the IP buffer. The 
beads were washed once in IP buffer for 10 min and collected by spinning down at 2,000 rpm, 1 min at 
4°C. 200 µl extract was incubated with presorbed beads in 1 ml final volume for 1 hr at 4°C on rotating 
wheel. Beads were washed and processed as described in Section 3.6.1.1. 
3.3.6.3 IPs using bridging antibodies 
200 µl extract was incubated with appropriate amount of antibodies for 1 hr at 4°C on a rotating wheel. At 
the same time, beads were coupled with bridging antibody and washed once after 1 hr incubation at 4°C 
with IP buffer and used for immunoprecipitation. Washing steps and final processing was performed as 
described in Section 3.6.1.1. 
3.3.7 Mass spectrometric analysis 
Analytical samples were run on two SDS-PAGE gels. One gel was used for WB validations and second – 
analytical gel was used for protein detection using mass spectrometry. The analytical gel was stained 
either using Colloidal blue (Invitrogen) or by silver staining method. Subsequently, the gel was cut into 
equal sized bands and subjected to in-gel digestion. Briefly, the bands were washed in deionized water 
twice, followed by 20 mM ammonium bicarbonate solution for pH adjustment. Residual Coomassie dye 
was removed from the bands by incubating them with 10 mM ammonium bicarbonate/50% (v/v) 
acetonitrile (ACN) for 30 minutes at 37°C while shaking at 600 rpm, following 3 washes of 20 mM 
ammonium bicarbonate. The bands were dehydrate by successive treatment of ACN and subsequently 
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rehydrated to reduce bisulfite bonds between cysteines by 10 mM DTT in 20 mM ammonium bicarbonate 
for 1 hr at RT. Cystein alkylation was carried out by adding 55 mM iodoacetamide (IAA) in 20 mM 
ammonium bicarbonate for 30 minutes at RT on dark. The gel bands were washed and dehydrated as 
before. Rehydration was carried out in presence of 25 ng/μL trypsin (Promega) in 20 mM ammonium 
bicarbonate for 30 min. Additional 20 mM ammonium bicarbonate was added to cover the gel pieces and 
digestion was performed over night at 37°C, shaking at 600 rpm. The solution was aspirated and acidified 
by trifluoroacetic acid (TFA) to an end-concentration of 0.1% (v/v) [Protocol from ZfP, Munich and Dr. 
Teresa Barth. The volumes are approximated based on gel-band size in the range of 150–175 µl, while the 
digestion was carried out in 50 µl volume]. 
3.4 Molecular biology methods 
3.4.1 Nuclei shearing and chromatin immunoprecipitation 
Embryos were collected and nuclei were prepared as described in 3.1.1 and 3.1.2 
The nuclei pellet was washed in NX-I buffer. Next, they were resuspended in RIPA and washed 3 times. 
Nuclei were then counted and frozen at -80°C in aliquots of ~10
9
 nuclei/ml. For shearing and ChIP, 
thawed nuclei were adjusted to ~2x10
8
/ml by dilution in RIPA and sheared with a Covaris S220 system 
(Covaris Inc. MA, USA) at 110 Watts, 20% duty factor and 200 cycles per burst for 25 min. Chromatin 
was pre-cleared using protein a A+G bead (1:1) mix for 1 hr at 4°C. Immunoprecipitations were set up 
overnight at 4°C with 200 µl chromatin and 4 µl of the respective antibody in total volume of 500 µl. 
RIPA-equilibrated protein A+G (1:1) mix was then added to precipitate the immune-complexes for 3 hr at 
4°C. For the rat monoclonal antibody (3F1), the chromatin immunoprecipitation was performed using 
presorbed protein G beads, with an excess of antibody for 3 hr at 4°C. Beads were washed subsequently 5 
times in 1 ml RIPA buffer. Residual RNA was digested by RNase-A (10 µg/100 µl, Sigma, Cat. No. 
R4875) at 37°C for 20 min. Subsequent protein digestion (using 25 µg/100 µl, Proteinase K, Genaxxon, 
Cat.no. M3036.0100) and reversal of crosslinking were performed simultaneously at 68°C for 2 hr. DNA 
was purified using GenElute™ PCR Clean-Up Kit (Sigma, Cat.no NA1020).  
3.4.2 Nucleosome immunoprecipitation for in vivo nucleosome position mapping  
2-8 hr old D. melanogaster embryos were used for mapping nucleosomes in the WT (yw and w1118) and 
mutant (acf1
7
) background in triplicates. This developmental time point is characterized by onset of 
zygotic transcription and has ubiquitous expression of ACF1 (160). Briefly, the embryos were collected 
after 6 hr of egg lying and incubated at 25°C for 2 hr.  
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Embryos were fixed and nuclei were prepared as described in 3.1.1 and 3.1.2. Nuclei were weighed in an 
Eppendorf tube and stored at -80°C after snap-freezing in liquid nitrogen.    
The nuclei were slowly thawed and resuspended in the MNase digestion buffer. 80 mg of nuclei were 
digested with 12.8 units (7.5 Becker units, for internal use) of MNase (Sigma, Cat.no N5386) for 15 min, 
37°C while shaking at 500 rpm. The reaction was stopped by adding 20 µl of 0.5 M EDTA, pH 8.0 and 
the tubes were quickly transferred to ice for 1 min. Nuclei were spun at 12,500 rpm, 10 min at 4°C. The 
pellet did not contain enough DNA and hence was discarded, while the supernatants were collected and 
the buffer composition was adjusted to RIPA.  
Chromatin immunoprecipitation (ChIP) was performed by first pre-clearing the chromatin sample using a 
protein A+G (1:1) bead mix for 1 hr at 4°C. 150 µl of chromatin was used for ChIP reaction in 500 µl 
total volume using 3.5 µl rabbit polyclonal anti-H3 antibody (Abcam, Cat.no ab1791). DNA was purified 
subsequently as described in Section 3.4.1.  
3.4.3 Sequencing library preparation and deep sequencing 
Total DNA was quantified using Qubit® dsDNA HS Assay Kit (Life Technologies, Cat.no.Q32851) and 
sequencing libraries were prepared using the MicroPlex Library Preparation kit (Diagenode, Cat. No. 
C05010011) starting with 2 ng DNA whenever possible. PCR amplification was monitored by 
quantifying amplified libraries (maximum 19 cycles). The libraries were sequenced on a HighSeq 1500 
(Illumina) instrument to yield roughly 15-25 Million 50 bp single end reads per sample (for ChIP-
sequencing) and 35 – 110 Million paired end reads per sample (for Nucleosome position sequencing).  
3.4.4 RNA sequencing 
2-8 hr old embryos (50-100 mg, Genotypes: yw, w1118, acf1
7
) were used for transcriptome profiling. The 
tissue was freshly collected in Trizol (Qiazol, Qiagen, Cat. No. 79306) and frozen down at -80°C until 
further use.  
The tissue was homogenized using electric pestle (Kontes glass company, Cat.no. 749540) in a low 
binding Eppendorf tube. For deep sequencing, total RNA was extracted using miRNeasy Mini kit 
(Qiagen, Cat.no. 217004) following the manufacturer’s guidelines. On-column DNase digestion was 
performed using RNase-free DNase (Qiagen, Cat.no.79254) to get rid of contaminating genomic DNA. 
Later, RNA was quantified with Nanodrop (Thermo Scientific) and aliquots were frozen at -80°C.  
The rRNA depletion method (RiboZero) was used for sequencing all non-ribosomal transcripts. Briefly, 
RNA integrity was analyzed on Bioanalyzer-2100 before and after depleting rRNA from the sample using 
rRNA depletion kit (Biozyme, Cat.no. MRZG12324). Subsequently, RNA was fragmented (NEB, 
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Cat.no.E6150S) to 50-200 bp and first strand of cDNA was synthesized (NEB, Cat.no. E7525S) as 
described.  
Directional second strand synthesis protocol (NEB, Cat.no.E7550S) without adding Actinomycin-D was 
employed. Hence, spurious or antisense transcription cannot be estimated from current data. The so-
obtained DNA fragments were end-repaired (NEB, Cat.no.E7442S) and ligated (NEB, Cat.no.E7445S) to 
respective adapters. The DNA fragments were cleaned up using recommended Agencourt-AMPure XP 
amounts (Beckmann Coulter, Cat.no. A63880) to select >200 bp fragments. The adapter ligated cDNA 
was amplified using high fidelity PCR (NEB, Cat.no. M0541S) for 6-10 cycles. The library was 
subsequently purified using AMPure beads (1:1 ratio) and analyzed on Bioanalyzer-2100 before 
sequencing.  
The sequencing libraries were prepared and sequenced as described in Section 3.4.3. 
3.5 Microscopy methods 
3.5.1 Immunofluorescence analysis of fly embryos 
The staged and unstaged embryos were collected on agar plates, washed thoroughly under tap water and 
dechorionated using 20% bleach solution for 3 min. The bleach was removed by washing the embryos 
under tap water.  
For slow fixation, the embryos were subsequently transferred to a glass- jar containing 2 ml n-Heptane 
(160, 197). Equal volume of fixing solution (PBS + 3.7% formaldehyde) was added the tube was shaken 
vigorously for 30 sec and then kept at RT for 20 min. Fixing solution was removed and 2 volumes of 
methanol were added to the jar for devitellinising the embryos. The jar was shaken for 15 sec and the 
embryos that sank down at the bottom were collected using a cut-pipette tip. The embryos were washed 
and stored in methanol overnight at 4°C.  
For heat fixation, the embryos were quickly transferred to boiling PBS and immediately transferred to ice-
cold PBS. The settled embryos were devitellinised using methanol and stored overnight in methanol at 
4°C. For live imaging, the embryos were handpicked and stationed on a sticky tape (197) mounted on a 
glass slide.  The chorion and vitelline membranes were carefully removed using forceps and the embryos 
were transferred to the blocking solution.   
The embryos were rehydrated using successive incubations in 20%, 30%, 80% and 100% PBS (in 
methanol) for 5 min. Next, the embryos were blocked in blocking solution [1X PBS, 0.3% BSA, 1% NGS 
0.1% Triton X100] for 3 hr at RT on a rotating wheel. Primary antibodies were diluted in blocking buffer 
and incubated with the embryos for 16-24 hr (Appendix A1.3). The embryos were washed 4 times in 1ml 
PBS [+0.1% Triton X100] for 15min. Secondary antibodies (1:400 dilution) conjugated to a suitable 
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fluorophore were diluted in 200 µl blocking buffer and incubated with embryos for 3 hr. The tissue was 
subsequently washed 4 times in 1ml PBS [+ 0.1% Triton X100] for 15 min. For GFP and RFP imaging, 
the ovaries were incubated with GFP- or RFP–booster (Chromotek, Munich). DNA was counterstained 
with DAPI and the tissue was subsequently washed 5 times. Embryos were mounted in Vectashield 
(Vector Labs, U.K.) medium. The images were acquired on Leica TCS SP5 II (Leica Microsystems Inc.) 
with 20X objective. 
3.5.2 Immunofluorescence analysis of fly ovaries 
The staining procedure was carried out at RT. The dissected ovaries were fixed in 500 µl PBS [+ 3.7% 
para-formaldehyde (prepared from powdered stock)] for 20 min on a rotating wheel. The solution was 
removed carefully and the ovaries were washed consecutively for 20 min and 90 min in PBS [+ 0.1% 
Triton X100] and PBS [+ 1% Triton X100] respectively. The tissue was blocked in 600 µl blocking buffer 
[PBS, 0.1% Triton, 5% NGS] for 1 hr on a rotating wheel. The ovaries were then incubated in primary 
antibodies (Appendix A1.3), diluted in the blocking solution (160, 197) overnight while rotating on a 
wheel. Next day, the ovaries were washed 4 times in 1 ml, PBS [+ 0.1% Triton X100] for 15 min. 
Secondary antibodies conjugated with a suitable fluorophore were diluted in 250 μl blocking buffer 
(1:400) and incubated with the ovaries for 3 hr. The tissue was subsequently washed 4 times in 1ml PBS 
[+ 0.1% Triton X100] for 15 min. For GFP and RFP imaging, the ovaries were incubated with GFP- or 
RFP –booster (Chromotek, Munich) as described above.   
The ovaries were then incubated in Vectashield (Vector Labs, U.K.) overnight at 4°C. The tissue was 
mounted on glass slides (Roth, Karlsruhe) by carefully separating the ovarioles using fine needles and 
covered using 18 X 18 mm HighPrecision cover glasses (Carl Roth, GmbH). The images were acquired 
on Leica TCS SP5 II (Leica Microsystems Inc.) with 20X objective. 
3.6 Bioinformatics methods 
For all analyses, Drosophila genome annotation, Dmel3 V5.75 was used. 
3.6.1 Nucleosome position data analysis 
Raw reads were mapped to D. melanogaster genome assembly Dmel5.75 using Bowtie v1.1.1 with “-X 
700” parameter setting. Respectively 3, 3 and 2 biological replicates of w1118, acf17 and yw genotype 
were sequenced. Two WT (w1118, yw) genotypes were used to score robust effects on nucleosome 
positions. Since the mutant flies are not backcrossed in any of the WT genotypes, use of two genotypes 
should increase the dispersion of the data and allowing scoring for robust changes. 
The quality of the raw reads was assessed using FASTQC v0.10.1. Dyad coverage vectors were obtained 
by computationally size-selecting fragments of length <200 bp and resizing their length to 1 bp fixed at 
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the fragment center, unless stated otherwise. For plotting cumulative dyad signals, the raw signal was 
smoothened in 5 bp running, non-overlapping windows. The analyses were performed by comparing 
acf1
7
 against two WTs (combined-WT).  
3.6.2 Autocorrelation function analysis 
Autocorrelation function (Acf) was calculated on the dyad coverage vectors obtained for entire 
chromosome, gene bodies, first 4 nucleosomes or intergenic regions in R environment. The vectors for the 
last 3 cases represent head-to-head appended regions of given annotation, considering their orientation. 
The function was run for the lag length of 1000 bp. Linker lengths were estimated from the Acf curves by 




 peak summits and subtracting 147.   
3.6.3 Spectral analysis 
Spectral analysis aims at identifying all possible frequencies along the given data series. The weighted 
frequencies in the spectrum were identified using Spectral Density Estimation function in R environment. 
For identifying regions of regularities (RoRs), or periodicities, the chromosomes were individually 
scanned in a moving window of 1000 bp in an incremental step of size 100 bp for all 5 WT replicates. 
Spectral density at 6 nucleosomes/ 1 kb (corresponding to 167 bp period) was used for thresh-holding 
analyses. An arbitrary cutoff was set for identifying genomic regions of regularities such that it allows 
20% false discovery rate for normally distributed spectral densities at 167 bp period.  
Similar analysis was done in the mutant background. Regions of reduced regularity were identified by 
comparing the distributions of spectral density using Student’s t-test. 
3.6.4 Nucleosome fragment density estimation 
Nucleosome fragment counts were obtained along given sequence features (or along 200 bp non 
overlapping genomic windows) and normalized by sequenced library sizes. Nucleosome densities were 
then compared using paired Student’s t-test statistics for all the genes. Raw/ non-normalized counts were 
subjected to DESeq2 analysis to obtain log fold changes after multiple testing correction and variance 
stabilization across the combined wild-types and acf1
7
. 
3.6.5 RNA-seq data analysis 
Raw sequencing reads were mapped using TopHat (198, 199) with a default Bowtie2 aligner against D. 
melanogaster genome assembly Dmel3_5.75 at the default parameter settings. The bam files were 
subsequently converted into .tdf file format for visualization in IGV (200). Further, HTSeq package (201) 
was used for counting the RNA-seq reads within the exons of each gene (Dmel3_v5.75) using default 
settings. In total, 3, 4 and 2 biological replicates for w1118, acf1
7
 and yw genotypes were sequenced. Raw 
counts were subjected to log-fold change analysis using DESeq2 package to identify misregulated genes. 
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RNA coverage vectors were obtained by size-normalizing the sequencing libraries to 1 Mio reads. RNA-
seq densities were computed along given genomic features or sequence coordinates using custom R-
scripts. 
For transposon analysis, raw RNA-seq reads were mapped along 179 transposons (BDGP transposable 
elements v9.4.1) sequences by building the new index files composed of these sequences. Differential 
analysis was carried out using DESEq2 package. Similarly, DNA copy number was estimated by 
mapping the nucleosome read densities along the indexed transposon files. 
For assessing translocation events in the genome, paired end nucleosome reads were mapped on the 
transposon sequences in such a way that one mate from the pair maps on transposon while the other on 
genomic sequence. All such regions identified on the genome, merged if they were within 1 kb distance to 
each other and center-position was considered for subsequent analyses. Differential analysis was carried 
out for combined-WT vs mutant using DESEq2 package.  
 3.6.6 ChIP-seq data analysis  
The raw reads were mapped to D. melanogaster genome assembly Dmel 5.75 using Bowtie v1.1.1 with 
unique mapping criteria of “m -1”. Quality of raw reads was assessed using FASTQC v0.10.1. The 
alignment .sam files were converted to .bam and .bed files using samtools and bedtools respectively. Bam 
files were subsequently used for generating Background-subtracted tag density tracks using SPP package 
(202). Peak, motifs identification and peak annotation were performed by HOMER suite, v4.7 under the 
default parameter setting (203). MACS 2.0 (204), cisGenome V2.0 (205) and SPP package (202) were 
further used for peak identification. Raw and Background-subtracted sequencing tracks were visualized 
by IGB (206) and IGV (200) genome viewers. Coverage objects for the ChIP and input samples were 
generated by size normalizing the libraries to 1 Million reads. Input normalized coverage vectors were 
also generated using arcsine transformation and Z-score normalization (207). The input normalized 
coverage vectors were used to score ChIP-seq profile signals along the genomic features of given sets of 
genomic regions. Customized R and Perl scripts were written to analyze the data and performing 
statistical calculations. Bioconductor packages such as ChIPPeaksAnno (208), DESeq2 (209) and 
Venneuler were used for annotating peaks, calculating log fold enrichments with multiple testing 
corrections and for plotting Venn diagrams, respectively. Gene Ontology enrichment analysis was 
performed using online resource at DAVID (david.abcc.ncifcrf.gov). 
3.6.7 Data comparison with modENCODE 
All modENCODE ChIP-seq profiles (151 histone and 153 non histone proteins, Feb’15, release 33) were 
used in this analysis. The representative peak file, in case of replicate experiments, was used while, the 
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raw sequence files from replicate experiments were mapped, converted to bam format and merged 
together using Bamtools.  
  
Page | 47 
 
4. Results 
4.1 Generation of transgenic Fly lines with recombineered fosmids 
To investigate the genomic targets and molecular interactions of ACF/ CHRAC complexes in vivo, ACF1 
and Chrac16 were tagged in flies using combinatorial tag cassettes. Previously published fosmid 
recombineering approach was employed to manipulate the gene loci, in their native genomic environment 
as discussed in Section 3.2.1 (195). The approach should allow expression of the genes under their native 
regulatory sequences. Moreover, the tags (peptide epitope + fluorophore) allow detection of recombinant 
proteins in a developing organism by immunofluorescence microscopy (IFM) and subsequent 
biochemical analyses of the interactions. Such analyses can further corroborate the antibody-based 
analyses for ACF1 and Chrac16. Recombineering method was further modified in the work to manipulate 
given gene loci.  
4.1.1 Transgenic fly lines with combinatorial tags  
I made use of the fosmid recombineering strategy previously established by the Tomancak lab (195). 
Briefly, the authors generated a fosmid collection of Drosophila genome carrying ~ 30 kb long genomic 
inserts in bacteria as a single copy plasmid. Clones pFlyFos021945 and pFlyFos016131 from this 
collection were used to tag Acf1 and Chrac16 genes respectively. Above clones carry 10-15 kb native 
upstream and downstream sequences to ACF1 and Chrac16 and likely includes the regulatory elements 
(Section 3.2.1). For generating contrasts in IFM analyses, ACF1 was tagged with 2X-TY1- EGFP-3X-
FLAG epitope at the N- or C-terminal, while, Chrac16 was tagged with 2X-TY1-mCherry-3X-FLAG 
epitope at the N-terminal (Section 3.2.1). The schematics of molecular cloning are outlined in Figure 4.1. 
C-terminus region of Chrac16 (16 kD) is implicated in modulating DNA binding activity of Chrac14-16 
heterodimer (155). To minimize potential functional masking of Chrac16, a 33 kD long mCherry tag was 
placed on its N-terminus. These flies are abbreviated as ACF1-nGFP, ACF1-cGFP and Chrac16-
nmCherry respectively in current work. 
Briefly, a 50 bp homology arm was included at 5’ of the 20 bp long recombineering primer (Appendix 
A1.4) and a tag cassette was PCR amplified. The fosmids were manipulated in liquid bacterial culture 
using homologous recombination approach under strong antibody selection pressure. The fosmid carries 
attB site which was used for specific integration of the reombineered fosmids into transgenic Drosophila 
carrying an appropriate attP landing sites. The integration was facilitated by germ-line expression of 
ΦC31 integrase in these flies. Successful integration events were scored in the F1 progeny using eye 
promoter driven dsRed, red fluorescence protein, expression. In principle, relative positions of the 
homology arms along a gene can be varied to delete regions of genes from the fosmid (Figure 4.1). This 
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strategy was further used to generate complete or partial gene deletion constructs and the corresponding 
Fly lines (Appendix A1.6). The protocol was further modified to use Gal4 DNA binding domain in the 
context of a combinatorial tag cassette. Gal4-DBD sequence has been successfully used and published 
elsewhere (210).  
 
Figure 4.1: Gene recombineering strategy for ACF1 and Chrac16. Fly fosmid carrying either ACF1 or Chrac16 genes were 
used for homology cloning. Tag cassettes are amplified using primers containing homology sequences to the site of 
recombination, as depicted in brown in right panel. The combinatorial tag contains a fluorophore flanked by TY1 and FLAG 
epitopes. The tag cassettes lack start and stop codons but were adjusted in the homology sequence. 
 
ACF1 domain deletion flies and Chrac16 transgenic flies were subsequently used by Kenneth Börner in 
the lab to study dose-dependent effects of ACF1 during oogenesis. The work describes increased 
apoptosis and derailed egg chamber packaging phenotypes due to increased dose of the remodelers during 
Drosophila oogenesis. Gal4-DBD tagged ACF1 will be used in the lab to study ACF1 containing 
complexes and their functions, in vivo.   
In addition to the transgenic Fly lines for ACF1, additional immunoreactive reagents were raised against 
ACF1 in this study. Two rabbit polyclonal antibodies were raised against the GST-tagged C-terminal 
domain of ACF1 (aa1065-1463) (Appendix A2.1). Moreover, two peptide derived monoclonal antibodies 
were raised against the Bromodomain of ACF1 (Appendix A2.2). ISWI is a motor subunit of 
CHRAC/ACF and hence immunoreactive two rabbit polyclonal antibodies were raised against ISWI, but 
were not used in this work (Appendix A2.3) 
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4.1.2 GFP tagged ACF1 forms CHRAC/ACF complex 
The transgenic flies were characterized for expression of full length protein by Western blot (WB) 
analysis. ACF1 is a 175 kD protein with two isoforms with molecular weight of170 kD and 185 kD (57). 
It was previously reported that a C-terminal tag pulls down the higher molecular weight band of ACF1 
while, N-terminal tag enriches for both the bands (93). Moreover, expression of recombinant ACF1 using 
full length cDNA leads to expression of both isoforms.  These observations suggest possible C-terminal 
proteolysis or RNA editing as a source of small isoform.  
Similar to above observations, a 33 kD increase of the long ACF1 isoform was observed when the tag 
was placed at the C-terminus. Same band also gets enriched during the immunoprecipitation (IP) if tag-
specific antibody is used (Figure 4.2). However, increase in the molecular weights (MW) for both bands 
was detected along with their enrichment in the IP when ACF1-nGFP embryo extracts were analyzed (not 
shown). The WB analysis further suggested degradation of the recombinant ACF1-nGFP in the tissue 
(not shown). Relative amounts of the proteins in 0-14 hr old embryo extracts were quantified by 
quantitative WB (LiCOR system). For ACF1-cGFP Fly line, overall amount of ACF1 was increased by 
two fold, unlike for the ACF1-nGFP flies where the total ACF1 amount remained unchanged. 
Interestingly, the levels of ISWI did not change in both transgenic fly lines (not shown). The recombinant 




 background to obtain complementation 
strains, where all ACF1 alleles were tagged.   
 
Figure 4.2: Western Blot and immunoprecipitation analysis in ACF1-cEGFP transgenic line. ACF1 appears as a double 
band on SDS-PAGE. C-terminal tagging of ACF1 results in an increase in the molecular weight of a long isoform (left panel), 
which further gets enriched in an IP (right panel). The recombinant protein further pulls down ISWI and Chrac16 (right panel). 
WT and Tra refer to the embryo nuclear extracts prepared from wild-type and transgenic embryos. 
 
Chrac16 protein is a diagnostic subunit of CHRAC complex and, in principle, can be used to compare 
developmental roles of CHRAC and ACF complexes. Previous attempts to generate highly specific 
monoclonal antibodies against Chrac16 in the lab had failed. During the course of this work, N- and C- 
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terminus peptides of Chrach16 were used to raise rat monoclonal antibodies. Two antigenic peptides were 
predicted using semi-empirical method outlined by Kolaskar and Tongaonkar (211) and the antibodies 
were raised in collaboration with Dr. Elizabeth Kremmer, Helmholz Zentrum, Munich (Appendix A2.4). 
The cell culture supernatants were tested in WB and subsequent positive clones were assessed in IP for 
their ability to pull down Chrac16 from nuclear extracts. Potentially promising clones were subcloned and 
re-examined in WB and IP experiments. Though the antibodies seemed to work in WB, none of them 
could IP the protein from crude nuclear extract (not shown). Therefore, Chrac16 gene was tagged in flies 
using recombineering approach as an antibody-independent tool for its biochemical analyses (Section 
3.2.1). Recombinantly tagged Chrac16 at N-terminus shows expected 33 kD increase in WB and can form 
complex with ACF1 and ISWI when tested in IP (not shown).  
4.1.3 GFP tagged ACF1 shows faithful expression pattern during development 
ACF1 shows a characteristic expression pattern. Immunoreactive ACF1 was observed to show strong and 
ubiquitous enrichment in early embryogenesis, when most of the cells are undifferentiated. In subsequent 
developmental stages, the protein was strongly concentrated in the neuroblasts and primordial germ cells 
(160). The ACF1 signal is also strong in germ stem cell of the germarium, and nurse cells in the egg 
chamber (K. Börner, D. Jain, submitted). Drosophila ovaries consists of sub-structures called ovarioles. 
Each ovariole represents an egg production line where a tip of the ovariole harbors germ stem cells in a 
specialized structure, the germarium. A germ stem cell divides asymmetrically to produce a 16-cell cyst 
that is further encapsulated by a progeny of somatic stem cells. The resultant structure, an egg chamber, 
so-formed matures in which one of the 16 cells become an egg nucleus, karyosome, while the remaining 
15 attain polyploidy and become nurse cells.     
The ACF1-cGFP transgenic embryos were immunostained for ACF1 where the GFP signal was boosted 
by GFP booster (Section 3.5.1, 3.5.2). The GFP signal was clearly visible in the neuronal and primordial 
germ cells of stage 15-16 (13 hr after egg lying) embryos (Figure 4.3, left panel). Also, the ovarioles 
were prepared for IFM by fixation and counter staining with DAPI. Strong GFP signal clearly showed 
presence of recombinant protein in the germ stem cells and along the polyploid nurse cells (Figure 4.3, 
right panel). Intense and focused GFP signal in egg chamber represents an oocyte nucleus, the karyosome 
(right panel). 
Similar staining was performed for ACF1-nGFP and Chrac16-nmCherry in embryos and ovaries. ACF1-
nGFP staining confirmed the known expression pattern in embryonic tissue and ovaries. However, the 
signals were weak even after GFP booster staining (not shown, Section 3.5). Chrac16 expression pattern 
in the ovarioles was similar to that of ACF1, albeit with low signal. However, the protein localization in 
embryos was not conclusively determined due to poor signal strength. It is possible that the formaldehyde 
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fixation step may render the fluorophore inactive. Hence, RFP booster and RFP antibody were used 
subsequently. However, the signal or staining quality remained poor. Nonetheless, a homozygous fly line 
was obtained after combining Chrac16-mCherry to Lamin-GFP and subsequently used for live embryo 
imaging. In principle, Chrac16 can be detected the embryos, but due to internal embryo movements, rapid 
bleaching of the fluorophore and limitations of the IFM setup at the time, expression patterns could not be 
conclusively determined (not shown). 
 
Figure 4.3: Faithful expression pattern of recombinant ACF1. C-terminus tagged ACF1 is faithfully expressed ubiquitously 
in early stages of embryogenesis but enriched only in neuronal and primordial germ cells in stage 15-16 (left panel). The intense 
GFP signal in the gut region of an embryo is an auto-fluorescence. GFP expression is further observed along the nurse cells and 
oocytes of an ovariole (right, upper panel). In the germarium, GFP signal is intense for the germ stem cells (right, upper panel).   
4.2 Characterization of the acf1
7
 allele 
Reported ACF1 deletion allele, acf1
1
, in the literature was generated using P-element integration along 
the 5’ end of the gene and its subsequent imprecise excision. As a result, 499 bp deletion was generated 
encompassing first intron and second exon leading to the absence of full length protein when assessed on 
WB  (159). This allele was subsequently used in studying in vivo functions of ACF1 by (160).Though the 
full length protein was not detected in WB, careful IFM analyses performed subsequently in the lab by K. 
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Börner, N. Steffen and S. Vengadasalam suggest that the mutant expressed leftover protein in the ovaries 
that could be detected using C-terminus specific monoclonal antibody (8E3) against ACF1 (Appendix 
A1.3).  
 
Figure 4.4: Characterization of ACF1 mutant alleles. (A) Western Blot analysis using rat monoclonal antibodies 3F1/ 8E3 
(raised against full length protein, recognize N- and C-terminal of the protein respectively) and rabbit polyclonal antibodies 
Rb1/Rb2 (raised against C-terminal PHD-PHD-Bromo domain, crude extract). The nuclear extract was prepared using 
ActiveMotif kit (B) Adopted picture from Kenneth Börner, elucidating ACF1 specific staining in wild-type (WT) and acf11 
mutants. Orb stains oocyte cytoplasm. (C) Quantitative PCR using amplicons placed along ACF1 gene as indicated on the gene 
cartoon. Embryonic tissue (0-14 hr) was used for RNA quantitation (D) RNA sequencing tracks in yw and acf17 show deletion of 
ACF1 gene locus in the mutant, as can also be seen in (C).   
 
A new additional acf1
7
 allele generated in the Fyodorov lab (Albert Einstein College of Medicine, Bronx, 
NY 10461) carries larger deletion of the ACF1 locus. This allele was generated by P{EP}Acf1
EP1181 
(P-
element) insertion in the 5’ end of ACF1 and its subsequent imprecise excision. I used this allele and 
performed cDNA sequencing on the expressed locus. A portion of the gene corresponding to aa 41-951 
(i.e. 3085 bp deletion on chr3R:31794682 – 31797767, genome build Dmel-R6) was deleted in acf17. 
Sequencing revealed that a 34 bp sequence (CATGATGAAATATCTGAAATATCAATGAAATGTC) of 
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unknown origin was inserted in this region close to aa 951 that adds a start-codon and in-frame 3 new 
amino acids to the remaining ACF1 translation frame. To further assess whether the leftover allele 
produces a truncated C-terminus part of the protein, nuclear extracts were prepared from 0-14 hr old WT 
and acf17 embryos and probed using polyclonal (Rb1, Rb2) and monoclonal, mAb, (3F1,8E3) antibodies 
(Appendix A1.3). Absence of immunoreactive bands on the gel suggested that no leftover protein is 
expressed from the allele (Figure 4.4A). To gain further confidence, the mutant ovarian tissue was 
stained for ACF1 using 8E3 mAb and the staining was compared to that from acf1
1 
by K. Börner (Figure 
4.4B). Unlike acf1
1
, the newly generated acf1
7
 allele did not produce any leftover protein in the ovaries 
and also embryos. A comparative quantitative PCR on the cDNA derived from embryos of both mutant 
genotypes suggested that acf1
1
 allele was transcribing most of the ACF1 mRNA, as against acf1
7
 allele to 
50% levels. Similar expression level was also observed from the ovarian tissues (Figure 4.3C). Due to 
the absence of leftover protein, acf1
7
 allele is considered null and successively used in the current work to 
compare effects of ACF1 against the WT. In later stage ChIP-seq experiment (Section 4.5) performed in 
the mutant acf1
7
 background, absence of the reads along the ACF1 deletion region in the sequencing 
libraries was further observed.   
 
Figure 4.5: C-terminal-tagged ACF1 completely rescues acf17 mutant phenotype. ACF1 deficiency (acf17allele) leads to 
fewer embryos hatching into larvae. The phenotype is completely and partially rescued by C- and N- terminal tagged ACF1 
respectively. By contrast, acf11 allele which bears a small deletion has a mild phenotype. Error bars represent standard deviation 
calculated from 8 collection experiments.  
 
Females of both ACF1 mutant alleles produce similar numbers of eggs when compared to the WT adult 
females. However, only acf1
7 
showed considerably reduced fraction of eggs transiting to the larval stage, 
unlike the incomplete deletion allele acf1
1
 (Figure 4.5). A complete rescue of this phenotype was 
observed when a recombinant copy of ACF1-cGFP was brought in the acf1
7
 background. By comparison, 
only partial rescue was observed in presence of recombinant ACF1-nGFP (Figure 4.5). Complementation 
of acf1
1
 background had no additional effects on embryo transition to larvae. In later stages of 
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development, escaped larval progeny from acf1
7 
background or its complemented progenies showed no 
additional growth defects (not shown).  
Whether the inability of acf1
7
 embryos to transit into the larval stage comes from embryonic lethality or 
due to deposition of unfertilized embryos is not clear. Preliminary microscopic observations suggest that 
it could be a combination of both (Appendix A3). 
4.3 Altered nucleosome organization in acf1
7
 background   
CHRAC/ACF complexes can assemble, slide and space nucleosome. Mechanistic studies suggest that 
ACF1 acts as molecular ruler and senses linker length to space the nucleosomes on the DNA molecule 
(77, 91, 157). Moreover, in vivo studies suggest a perturbed nucleosome organization in the absence of 
ACF1 (159, 161). It was therefore important to determine the nucleosome organization in the acf1
7
 
background at higher resolution to better understand the contributions of ACF1 towards in vivo 
nucleosome organization. Nucleosome occupancies were mapped after subjecting the DNA obtained from 
micrococcal nuclease (MNase) digestion to deep sequencing in WT and mutant embryos of 2-8 hr old. 
This post syncytial-blastoderm stage of development shows ubiquitous expression of ACF1. In total, 2 
(yw), 3 (w1118) and 3 (acf1
7
) biological replicates were obtained for 3 genotypes. Differences in acf1
7
 
genotype were robustly scored against the combined WT (yw and w1118). The sequenced paired end 











). The spectral density estimation 
analyses were performed by Dr. Tobias Straub, BMC, Munich. Subsequent analyses were performed in 
collaboration and after discussions with him 
4.3.1 Wild-type nucleosome profiling identifies discontinuous patches of Regions of Regularity 
(RoR) across genome  
Nucleosome occupancies, positioning, spacing and phasing are described in Section 2.7. Earlier studies in 
yeast had suggested that several regions in the genome such as transcription start sites (TSS), enhancer 
regions or factor binding sites exhibit well organized nucleosomal arrays along them. These sites are 
referred as barrier sites where the DNA is nucleosome depleted or bound by a chromatin factor and 
further show phasing of the nucleosome arrays around them. Especially, such phasing observed at the 
TSS seems to be a conserved feature in eukaryotes (106, 111, 113). Remodeling factors play an active and 
consorted role in bringing about such phasing at the TSS (Section 2.8).  
Conventional workflows dealing with nucleosome mapping data make use of barrier site such as TSS as a 
reference position to identify alterations in the treatment samples. However, in order to identify regularly 
phased nucleosome regions across the genome without known reference points, alternate approaches are 
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needed. In this work, we use spectral density estimation (SDE) method. SDE approach treats the 
nucleosome occupancy signal across the genome as a composite periodic signal and decomposes it into a 
linear combination of simple periodic functions using Fourier transformation. Each of the simple periodic 
functions (or wave functions), after decomposing the nucleosome occupancy data, bears a weight term 
that determines contribution of a periodic function to the overall observed signal (Figure 4.6). These 
weights are referred to as spectral density (SD), and the period for each of the periodic functions refers to 
the repeating length in the nucleosome occupancy signal. The period can also be an NRL for special 
circumstances such as highly phased arrays.   
 
Figure4.6: Illustration of SDE approach. The nucleosome occupancy data is decomposed into linearly additive sine or cosine 
functions using the Fourier transformation. The result can be displayed as a frequency spectrum in which X-axis represents all 
possible frequencies (same as 1/periods) in the dataset in bp-1 unit. Y-axis corresponds to the weight of each frequency, which is 
referred to as spectral density. Highest spectral density in this representation identifies dominant period as 170 bp (or frequency 
0.00589).  
 
Spectral densities were calculated for all 5 WT samples by generating a nucleosome occupancy dyad 
coverage vector for each sample (Section 3.6.1, 3.6.3). Fragments corresponding to <300 bp from the 
paired-end nucleosome mapping datasets were computationally retrieved and resized to 50 bp along their 
midpoints to obtain coverages. These coverage vectors were subjected to spectral density estimation in a 1 
kb moving window across the genome where the windows were shifted by a step size of 100 bp. The 
spectral densities corresponding to a period of 100 bp to 500 bp were retrieved from the frequency 
spectrum to generate a heat map display where X-axis corresponds to the genomic locations and Y-axis 
corresponds different periods. The color scheme represents the spectral density (Figure 4.7A). Visual 
inspection of the nucleosome dyad positions and the heat maps derived from spectral analyses suggested 
several regions with regularly positioned nucleosomes (Figure 4.7A). These regions are dispersed across 
the genome encompassing TSS regions. Interestingly, the frequency spectrum identified 170 bp as the 
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dominant period across all 5 WT datasets. It is important to note that the analyses here are not biased by 
differences in the library sizes for different samples as alternative data normalization methods to generate 
coverage vectors shows similar outcomes. For instance, library-size or Z-score transformation based 
normalization on coverage vectors obtained by reducing the sequenced fragments to 1 bp or 50 bp show 
the same outcome (not shown).  
 
Figure 4.7: Identification of RoRs. (A) Nucleosome dyad densities are displayed for 5 WT samples of two different genotypes. 
In lower panel, spectral densities obtained from sample row 5 are displayed in the range of 2 -10 nucleosomes/ kb (100–500 bp 
period). SD corresponding to 170 bp were averaged across the genome for all the samples. A 20% FDR arbitrary threshold 
identifies ‘regions of regularity’ (RoR) that are displayed as blue blocks running along the track. (B) Genomic and (C) chromatin 
state distributions of the RoRs against the random intervals.     
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In order to identify regions of regularly spaced nucleosomes, the SD values corresponding to a period of 
170 bp were retrieved across the genome from all 5 WT replicates and averaged. The averaged values 
follow a normal distribution, from which an arbitrary value corresponding to 20% false discovery rate 
was identified (Figure 4.7A). Using this value as a threshold, 12803 regions were identified from the 
genome as ‘Regions of Regularity’ (RoR). The minimum length of the RoR is 100 bp which correspond 
to the step size used in spectral density estimation procedure. Identified RoRs account 16% of the genome 
and distributed close to randomly across the genome. These regions were further annotated to identify that 
1/3
rd
 of them were localized within 1 kb distance to known TSS, suggesting promoters/TSS as major 
contributor (Figure 4.7B). In order to calculate the enrichments, equal number of random intervals was 
selected from the genome using Bedtools. Relative enrichments for the RoRs were identified for each 
annotation category against the random regions. The calculation suggests that RoRs are preferentially 
enriched (1.9 fold) for promoter/TSS as compared to the random intervals. This observation falls in line 
with previously reported findings where strong phasing was observed at the promoter regions/NDRs. In 
addition to promoter/TSS, 8185 RoRs are found to localize at least 1 kb farther to TSS with close to 
random distribution.    
To identify the underlying chromatin features along the RoRs, a comparison was made to the 9-state 
chromatin model described by (212). Briefly, based on different epigenetic modifications, TF and other 
chromatin protein binding signatures cataloged in S2 cells, the genome is partitioned into 9 distinct states 
that encompass features ranging from actively transcribing chromatin to the repressive or silent 
chromatin. The comparison to 12803 random control intervals suggests that actively transcribing 
chromatin (state 1) is enriched along the RoR (Figure 4.7B). 
Highly transcribing genes tend to show well phased nucleosomes at the TSS. Earlier studies in Drosophila 
and yeast suggest that H2A.V variant is enriched along such well-phased arrays and overall H2A.V signal 
positively correlates with the gene activity. Is H2A.Z deposition a prerequisite for well-phased array 
formation? If there is such correlation, then do the RoRs show similar H2A.V enrichment? In order to 
address these issues, modENCODE H2A.V profiles from 14-16 hr old embryos (modE5075) and S2 cells 
(modE5596) were assessed. Raw sequences from these profiles were analyzed using the outline described 
in Section 3.6.6/ 3.6.7. Background-subtracted tags were counted along all RoR intervals. The analysis 
suggests that with an exception of promoters the remaining RoRs do not have significant H2A.V 
enrichment (Figure 4.8). 
Insulators such as CTCF, BEAF-32 and Su(Hw) bind to boundary elements and establish barrier sites that 
may further lead to phasing of the nucleosomes. To assess whether the RoRs are organized by insulator 
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proteins, their binding sites were predicted along the RoRs using MEME suite. Depending on the p-value 
threshold, a minor fraction of the RoRs was observed to carry insulator motifs [i.e. 949 (7%) and 2046 




, FIMO-MEME suite]. The 
observation suggests that insulators are not the origins of non-promoter RoRs. Furthermore, nucleosomes 
were phased along the in silico genomewide predicted motif sites of Su(Hw) and BEAF-32 (590 and 4031 
respectively, p-value < 10
-6
 ). These predicted sites further showed poor overlaps with the RoRs. CP190, a 
member of gypsy insulator family, was mapped in 0-12 hr old embryos in duplicate using antibody 
described in Appendix A1.3 (Section 3.4.1, 3.6.6). A large fraction of CP190 peaks are localized in the 
promoters and also therefore overlap with RoRs. Well-phased nucleosomes were observed along the 
CP190 peaks that likely arise due to the underlying promoter feature (not shown).  
 
4.3.2 ACF1 deletion affects RoRs with a motif signature 
ACF1 is a nucleosome spacing factor. To better understand its effects on in vivo nucleosome 
organization, nucleosome occupancies were obtained in acf1
7
 mutant background and compared against 
wild-type embryos of the same developmental stage. Total numbers of sequenced reads obtained for the 
mutant experiments were less compared to the WT. However, the read distribution across the genome was 
comparable to WT. Furthermore, the fragment size distribution in the paired end sequence libraries for 
both genotypes were comparable without any bias (Figure 4.9A,B). Hence, chromatin periodicities were 
assessed using previously outlined SDE approach in acf1
7
 background. Spectral densities corresponding 
to 170 bp period were retrieved from all three replicate experiments. The 20% FDR threshold value 
derived from the WT was used as a threshold to identify RoRs that are retained, lost or gained in the 
mutant background. Visual inspection of the spectral densities when juxtaposed to the nucleosome 
Figure 4.8: H2A.V signal distribution along the RoRs. 
Background-subtracted tag counts for H2A.V were obtained 
along the RoRs that were subsequently grouped based on 
their genomic annotation.  
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occupancy tracks identify that phasing at the TSS is largely unaffected upon loss of ACF1. However, 
there are several genomic sites where the nucleosome occupancies are reduced or their phasing is affected 
in acf1
7
 background. To quantify these changes, the spectral density values corresponding to 170 bp 
period were obtained across 12803 previously defined RoRs from both backgrounds. Differential 
intervals were identified by performing Students’s t-test with p-value cutoff <0.01. In total, 2147 regions 
with reduced regularity in the mutant background were obtained with a fairly random distribution across 
the genome (Figure 4.10A).   
 
Figure 4.9: Sequencing libraries properties for WT and acf17 background are comparable. (A) Fragment length distribution 
for all biological replicates of the three genotypes. Fragment density represents a scaled relative proportion in the library. (B) 
Distribution of mapped sequencing fragments across the chromosomes for all genotypes. 
 
Most of the reduced Regions of Regularity (rRoRs) are localized within the introns or intergenic regions, 
distant to known TSS. A closer inspection of the rRoRs by de novo motif prediction using HOMER 
package revealed that the underlying sequences were either AT or GC rich. To gain further insights, de 
novo DNA motifs were predicted using MEME. Interestingly, a complex motif site with conserved 
ATACGCC heptad which I will call ‘Spectral Motif’ henceforth was found to be present in >75% of the 
sequences (Figure 4.10B). The rRoRs do not arise due to reduced nucleosome occupancies along them. 
Library size normalized fragment counts were obtained along the rRoRs for both genotypes and either 
visualized using boxplot or compared using a statistical framework of DESeq2. The result suggest that 
comparable nucleosome occupancies along the rRoRs. Moreover, most of the rRoRs could be identified 
when nucleosome coverage vectors were prepared using the alternate Z-score normalization method (not 
shown). Taken together, the observations suggest that in the mutant background nucleosome positions are 
fuzzier along the rRoRs. 
Comparison of the spectral motif to known JASPAR motif databases using TOMTOM (MEME package) 
did not yield close similarities in insect or vertebrate genomes. However, such comparison identified 
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cross-species distant matches such as chorion factor-2 (Cf-2) in mammals or a transcription factor, Fus3, 
from the A. thaliana with high expect values (>0.1). Protein BLAST or homolog search did not reveal 
homologs of these proteins in Drosophila.  
 
Figure 4.10: Identification of the regions with reduced regularity of nucleosome positioning. Combined WT (red) and acf17 
(cyan) tracks show nucleosome dyad densities for all biological replicates. The SD for 170 bp period is displayed for the 
exemplary samples of both genotypes. Differential regions with reduced regularity were identified using Student’s t-test statistics. 
A comparison of changed (carrying blue identifying block below it) to the unchanged region (neighboring TSS) is shown. 
 
ACF1-containin factors have been previously suggested to facilitate replication programs though 
heterochromatin (146, 177). Hence, I wondered whether motif-containing RoRs had any relationship to 
replication origins. The Paro lab recently mapped origins with a single base pair resolution in two 
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Drosophila cell lines by deep sequencing of the nascent leading DNA strands (213). These replication 
hotspots show poor overlap with RoRs or spectral motif regions. Only 11% and 12.6% of RoR intervals 
map to origins in S2 and BG3 cells respectively [7% and 5% spectral motif regions overlap with origins. 
P-values representing significance of overlaps were not calculated]. 
4.3.3 Spectral motifs are enriched in silent chromatin 
Sequence similarity to the ‘spectral motif’ is not limited to rRoRs, but also found elsewhere. To assess 
whether spectral motif plays a global role in nucleosome phasing a genome-wide collection of 3457 
spectral motif sites (p-value <10
-7
) were analyzed for nucleosome positions in the WT and mutant 
genomes. Coverage vectors for nucleosome dyads were prepared by reducing the sequenced fragment 
lengths to 50 bp intervals centered at the fragment midpoint. The coverage vectors were normalized for 
the respective library sizes. Heat map and cumulative density representation in both genotypes suggest a 
very homogeneous phasing along the spectral motif in WT background, which becomes fuzzier upon the 
loss of ACF1. By contrast, the nucleosome phasing at the TSS did not show any conspicuous alterations. 
However, a careful look remote to the TSS shows that nucleosomes after the +4 nucleosomes are mildly 
sifted away from the NFR in the mutant background (Figure 4.11). It is important to note that the motif 
site is localized within the linker region and show regularly phased arrays containing 8-9 nucleosomes on 
the either ends of the motif.  
For further analyzing the differential nucleosomal arrangements in WT and acf1
7
, a K-means and 
unsupervised expectation maximization clustering algorithms were used. The analysis was aimed at 
identifying subgroups in the datasets that show distinct changes along the nucleosomal arrays over the 
transcribing region. Briefly, nucleosome dyad density signals obtained in acf1
7
 over 1.5 kb window 
downstream of TSS were subtracted from that in WT. The selection of 1.5 kb window is appropriate as it 
encompasses ~7 nucleosomes, which can be reliably identified from cumulative density plots. Employing 
both algorithms on a difference matrix identify one large cluster carrying most of the 14320 genes, while 
the remaining clusters contain only few genes. Absence of partitioning in the dataset suggests a 
homogeneous effect in a manner that nucleosomal array shifts in the mutant background are observed on 
almost all of the genes. The phenotype partly resembles Iswi2 dependent nucleosome alterations reported 
in yeast (188), where the nucleosomes are shifted away from NDRs. Corroborating to the observation, 
classification of the genes based on their expression strengths [in 2-8 hr old embryos (Section 4.4)] or 
lengths have no obvious effects on the nucleosome organization in the mutant background. The 
cumulative dyad density plots show similar mild downstream shifts away from the TSS in the mutant 
background (not shown). 
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Figure 4.11: Organization of nucleosomes along the genomic spectral motif centers.  Nucleosome dyad densities obtained in 
1 kb window along the motif center or top 20% expressed genes in 2-8 hr old embryos are displayed as heat map (upper panel) 
and cumulative plots (lowe panel) for combined WT (red) and mutant (cyan).  
 
Spectral motif containing regions (1 kb long interval centered at the motif) are enriched in the introns and 
intergenic regions (Figure 4.12A). Interestingly, 62% of the motif regions are localized within the silent 
chromatin (state 9) that carries H3K27me3 epigenetic mark and is not bound by the polycomb complexes. 
Polycomb domains, by contrast, carry only 5% of the spectral motifs (state 6) (Figure 4.12B). 
Corroborating results were obtained when the spectral motif regions were compared to the developmental 
transcriptome of Drosophila (214). modENCODE consortium has profiled RNA transcripts in 
embryogenesis and across all stages of developing in Drosophila using RNA-seq and RNA-chip 
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approaches respectively. Adopting a strategy where genes expressed in top 50 percentile are considered 
ON and the remaining are called OFF; all 14320 genes in Drosophila were awarded binary ON/OFF 
assignments. Overall, 886 genes (RNA-chip experiment) overlapped with 1732 spectral motif regions. 
Out of which,  only 160 genes carrying 325 motifs were stably expressed across all stages of 
development, suggesting that only 18% motifs overlap with stably expressed genes. There are examples 
that nucleosome organization affects gene expression program (215). Since mutant background shows 
altered nucleosome occupancy and phasing along the spectral motifs, it was interesting to check whether 
the transcript levels alter along them in the mutant background. To address the issue in details, 2-8 hr old 
embryo RNA-seq data (Section 4.4) was used to compare tag densities in the window of 500 bp and 1 kb 
centered on motif midpoint in WT and acf1
7
. The RNA-seq data used for such analysis supports 
identification of non-polyA transcripts. Tag counts along spectral motif regions remained poor (0- 195 
counts, mean 2.5 and median 0.23, values fall below the ON category defined above for RNA-seq 
experiments) suggesting that the regions were not expressed in either backgrounds.  
 
Figure 4.12: Characterization of genomic spectral motif sites. (A) Genomic and (B) 9-state chromatin annotations for 3457 
genomic motif sites. The numbers in bracket represent enrichment of the annotation when compared to the randomly distributed 
same numbers of intervals. 23 bp long motif site was resized to 1 kb, centering on the motif center. (C) 15-way insect genome 
alignment based Phastcons conservation scores per base were retrieved from UCSC and mean scores were calculated against 
rRoRs, genomic spectral motifs. Background refers to rest of the genomic sites.  
 
Are the spectral motif regions which show altered nucleosome phasing in acf1
7
 background remain 
conserved across insect genomes? To address the issue, DNA sequence conservations scores (15 way 
insect genome alignment derived PhastCons scores, UCSC database) were used. PhastCons scores 
represent a probability of any given DNA base to remain conserved across the aligned genomes, hence 
during evolution. To acquire the probability score for a genomic base, the genomes (here 15 insect 
genomes), are aligned end to end. Using predictive models, a probability of given base to remain in the 
alignment (hence conserved) is calculated. The score of 1 refers to complete conservation across all 
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aligned genomes. The comparison suggests that intronic and intergenic regions carrying the rRoRs are 
well conserved compared to the background (Figure 4.12C). Furthermore, overall percent GC content of 
the spectral motif regions (1 kb intervals, centered on motif midpoint) were similar to genomic 
background suggesting no sequence composition bias, at large.   
Enhancers are often located distant to the TSS and exhibit activating effects on transcription by looping to 
the promoter regions. Activity of genome-wide enhancers has been previously documented in S2 and 
OSC-ovarian cells by STAAR-seq approach (216). Also, the genome-wide contact frequency maps to 
other potential cis/trans sites are worked out earlier in developing embryos by Hi-C methods (217). If the 
spectral motif regions are active enhancers, strong overlap with reported enhancers or closeness to High-
C contact points can be expected. However, poor overlaps (< 5%) or the closeness (assessed by 
identifying nearest distance between the motif sites and the functional intervals) to the above functional 
datasets were observed (not shown). 
The spectral motif regions are conserved across sequenced insect genomes with well phased nucleosome 
arrangement in the WT background that gets fuzzier in acf1
7
. Does this motif phase nucleosome arrays in 
evolutionarily distant species such as yeast or mouse? Nucleosome occupancy data are available in yeast 
(218) and mouse (100) and were explored. Spectral motif was predicted across the mouse and yeast 
genome with p-value threshold < 10
-6
 using MEME. However, nucleosome phasing was not observed at 
the motif center suggesting that the spectral motifs as such do not lead to nucleosome phasing (not 
shown).  
In order to see if any other remodeler mutant would display a loss of regularity at the spectral motif sites, 
published nucleosome profile for Brm knockdown in S2 cells were compared to the control data (192). 
The comparison suggested poor nucleosome alignment at the spectral motif sites to start with and 
subsequent lack of phasing around them in either control or Brm knockdown experiments (not shown). It 
is likely that the S2 cell nuclei were over-digested in both experimental conditions. Another paired end 
nucleosome-mapping data in Drosophila S2 cells is available from Lis lab. To compare whether there are 
changes in phasing observed at the spectral motif site in embryos v/s S2 cells, cumulative dyad densities 
and heat maps were plotted using the S2 data (219). Most of the spectral motif sites in S2 cells show 
regular phasing along them similar to that observed in the embryos. However, a fraction of the sites 
exhibit well-positioned nucleosome on top of the motif site, as an effect burying the site within the 
nucleosomal DNA (not shown).  
A colleague, Dr. Alessandro Baldi, obtained high quality nucleosome profiles in Drosophila neuronal cell 
line, BG3 upon knockdown of ACF1, RSF-1, ISWI or ACF1 & RSF-1. Neuronal tissue from embryos 
and larvae strongly expresses all three remodelers. Immunoreactive ACF1 is strongly concentrated in the 
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neuronal cells while the ISWI and RSF-1 are localized ubiquitously [Section 4.1.3, (143, 160) and not 
shown]. Interestingly, phased arrays can be seen along the spectral motifs in BG3 cells that become 
fuzzier upon ACF1 knockdown or double depletion of ACF1 and RSF-1. Curiously, depletion of ISWI or 
RSF-1 has no effects on nucleosome phasing along the spectral motif sites (not shown).  
Taken together, the findings suggest that repressed and conserved regions display ACF1 dependent 
phasing at the sites of spectral motif. It is not clear whether the motif itself is involved.  
4.3.4 Autocorrelation analysis identifies changes in linker lengths 
The SDE method proves useful in analyzing short stretches of the genomic regions. At a more coarse 
level, autocorrelation function (Acf) was used to derive bulk periodic properties in the nucleosome 
mapping data. Similar to spectral analyses, Acf is also potentially biased by well-positioned nucleosomes 
across the genome. Essentially, Acf calculates correlation coefficient between a given numeric array 
against itself by shifting it in stepwise manner. Here, nucleosome occupancy values (dyad coverage data) 
were subjected to Acf analysis for 1000 shifts (lag length) of 1 bp step size. Acf returns correlation 
coefficients for each of these 1000 comparisons which are plotted against the shifts (Figure 4.13).    
 
Figure 4.13: ACF1 does not organize nucleosomes around transcription start sites (TSS). Changes in nucleosomal 
periodicity are estimated using autocorrelation function. Increased periodicity and subsequent loss are evident in the acf17. 
Autocorrelation calculated for different genomic features suggest that except first four nucleosomes from TSS, the nucleosome 
organization is affected genome-wide. Exemplary analysis for chromosome 2R is shown here. Gray shading along the curve 
represents standard error of mean. 
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To assess whether ACF1 contributes particularly to the regularity of nucleosomal array along certain 
genomic feature, a more defined analysis was performed. Hence, in addition to analyzing the regularities 
at the phased nucleosomes just downstream of TSS, other sites in the fly genome were virtually fused and 
subjected to the autocorrelation analysis. As a result, Acf was calculated along the entire chromosome 
lengths or for selected portions of the genome like gene bodies, first 4 nucleosomes downstream of the 
TSS or intergenic regions (Section 3.6.2). When compared to wild-type, Acf periodicity in acf1
7
 
decreases rapidly after the 3
rd
 autocorrelation peak (dampening) (Figure 4.13) for the entire lengths of the 
chromosomes. This suggests that the nucleosomal array is less regular in absence of ACF1. Similar 
observations were made for the gene bodies or intergenic regions. Interestingly the regular phasing of the 
first 4 nucleosomes downstream of TSS was not affected by ACF1 deletion. This observation 
corroborates earlier reported finding (Section 4.3.3). Apparently, ACF1 contributes to organization of 
chromatin fiber genome-wide but not at the phased arrays downstream of TSS. It is possible that the 
dampening of the Acf peaks arise due to altered nucleosome occupancies.  
It is important to note that Acf analysis is not biased by fragment length distribution in the sequencing 
libraries as the calculations were performed on computationally selected fragments below 200 bp 
(Section 3.6.2). In any case, the overall fragment size distribution in all sequenced samples was 
comparable (Figure 4.9A). It becomes further obvious when fragments of different length regimes were 
computationally selected and subjected to the Acf analyses in WT and mutant background. All the length 
regimes showed shifts and dampening of the Acf peaks in the mutant background (Figure 4.14A). 
Amplitude of the Acf peaks however, appears to correlate with size of the library such that deeper 
sequencing leads to stronger autocorrelation values (Figure 4.14B). Of note, the library sizes need to be 
reduced by more than 2/3
rd
 to see the dampening comparable to acf1
7
 which is not the case. To further 
substantiate the observed differences between WT and acf1
7
, equal numbers (19 x10
6
) of reads were 
randomly sampled from each library and subjected to the Acf analysis. Indeed, the shifts and dampening 
of the Acf peaks were robustly identified in mutant background (Figure 4.14C). Furthermore, changing 
the normalization methods to Z-score did not affect the outcomes (not shown). 
Characterization of acf1
7
 allele suggested that there may be a slight delay in embryonic development 
(Section 4.2, Appendix A3). To assess whether Acf changes are manifested due to unintentional 
comparison of slightly different developmental stages of WT and acf1
7
, a 0-12 hr WT embryo 
nucleosome mapping dataset obtained by Dr. Alessandro Baldi was compared against 2-8 hr old WT 
embryo dataset. The result suggests a minor shifts with no associated array dampening across the 
analyzed chromosome 2R (Figure 4.14D).  
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Figure 4.14: Autocorrelation changes in the acf17 mutant. (A) Observed Acf alterations are independent of fragment sizes. 
Fragments of different lengths, as represented in box headers, were used to calculate autocorrelation function. Representative 
example for chromosome 2R is displayed. (B) Amplitude of Acf change with drastic changes in library size. An illustration 
displays Acf generated on randomly selecting fragments in the range of all to 40% of the original library size. (C) Acf changes 
are observed for randomly selecting 19 Mio sequences from all samples. Graph shows Acf calculated for chromosome 2R. Gray 
shading in (A) and (C) represents standard error of mean. (D) Acf calculated for chromosome 2R in 2-8 or 0-12 hr old embryos is 
displayed.  
 
Linker lengths are the hallmark of nucleosome organization that can vary between actively transcribing 
regions and the silent domains. Acf exhibits periodic maxima that reflect the underlying nucleosome 





 Acf maxima were selected to estimate the linker lengths. The selection is appropriate as in the mutant 
background identification of the maxima beyond 3
rd
 Acf peak is not reliable. The linker-lengths obtained 
from each sample were averaged to derive mean values for the WT and acf1
7
 genotypes for each of the 
following genomic features -entire chromosome, gene bodies, intergenic regions and first 4 nucleosomes 
downstream of the TSS. Clearly, the linker length seems to increase in acf1
7
 (one-tailed Student’s t-test, 
p-value 10
-10
). The mean linker length for WT chromatin was determined to be 47 bp. This compares well 
with the values of linker obtained by (220, 221). By contrast, the linker DNA length in the mutant 
background is apparently increased to 63 bp. For gene body and intergenic regions, the overall variance in 
estimated linker lengths is considerably higher in the mutant, suggesting perhaps a fuzzier underlying 
nucleosome organization (Figure 4.15).  Acf analyses were further carried out to estimate linker lengths 
with respect to gene expression strengths and gene lengths. It appears that strongly expressed genes tend 
Page | 68 
 
to have shorter linkers (42 bp) compared to poorly expressed genes (51 bp), when the expression values 
were categorized into 4 equal sized groups. And, longer genes tend to have overall long linkers (>4.2 kb 
long, 53 bp) than shorter genes (<1 kb long, 35 bp). The length effect may arise due to enrichment of 
introns in longer genes (not shown).  
 
Figure 4.15: Linker lengths seem to increase in the acf17. Autocorrelation plots were used to estimate linker lengths. In the 
mutant background, overall linker lengths seem to increase. Error bars represent standard deviation from the mean. 
 
To assess whether the increased linker lengths or their varied distribution result from reduced nucleosome 
density along these sites, raw reads were mapped along the entire length of the genes. The tag counts were 
compared using multiple testing correction offered in the DESeq2 package in R environment (209). The 
analysis suggests no significant difference in the compared genotypes, at large (Figure 4.16A). However, 
311 genes (adjusted p-value < 0.01) showed reduced nucleosome tag counts in the mutant. Among those, 
the histone gene cluster (1.4 fold to 2.5 folds) was the major contributor. Given the large numbers of 
histone copies, it is likely that such an effect may arise due to improper read assignments. To further 
investigate potential changes in nucleosome densities, read counts were obtained along 200 bp non-
overlapping windows across the genome and assessed for differential nucleosome occupancy using 
DESeq2. These bins were subsequently annotated for “gene body”, “+1 nucleosome” and “intergenic 
regions” by requesting at least 50 bp overlap with the features. After a multiple testing correction (p-value 
<0.05 and at least 2 fold change) 1049 bins (0.16% of total, including 18 that come from the deleted 
ACF1 locus) of reduced and 439 bins of gained nucleosome occupancies in acf1
7 
were obtained against 
WT (total 648,335 genomic bins) (Figure 4.16B). In addition to being a small fraction of total bins, they 
do not enrich for any particular underlying chromatin type (212) (not shown). 
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Figure 4.16: Overall histone density does not change in acf17. (A) Density plot shows FPKM counts of the nucleosome reads 
along annotated genes in Drosophila. Pairwise comparison of WT and mutant using t-test is displayed. (B) Nucleosome 
fragments were counted in 200 bp non-overlapping windows across the genome. Boxplot shows average tag density per bin in for 
each of the three sequenced genotypes. Box represents range of 1st and 3rd quartile with median signal as a separator.   
 
Histone H1 binds long linker DNA to facilitate compaction of chromatin fiber. It is known that NRLs 
vary across genome with respect to the underlying chromatin feature (Section 2.7). How do the 
nucleosomal arrays around spectral motif and those downstream of the TSS compare with respect to 
nucleosome spacing? And is H1 linker histone differentially enriched along these sites? To address these 
questions, ChIP-chip profiles for H1 in the BG3, Kc cells and L3 larvae were examined (modENCODE 
resource, modE3299, 5134, 5073). The background-subtracted tags were counted along the RoRs, 
spectral motif regions, top 20% expressed genes [obtained from Section 4.4] in 2-8 hr WT old embryos 
and active promoter regions [these are Phantom Peaks, described in details in Section 4.5]. Actively 
transcribing genes have less H1 bound compared to the RoRs (that contain 2/3
rd
 non-promoter regions) or 
spectral motif regions (predominantly found in silent chromatin) (Figure 4.17A). To estimate the linker 
lengths along these features, nucleosome dyad densities were obtained along the midpoints or TSS (in 
case of genes) in 2 kb window and subjected to Acf analyses. Importantly, for top 20% expressed genes, 
regions correspond to first 5 nucleosomes downstream of the TSS were used. The Acf plot clearly 
demonstrates that RoRs and spectral motifs have increased NRLs (by 10 bp in WT) compared to actively 
transcribing genes (Figure 4.17B; follow the maxima positions with respect to the vertical dashed line). 
The difference increases even further in the mutant background (to upto 20bp).   
In summary, Acf analysis suggests an overall increase in the linker length in absence of ACF1. These 
estimations are not biased by library size, developmental stage, nucleosome densities or normalization 
methods.  
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Figure 4.17: Linker histone, H1, ChIP signal is enriched along RoRs and spectral motif sites. (A) Background-subtracted 
tag density from the H1 profiles were counted across displayed querying intervals. Enrichment signal along all query intervals are 
displayed in boxplot representation. Active promoters represent Phantom Peaks detailed in Section 4.5. (B) Along the midpoints 
of querying intervals, nucleosome occupancies were obtained in 2 kb windows in combined WT and mutant background. Acf 
was calculated for each query type by fusing the intervals head-to-head (see text for details).  
 
4.3.5 Spectral motif pulls down potential DNA binding factors 
The spectral motif was found in the central linker of a most regular nucleosomal array, which was 
perturbed by ACF1 depletion. These sites were not found to contain nucleosome disfavoring sequences 
such as long dA:dT. Therefore, it is likely that the sequence motif constitutes a binding site for yet 
unknown DNA binding protein and potentially acts as a barrier for subsequent nucleosome array 
formation. Insulator proteins give rise to similar phasing of neighboring nucleosomes. For example, 
human CTCF was shown to position 20 nucleosome long array where the binding site was located in the 
central linker region (101). As most of the spectral motif sites do not show enrichment of known 
insulators, potential motif binders were investigated in collaboration with the Butter lab (IMB-Mainz). 
The analyses involved pull down of the proteins binding to in vitro synthesized motif containing DNA 
fragments and subsequent identification by label-free mass spectrometric quantification. Briefly, 2 top 
scoring predicted spectral motifs (23 bp) were selected and 22 bp of additional DNA sequences at 5’ and 
3’ end from their respective genomic context were included to synthesize 67 bp long motif regions. These 
sequences were concatenated and covalently attached to agarose beads. As a control, two random 23 bp 
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sequences were used in place of the motif. Motif DNA binding proteins were fished from the high and 
low salt Drosophila embryo nuclear extracts (Section 3.3.1, 3.3.2) and quantified in 4 replicates (by the 
Butter lab).  
The likelihood of identifying a true differentially binding protein in the experiment over a control (p-
value) was calculated across the replicates and plotted against the net relative median intensity of the 
corresponding peptide signal for a protein in a Vulcano plot. An arbitrary cutoff value was selected based 
on the control and samples intensities to derive a list of potential motif sequence binding proteins. 
Unfortunately, high salt extract pulldowns did not show any enriched candidates and were hence omitted 
from further analysis. Amongst others, kayak, Q9VQ77, abrupt, cis, jra and mod(mdg4) were reliably 
identified in both pull downs (Figure 4.18). These proteins are the candidates that bind either to the 
spectral motif or the 5’ end of the bait sequences.   
 
Figure 4.18: Spectral motif pull down identifies several potential chromatin binding candidates. Two motifs, as displayed 
on the top of each plot area, were used for the pulldown experiment. P-values corresponding to reliably identifying a protein were 
plotted against their median control corrected intensities. An arbitrary cutoff was used to generate Vulcano representation. 
Proteins enriched in motif pulldown or control pulldown labelled and shown with pink marks. The false hits are displayed with 
green marks. Proteins reliably identified in both experiments are displayed in red.  
 
Modifier of mdg4 (mod(mdg4)) is a member of a gypsy insulator complex and potentially interacts with 
CP190 or Su(Hw) to alleviate transcriptional repression (222). It carries BTB (bric-a-brac, tramtrack and 
broad complex) domain that is a conserved protein-protein interaction motif found in several transcription 
factor, chromatin remodelers and insulators related to development. Studies also suggest that mod(mdg4) 
can form a stable higher order multimers (223). To understand the nature of mod(mdg4) binding to 
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spectral motif, ChIP-chip profile mapping mod(mdg4) in the S2 cells and L3 larvae were analyzed 
(modENCODE resource, modE2674, 3789 and 4094). Background-subtracted tags were counted along 
the reported mod(mdg4) peaks, RoRs, spectral motif sites and active promoters [the Phantom Peaks, 
described in details in Section 4.5]. None of the querying intervals, except mod(mdg4) peaks, showed 
mod(mdg4) ChIP signal enrichment (Figure 4.19A). To gain further insights into the distribution of 
mod(mdg4) peaks with respect to the motif sites, the cumulative distribution of the peak distance to the 
spectral motifs was plotted. The analyses suggest that more than half mod(mdg4) peaks are at least 1 kb 
away from the spectral motif region (Figure 4.19B).   
Q9VQ77 is an uncharacterized chromatin binding protein, which has been mapped using DamID (224). 
Top 1% scoring probes in the two replicates were identified and regions of potential factor binding and 
retrieved as peaks as described in Section 3.6.7. Q9VQ77 peaks are even remotely located to the spectral 
motif sites and the overall signal seems to be enriched along the pericentric heterochromatin region (state 
7) (not shown). 
 
Figure 4.19: mod(mdg4) ChIP-chip profiles do not show signal enrichment along the spectral motif regions. (A) 
Background-subtracted tags were counted across displayed querying intervals. Active promoters refer to Phantom Peaks 
[described in Section 4.4]. Spectral motifs intervals were adjusted to 1 kb length by centering around the motif midpoint. (B) 
Cumulative nearest-distance of a peak from the spectral motif is plotted against the absolute distance for the comparisons. 
Reported peak for mod(mdg4) profiles were used.   
 
Hence, it appears that spectral motif region may be bound by either some TF (such as Kay, Jra) or 
insulators or both. ACF1 may preferentially organize nucleosomes along them. I am currently following 
up this part to further scrutinize whether the motif binders have any measurable effects on nucleosome 
organizations.  
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4.4 ACF1 deletion does not lead to major transcriptional deregulation during embryogenesis 
Transcriptional outcome of a cell can be influence by various aspects of chromatin organization. Deletion 
of ACF1 leads to sloppy chromatin organizations which at high resolution level show increased 
nucleosome linker lengths and fuzzier organization along homogenously well-phased nucleosome in 
embryos [Section 4.3]. Whether ACF1 plays a role in transcription regulation directly or indirectly via 
chromatin structure remains interesting. In order to assess the effects of ACF1 on transcription, 
transcriptomes were mapped in 2-8 hr old embryos of w1118, yw (WT) and acf1
7
 genotypes [Section 
3.4.4, 3.6.5, Appendix A3]. In total, 3, 2 and 4 biological replicates were sequenced at comparable depth 
for the respective genotypes. For all subsequent analyses the mutant samples were compared against 
combined WT (or WT in following section).  
To assess potential change in coding and non-coding transcripts, ribosomal RNA depletion approach was 
used for preparing RNA samples from the 2-8 hr developmental stage (225). At present, spurious 
transcription or small ncRNA cannot be estimated in current work due to technical limitations. 
Furthermore, a reliable assessment of antisense-transcription remains beyond scope of this study as the 
adopted protocol for library preparation did not include Actinomycin-D during reverse transcription step 
(226) (Section 3.4.4). The sequencing libraries for the analyses were prepared by Fr. Krause and Dr. C. 
Regnard. The sequenced single end libraries have average library sizes and standard deviation as 
following – (yw) 26.7 x106 (3.1 x106), (w1118) 25.4 x106 (0.67 x106) and (acf17) 30.2 x106 (5.88 x106). 
 
Figure 4.20: Overall transcriptional program is not affected in the acf17. Vulcano plot showing gene expression changes 
observed in acf17 when compared against WT (calculated as differential over WT). Red dots in the plot represent the genes 
identified as differentially expressed (p-value for multiple testing correction <0.01).  
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Read counts for the exons from the sequenced samples were obtained using HTSeq package (Section 
3.4.4) and the variance corrected differential gene expressions were estimated using DESeq2 package. In 
total, 181 down- and 172 upregulated genes were identified in the mutant background (p-value <0.01, at 
least 2 fold change) (Figure 4.20). Downregulated genes in the mutant tissue enrich for functional 
categories such as head segmentation, transcriptional regulation, neurogenesis, muscle development and 
imaginal disc pattern formation (DAVID online tool, p-value < 2 X 10
-6
). It is possible that enrichment of 
these terms manifest from a slightly delayed development of mutant embryos (Appendix A3). The 
upregulated genes do not show enrichment of any functional categories. As the number of misregulated 
genes is fairly small, assessment of alterations in nucleosome organization along them becomes 
unreliable. This dataset allows for estimating changes in non-coding or stabilized non-polyA transcripts. 
Deletion of ACF1 did not affect most of the annotated non-coding transcripts. For further assessing 
changes in RNA-tag densities across the genome, the tag counts were obtained in either 200 bp or 500 bp 
non-overlapping windows. Subsequent analysis of the counts using DESeq2 package in mutant and WT 
suggest only handful of intervals with altered tag counts. 
RNA-seq data can be potentially used to assess alterations in the transposon expressions. Substantial 
fraction of eukaryotic genomes is composed of transposable elements. These mobile genetic elements, if 
expressed, can lead to an RNA level toxicity, a risk of lateral mobilization in the genome causing DNA 
double strand breaks and a potential genome instability (227). However, studies from plants further 
suggest that transposable elements may play a role in evolution of the genomes (228). Roughly 30% of 
the Drosophila genome is composed of transposable elements and hence warranted additional attention. 
Since the transposon copies are often unannotated, following approach was used. In total, 179 
transposable elements were retrieved from Berkeley Drosophila Genome Project (BDGP) and raw reads 
mapping along these sequences were counted from the RNA-seq and nucleosome mapping datasets. 
Differentially expressed transposons (adjusted p-value <0.05, minimum fold change 2) and copy number 
changes (adjusted p-value < 0.05, minimum fold change 1.2) were identified by applying multiple testing 
correction. Interestingly, 10 LTR transposons and 4 LINE-like elements were found upregulated in the 
mutant background, without apparent increase in the DNA copy numbers (Figure 4.21). The thresholds 
applied for identifying the differential expression in this analysis are arbitrary.  
The mutant flies analyzed in this study had been kept as homozygous stocks for at least 25 generations. If 
the transposable elements of the LTR class are derepressed, they may translocate in cis or trans to the new 
locations in the acf1
7
 background. Assuming that the transposon DNA is packaged with similar densities 
of nucleosomes, paired-end nucleosome occupancy data was used to investigate lateral mobilization 
events. Briefly, the mate pairs whose one end maps to the transposon and another end to the rest of the 
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genomic sites were selected. All potential genomic locations from such hybrid mate pairs were obtained 
and combined if they fall within 1 kb distance to each other. These locations were represented by the 
midpoint of the fused intervals. The tag counts so-obtained for each of the combinations were analyzed by 
DESeq2. However, this study suffers from the low numbers of hybrid mate pairs leading to a very few 
counts (median 52, mean 127 counts) which is presents an inconclusive statistics.  
 
Figure 4.21: LTRs are upregulated in the mutant background. DNA copy number was estimated from the nucleosome 
positioning data and compared to the RNA-seq data from the same genotypes [see text for details].  
4.5 Attempts to map genomic targets of ACF1 leads to identification of ‘Phantom Peaks’ 
ACF1 deletion has subtle effects on nucleosome organization predominantly distant to the TSS. How is 
ACF1 localized with respect to the affected sites? Are there any correlations between ACF1 binding and 
regularity around the spectral motifs? With these questions in mind, I mapped ACF1 using variety of 
immunoaffinity reagents in the embryos of age 0-12 hr (Section 3.4, 3.6.6, 3.6.7). A parallel project by 
Dr. Baldi in the lab aims at studying RSF-1 remodeling factor using similar approaches and involves 
mapping the genomic binding sites of RSF-1. I used 2 RSF-1 ChIP-seq profiles generated by Dr. Baldi 
and Fr. A. Zabel for comparisons. As an outcome of the mapping analyses, we became aware of 
consistently identified false positive enrichment regions across the genome. These regions are further 
found to be enriched along several of the publically available modENCODE ChIP-seq profiles. Following 
section is already published with similar final figures (229).  
4.5.1 Multiple reagents identify overlapping genomic targets of ACF1, persisting in mutant 
Genomic target identification of ACF1 was carried out by employing a panel of immunoaffinity reagents. 
These reagents included a) two different rabbit polyclonal antibodies (Rb1, Rb2) raised against the C-
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terminus of ACF1 (Appendix A2.1), b) a rat monoclonal antibody (3F1) that detects the N-terminus of 
ACF1 and c) a goat αGFP polyclonal antibody for detecting GFP tagged ACF1 expressed from a 
recombinant fosmid transgene (230). The acf1
7
 allele was used for characterization of the antibodies 
(Figure 4.4A). Rb1 and 3F1 αACF1 antibodies show highly specific signal on the WB, while Rb2 show 
minor cross-reactivity to other extract proteins. Previously published monoclonal antibody against ACF1 
(8E3) was less efficient in pulling down the antigen under ChIP conditions. The deletion of ACF1 gene 
was confirmed by the absence of sequencing reads for the corresponding genomic region in input 
chromatin of the acf1
7
 (Figure 4.4B). 
 
Figure 4.22: ChIP-qPCR assessment of the antibodies. Immunoprecipitation with all antibodies enrich genomic candidate 
ISWI binding sites suggested from modENCODE ISWI profiles, mapping to the Fz2, CG6465, Ro/T48 loci. Intron 9 of timeout 
serves as a negative control region. For each amplicon the corresponding ChIP-chip profile of ISWI as provided by 
modENCODE I shown on the top. The position of the amplicon is indicated by a red box. Bottom: ChIP-qPCR analysis using the 
indicated antibodies. Enrichments are given in percent of the input values. 
 
Likewise, a rabbit polyclonal serum raised against RSF-1 was characterized for its specificity in WB 
using embryo nuclear extract prepared from the mutant rsf1
3602
 (143) and IFM by Dr. Baldi elsewhere 
(229). Anti-RSF-1 antibody was generated in Peter Verrijzer lab (Erasmus University Medical Center, 
3015 Rotterdam, Netherlands) (Appendix A1.3). The enrichment analyses were performed for ACF1 and 
RSF-1 using protein specific antibodies by quantitative PCR. Candidate genomic loci in this analysis 
were derived from modENCODE ISWI ChIP-chip profiles in Kc, S2 and BG3 cells (modE3030, 3031, 
3032 and 5062) with strong ISWI enrichment. The data for RSF-1 antibody in above picture was obtained 
by Fr. A. Zabel and presented here for illustration purpose, with permission (Figure 4.22).  
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Wild-type embryos collected 0-12 hr after egg laying were fixed with formaldehyde and sheared with 
Adaptive Focused Acoustics (Covaris) to 200 bp mean fragments and subjected to ChIP-seq analysis 
(Section 3.4.1-3). Using 3 ACF1-specific antibodies (Rb1, Rb2, 3F1) a total of 7 profiles in WT 
background were obtained. Visual inspection revealed a strong overlap and localization of the peaks 
along promoter regions (Figure 4.23A, blue tracks). In case of ACF1, 3F1 monoclonal antibody (mAb) 
shows the best signal-to-noise ratio which is followed by Rb2 and Rb1. Despite the variable strengths, 
peaks can be clearly identified against the background when the profiles are visually browsed.  
 
Figure 4.23: ChIP-seq profiles obtained for ACF1 and RSF-1 in wild-type and mutant embryos show strong overlap. (A) 
Smoothed and background-subtracted tag density profiles are displayed over a representative region of chromosome 2L. The 
profiles were obtained with antibodies directed against ACF1 or RSF-1 by ChIP from chromatin of wild-type (WT) and mutant 
embryos as indicated to the right. The positions of Phantom Peaks are indicated by black boxes in the center track and grey-
shaded rectangles across all profiles. (B, C) Venn diagrams illustrating the overlap between the peak regions of (B) ACF1 in WT 
and acf17 mutant embryos and (C) RSF-1 in WT and rsf-13602 mutant embryos. The peaks overlapping in (B) or (C) were termed 
‘ACF1 common’ or ‘RSF-1 common’, respectively. (D) Venn diagram illustrating the overlap between ‘ACF1 common’ and 
‘RSF-1 common’ peaks. The union of those peaks yields a set of 3090 loci, which we term ‘Phantom Peaks’. 
 
Active promoter localization is counterintuitive to previous observation where silent chromatin regions 
carrying spectral motifs were the only places where effects of ACF1 were detected. Earlier studies in 
yeast had identified actively transcribing chromatin as a source of false positive signals. To rule out the 
such bias, pre-immune serum-based normalization was suggested (231) and therefore such preimmune 
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control was further obtained. However, visual inspection of the preimmune profiles or data normalization 
against them could not explain the active promoter enrichment of ACF1 (not shown). Curiously, both the 
spectral motif regions and the promoters of misregulated genes in acf1
7
 showed poor ACF1 ChIP-seq 
signal suggesting a functional disconnect.  
The observations maybe explained in several hypothetical ways. A) Stably identifiable ACF1-DNA 
interactions in ChIP assays are not functional. B) It may be difficult to obtain ACF1 footprint along its 
functional sites, due to the transient interactions. C) There is a functional redundancy or D) the observed 
regions of enrichment are false positive altogether.  
Interestingly, another viewpoint was offered by a parallel study in the lab by Dr. Baldi who found that the 
combined deficiency of ACF1 and RSF-1 lead to synthetic lethality at the embryonic stage while the 
escapers have defects during all subsequent stages of development. To assess whether the functional 
complementarity arises at molecular level, genomic target sites for RSF-1 were identified by ChIP-seq in 
collaboration with Dr. Baldi. The smoothened, background-subtracted sequence tag density profiles show 
strong similarities in the genomic targets of both remodelers (Figure 4.23A). RSF-1 antibody appears to 
produce excellent signal to noise ratio when juxtaposed to the ACF1 profiles. Most of the enrichment 
regions localize in the promoter regions, suggesting an extensive co-localization of ACF1 and RSF-1. 
To substantiate the localization patterns for ACF1 and RSF-1, respectively 3 (by myself) and 1 (by Dr. 




 mutant embryos that do not express the 
corresponding factors were obtained. Astonishingly, the profiles in the mutant background were nearly 
identical to WT. Given that both the mutant alleles are null, the observed enrichment of the signal in both 
backgrounds (WT and mutant) is must be considered false positive.  
4.5.2 Identification of the ‘Phantom Peaks’ 
To further understand the nature of false positive signals, peaks were called using HOMER software 
(203) for ACF1 and RSF-1. The profiles generated by different reagents and their biological replicates 
were considered as replicates and the consensus peak lists were obtained for both remodelers in WT and 
mutant background. HOMER offers an advantage in which peaks of fixed width are called that confer 
increased sensitivity. For the remodeler profiles, peaks obtained in the pre-immune control datasets 
(n=60) were omitted to identify only antibody-specific peaks. 
Among the identified genomic sites, 1240 peaks were identified in WT and mutant acf1
7
 background for 
ACF1. The peaks exclusive to mutant background were not identified as peaks in WT due to the peak 
calling thresholds but carry a visible and persistent enrichment. Similarly, RSF-1 antibody retrieved 3030 
common regions from WT and rsf1
3602 
embryo chromatin (Figure 4.23B, C). Majority of the peaks 
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identified as false positives for each of the remodelers, in turn show strong overlap (Figure 4.23D). The 
lists of false positive peaks from either sample were therefore combined to generate a final peak list of 
3090 unique peaks -referred as ‘Phantom Peaks’.  
The similarities amongst 16 ChIP-seq profiles used here were determined along the Phantom Peak regions 
using Spearmann-ranked correlation. The method works by ranking the signal density along each profile 
and then comparing the ranks thereby obviating the differences in ChIP-seq signal strengths. The analysis 
indicates a good correlation within the replicate profiles and a clear separation from input samples 
(Figure 4.24).  
 
Figure 4.24: Comparison of the ChIP-seq profiles. Correlation between the ChIP-seq profiles. The size-normalized sequence 
tags were counted for all 16 ChIP and 10 input samples in the Phantom Peak regions. The matrix illustrates the degree of 
similarity obtained by a correlation analysis using Spearman rank-based correlation. The heat map displays the correlation 
coefficient values for all pairwise comparisons [Appendix A4 for file descriptions]. 
 
Some trivial explanations for the appearance of Phantom Peaks could be rule out. First, these peaks are 
not enriched in the input chromatin suggesting no apparent bias in chromatin solubility along the 
accessible regions. Second, ACF1 specific antibodies were raised against different and distinct parts of 
the protein in different species. Hence potential shared epitope cross-reactivity for ACF1 and RSF-1 
antibodies or cross-talk of their sera can be excluded. And third, the bead control (where a primary 
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antibody is omitted) or the mock control (preimmune control) does not enrich for Phantom Peaks (not 
shown). It is interesting to stress here that Phantom Peaks manifest only with the real target specific 
antibodies. 
Antibody titration is an important aspect of ChIP-seq procedures as a large excess should be avoided. 
Therefore, ACF1 antibodies were titrated in the dilution range of 1:62.5 (8 µl) to 1:1000 (0.5 µl) (not 
shown). The titration suggests that use of 4 µl antibody per 500 µl ChIP is within the linear signal range. 
Also, earlier studies in the lab that define functionally meaningful genomic target sites for other proteins 
had used similar amounts of antibodies , for example JIL-1 (5 µl), MSL1 (5 µl), MSL2 (1 µl), MSL3 (4 
µl), MLE (4 µl) and MOF (2.5 µl) (207, 210, 232). Furthermore, total immunoglobulin (Ig) fraction in 
preimmune and immunized sera (Rb2) was estimated by visualizing the protein retained on protein A+G 
bead mix (1:1 in volume). This suggested that the beads are not saturated with the use of 4 µl serum. 
Qualitative comparison of Rb2 and pre-immune serum further suggested that overall Ig content of both 
sera were comparable (not shown). 
It has been previously suggested that unannotated high copy number regions in the genomes can lead to 
false positive peak calls during the peak calling procedures (233). Also, it has been observed in this study 
and elsewhere that the actively transcribing regions are enriched in the inputs. Therefore any biases 
should be accounted for by employing input sequencing control in the normalization method (234). 
Phantom Peaks are not due to this numerical artifact. First, the ChIP-seq profiles are corrected for the 
input control. Second, visual inspection of browser screen shots reveals their predominant location in the 
promoters. And third, Phantom Peaks are not enriched in the input samples as can be seen in the library-
size normalized tag counts plotted along the Phantom Peak summits (Figure 4.25). Moreover, the 
Phantom Peak regions were compared to the 30599 regions obtained as the top 1% scoring regions in the 
input samples (high read density regions, HDRs). These HDRs correspond to ~3% of the genome. The 
analysis revealed that only 5% of the Phantom Peaks overlap with the top 1% input signal (p-value <0.05) 
(235) indicating that the peak regions are either enriched during immunoprecipitation or selectively 
amplified during library preparation. 
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Figure 4.25:  Phantom Peak regions show specific enrichment in the ChIP samples. Library size-normalized reads are 
plotted along all 3090 Phantom Peak regions for the ChIP and corresponding input control samples. The header   includes 
immunoprecipitated protein, the antibody, the corresponding genotype and the replicate. 
 
4.5.3 ‘Phantom Peaks’ tend to occur in promoter regions of highly transcribing genes 
Total 3090 orthogonal regions were identified in this section as potential false positives in an attempt to 
map chromatin remodeling factors ACF1 and RSF-1 genome-wide. Interestingly, the annotation of the 
peaks reveals that about 92% of the peaks fall in promoter or TSS proximal regions (Figure 4.26A). 
Further, 8% of Phantom Peaks localize to transcription termination sites (TTS) and introns. The sequence 
composition was assessed by identifying the motif signatures along Phantom Peaks using HOMER. De 
novo DNA analysis reveals that promoter-specific motifs are enriched in up to 40% of the peaks (Figure 
4.26B). For several highly enriched motifs, the corresponding interacting proteins in Drosophila are not 
known, however these motifs share strong similarities to known recognition motifs of mammalian or 
yeast proteins. For example, yeast RTG3 or mammalian TBF1 and BRCA1 motifs are present in one third 
of the sequences. Interestingly, besides the consensus binding sites for a number of transcription factors, 
the sites for insulator proteins such as BEAF-32 and CTCF, also were also present to a considerable 
extent in the Phantom Peaks (Figure 4.26B). Drosophila genome is AT-rich (57%) and this composition 
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is reflected in all the sequencing libraries, ruling out any biases during sequencing or bioinformatics 
analysis.    
 
Figure 4.26:  Characterization of the Phantom Peaks. (A) Distribution of the 3090 Phantom Peaks between promoters, 
introns, transcription termination sites (TTS) and intergenic regions. Localization to coding regions or UTRs was negligible. (B) 
Prevalent sequence motifs within Phantom Peak regions. For each motif the sequence logo, its p-value of enrichment, the fraction 
of regions with a motif and the best matching motif in the JASPAR database are indicated. (C) Annotation of Phantom Peak 
localization according to the ‘Nine States’ of chromatin (212).  
 
The genes carrying Phantom Peaks in their promoter regions enrich for house-keeping functions such as 
cytoskeletal/ spindle organization, vesicle transport, transcription and RNA metabolism. A subset is 
further enriched for embryonic morphogenesis function. In line with this annotation, 70% of the peaks 
map to open chromatin regions derived from  S2 cells [state 1 in the modENCODE nomenclature (212)]. 
This state is characterized by prevalent active histone modifications such as H3K4me3 and H3K9ac 
(Figure 4.26C). S2 cells are derived from later stages of embryonic development and can give good 
approximation to the chromatin states for mixed-stage overnight embryos. Curiously, 16% of Phantom 
Peaks maps to the repressed chromatin in S2 cells, which carries H3K27me3 marks (Figure 4.26C).  
How do the active promoter regions carrying Phantom Peaks compare during the course of development? 
In order to address this issue, Phantom Peaks were compared against the ChIP-seq profiles of different 
histone modifications deposited in the modENCODE database. For counting such overlaps, a binary 
scoring scheme was used. For example, an overlap of the histone modification profile peak with the 
Phantom Peak is awarded a score of 1 else 0. The resulting heat-map shows that Phantom Peak regions 
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tend to harbor active chromatin marks during the entire span of Drosophila development (Figure 4.27). 
To elucidate further, the promoters carrying Phantom Peaks were analyzed for their expression strengths 
using Drosophila developmental transcriptome (214). Indeed, these promoters tend to be highly active 
(Figure 4.28A) and show strong activity across all stages of embryonic development when compared to 
other modENCODE expression profiles (either RNA-seq or microarray).  
 
Figure 4.27: The Phantom Peak regions tend to harbor active chromatin marks during different stages of development. Phantom Peak 
regions were mapped across active (H3K4me1/me3, K9ac, K27ac) and repressive (H3K9me3/ 27me3) histone modification profiles deposited in 
the modENCODE resource. Binary scoring of the presence of a mark along the investigated site was used to generate the heat map. Dark blue 
represents overlap with the histone mark. 
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In agreement with their mapping to active promoters, most of the Phantom Peaks co-localize with sites of 
transcription factors clustering (236). These regions have been extracted from the ChIP profiles of 41 
sequence-specific Drosophila transcription factors (a modENCODE and BDTNP initiative). The analyses 
identified 1962 High Occupancy Target (HOT) genomic regions that are bound by more than 8 and up to 
24 different transcription factors. These sites of clustered ChIP signals collectively constitute roughly 3% 
of the genome. It is important to note that not all HOT sites have known functions in transcription control. 
It has been speculated that they may just serve as storage hubs for transcription factors and chromatin 
proteins. It appears that roughly one third of the Phantom Peaks overlap with annotated HOT regions 
(Figure 4.28B).  
 
Figure 4.28: Phantom Peaks are localized to highly expressing and crowded sites. (A) The prevalence of Phantom Peaks 
correlates with promoter strength. Promoters were binned into five equally-sized groups based on the 10-12 hour old WT embryo 
expression data (214). For each group the gene expression levels and the fraction of promoters containing a Phantom Peak are 
displayed. (B) Phantom Peaks tend to map to clusters of transcription factor binding sites. Sites containing the indicated number 
of transcription factor binding events were derived from modENCODE (236). Sites with more than 8 transcription factor binding 
events are termed ‘HOT regions’. The graph shows the fractions of Phantom Peaks that harbor the given number of transcription 
factor binding sites. 
 
4.5.4 Manifestation of the Phantom Peaks is independent of formaldehyde concentration 
It is important to note that the formaldehyde (FA) concentration used for tissue fixation in this study 
(3.7%) was higher than modENCODE protocols (1% for cells and 1.8% for tissues) (Section 3.4.1). 
However, the embryo fixation protocol had been previously optimized in the lab and was successfully 
used to map MSL1 protein (237). The resultant MSL1 profile shows a functionally relevant enrichment of 
the factor that is distinct from Phantom Peaks. Nevertheless, for more direct comparison to the 
modENCODE profiles, ChIP-seq experiments were repeated using 1.8% FA in embryos. Two profiles 
each in the WT and acf1
7
 were obtained using Rb2 and 3F1 antibodies to assess whether the Phantom 
Peak enrichment are FA concentration dependent.  
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Figure 4.29: Comparison of ChIP-seq profiles obtained using lower formaldehyde concentrations. ChIP-seq analysis for 
ACF1 was performed using 3F1 and Rb2 antibodies in WT and mutant background where 0-12 hour old embryo tissue was fixed 
using 1.8% formaldehyde. (A) Background-subtracted tag density profiles in WT (blue) and acf17 (red). For comparison, Rb2 
ACF1 ChIP-profile obtained using 3.7% formaldehyde is juxtaposed. (B) ChIP-seq signal along the previously identified 3090 
Phantom Peaks is displayed as cumulative density or heat-plot. The column headers indicate profiled protein and the genotype. 
Changes in formaldehyde concentration are indicated in brackets. (C) Overlap analysis of peaks identified in 1.8% formaldehyde 
fixed WT and acf17 tissues with the Phantom Peaks. (D) Genomic feature annotation; (E) chromatin state assignment and (F) 
transcription factor co-localization along the “Phantom Peaks (1.8% FA)” are displayed.   
 
All sequencing libraries were processed as described in (Section 3.6.6). Cross-correlation analyses and 
visualization of background-subtracted tag densities suggested that these profiles are of moderate quality 
compared to the excellent profiles obtained previously (not shown, Figure 4.29A). However, along all 
Page | 86 
 
the previously defined Phantom Peak locations a persistent enrichment was observed either visually in the 
genome browser or computationally by plotting either cumulative densities or heat maps (Figure 4.29B). 
Fewer peaks were detected by HOMER in both WT and mutant profiles; however they completely 
overlap with the Phantom Peaks. To assess the nature of these peaks identified upon lowering FA 
concentration, the combined set of 460 WT and mutant peaks was identified as “Phantom Peaks (1.8% 
FA)”. Subsequent analyses of the 460 peaks clearly show that they are preferentially localized in the 
promoter regions marked by active chromatin modifications such as H3K4me2/3, H3K9ac (State 1). 
Moreover, these regions preferentially overlap with transcription factor crowding regions (or HOT 
regions) (Figure 4.29C-F). 
 
Figure 4.30: Phantom Peaks can be identified upon lowering the formaldehyde concentration from S2 cells. (A) 
Background-subtracted tag smoothened tracks show ACF1 ChIP-seq profiles from 1% FA fixed S2 cells using two antibodies. 
Enrichment along the Phantom Peaks is visible. (B) Peaks identified in S2 cells strongly overlap with Phantom Peaks. (C) 
Cumulative density plot and heat-map representation of the ACF1 ChIP-seq signals along Phantom Peaks in combined S2 cell 
profiles. The log transformed signal in the heat-map appears quantized due the use of low resolution input normalized ChIP-seq 
wiggle files calculated by SPP package. 
 
Furthermore, S2 cell chromatin was prepared using 1% FA according to several modENCODE 
publications (212, 238). This chromatin was subjected to ACF1 ChIP using Rb2 and 3F1 antibodies. S2 
cell ChIP-seq profiles are of excellent quality as judged by the cross-correlation analysis and high signal-
to-noise ratio (Figure 4.30A). Out of 1652 consensus peaks identified by HOMER, 76% overlap with the 
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Phantom Peaks with a visibly clear enrichment of the S2 ChIP signal along almost all Phantom peaks 
(Figure 4.30B-C).  
Taken together, the data suggests Phantom Peak occurrence is not a result of specific FA fixation 
condition. 
4.5.5 Prevalence of Phantom Peaks in the modENCODE profiles 
The Phantom Peaks are not the outcome of the Covaris shearing method. Earlier, the protocol had been 
successfully used in the lab to map male-specific-lethal (MSL) proteins to specific genomics sites that are 
distinct from Phantom Peaks (207). For example, only 10% and 4% of the MSL2 and MLE peaks, 
respectively, show overlap with Phantom Peaks (p-value < 0.05)(235).  
To further explore whether Phantom Peaks are limited to some specific aspects of Covaris shearing 
methodology, all ChIP-seq profiles deposited in the modENCODE resource were mined to identify their 
overlaps with Phantom Peak loci. In total, 153 non-histone chromatin protein and 151 histone 
modification ChIP-seq profiles were compared against the Phantom Peaks, requesting an overlap of at 
least 50 bp. The statistical significance of the overlap intervals between two peak sets was calculated 
using the asymmetric comparison framework outlined by Chikina and Troyanskaya by considering a 4 
kilobase (kb) window centered at TSS as reference regions (235). This choice of reference is appropriate 
as 92% of Phantom Peaks are localized within such regions. The analysis for non-histone protein ChIP-
seq profiles reveal that 31% of the modENCODE profiles consist of peak sets with more than 20% (p-
value <0.05) of the reported peaks overlapping with Phantom Peaks (Figure 4.31A). 
To ascertain the findings, some of the modENCODE profiles were re-analyzed using the current data-
analysis workflow (Section 3.6.6). The overlap analysis indicates that there are several similar profiles for 
example, those for transcription (co-)regulators such as Sin3A, Fer-3, Chriz and Hr78 (55%, 53%, 39%, 
24% respective overlap, p-value <0.05), histone deacetylases HDAC1 and HDAC6 (31%, 25% respective 
overlap, p-value <0.05) and insulator proteins such as BEAF-32, CTCF and CP190 (36%, 26%, 23% 
respective overlap, p-value <0.05). These overlap percentages probably underestimate the numbers of 
shared peaks considering the fact that not all potentially enriched regions are called by the peak calling 
softwares in case of Phantom Peak and modENCODE, due to thresholds. When the similarly processed 
tracks for weakly overlapping factors such as Prd and Su(H) (13%, 1.4% overlap, p-value <0.05) and 
representatives of the high overlapping factors were visualized side-by-side, there appears a clear visual 
enrichment along the Phantom Peaks in later cases (Figure 4.31B).  
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Figure 4.31: Phantom Peaks coincide with peaks of several modENCODE profiles. (A) Peaks called by mod-ENCODE on 
153 different non-histone chromatin factors were tested for overlap with Phantom Peak regions. For each profile the scatterplot 
graph depicts the number of peaks defined by modENCODE and the fraction of these peaks overlapping with Phantom Peaks (p-
value <0.05). The p-values indicate the significance of proximity of the modENCODE profile peaks to the Phantom Peaks. (B) 
Smoothed and background-subtracted tag densitiy profiles of selected modENCODE profiles are shown in a representative 
genomic region on chromosome X. The positions of Phantom Peaks are indicated by black boxes and grey-shaded rectangles 
across all profiles. 
 
Comparison of the profiles for different factors across different developmental time points suggests that 
there is apparently no preference for a factor or for a developmental stage where the overlap between 
Phantom Peaks and a factor-ChIP is strongest (Figure 4.32). Interestingly, visual inspection reveals a 
strong correlation between Phantom Peaks and several insulator protein profiles (Figure 4.31B). Indeed, 
Phantom Peaks show strong coincidence with the ChIP-seq peak sets obtained for CP190, CTCF, BEAF-
32 and Su(Hw) from 12-14 hour old embryo chromatin, (82%, 47%, 81% and 25%, respectively). 
Curiously, many of these insulator peaks do not contain respective consensus binding motifs. Only 9.2%, 
22.2% and 24.8% of BEAF-32, CTCF and Su(Hw) peaks contain the target sequence motif to which these 
Page | 89 
 
insulators are documented to bind. Similar levels of overlaps were also found for the insulator peaks 
documented in S2 cells where many peaks do not contain the binding site motifs. It is possible that the 
remainder of the sites obtained as peaks for the insulator proteins after crosslinking may be due to 
targeting principles other than direct DNA binding (239, 240) or these peaks may even contain false 
positive signals just like Phantom Peaks. 
 
Figure 4.32: modENCODE profile overlaps with the Phantom Peaks. Heat map displaying the percent overlap of all 
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Figure 4.33: The modENCODE peaks overlapping with Phantom Peaks seem to have higher calculated peak strengths. 
We selected 96 non-histone modENCODE ChIPseq profiles for which peak scores were provided. The scores were quantile-
normalized for each profile and partitioned into set overlapping or not with Phantom Peaks. Both sets are plotted as boxplots.  
Panel headers indicate modeENCODE accession number, target and developmental stage. 
 
It is possible that the peaks are identified in regions where the signal-to-noise ratio is not particularly 
strong. Such apparently false calls have low associated peak scores compared to the high signal peaks. 
Total 96 non-histone ChIP-seq profiles were analyzed to assess the trend. Surprisingly, the modENCODE 
peaks that overlap with Phantom Peaks are amongst the high scoring peaks in many ChIP-seq profiles of 
the epigenetic regulators (Figure 4.33). 
4.5.6 DamID mapping identifies similarities and differences to the Phantom Peaks 
DamID offers an antibody-free approach to map proteins of interests. In this approach, chromatin protein 
of interest is tethered by E.coli Dam DNA methylase and expressed at very low level from a minimal 
promoter. The fusion protein will methylate DNA in vicinity of its chromosomal binding sites which can 
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be subsequently analyzed by methylation-specific restriction digestions and hybridization or sequencing 
(241). Steensal lab has published 219 DamID profiles (including replicates) for large numbers of 
chromatin factor under native or RNAi conditions from Drosophila Kc cells (224, 242). Kc cells are 
derived from 8 -12 hr old dissected embryos and in principle should give a reasonable proxy for the 0-12 
hr old embryos. The reported signals for DamID profiles were already normalized against Dam only 
background control. Therefore, the enrichment regions for the DamID profiles were defined by retrieving 
top 1% scoring probes on the chip, followed by extending them to 1 kb and fusing overlapping intervals. 
In total, 29 profiles corresponding to 16 chromatin proteins (CG4617, CG9797, TIP60, BEAF32B , 
DMAP1, TBP, CG7928, PHOL, FAIRE, CG10267, CG4936, SIN3A, DWG, MNT, MAX, PCAF) show 
20-40% peak overlap with Phantom Peaks (p-value < 0.05) (Figure 4.34A-B).   
We reason that genomic regions identified by DamID are likely to represent bona fide binding sites, even 
if they are among the Phantom Peaks list. Phantom Peak regions that are not recovered during DamID are 
most likely to be false positive. There are similarities and differences in the comparison of DamID 
profiles to the crosslinking ChIP experiments. For example, Sin3A and BEAF32 overlap with the 
Phantom Peaks. On the contrary, DamID profiles for CTCF and Su(var)3-9 show very poor overlap with 
the Phantom Peaks, unlike their ChIP. Of note, ISWI (the ATPase component of ACF complex) shows 
poor overlap (~8% for 2 replicates, p-value < 0.05) with Phantom Peaks. A 5-state chromatin model is 
defined based on DamID profiles, which segments the genome into active, repressive or null states 
(Figure 4.34C). Comparison of Phantom Peaks to the chromatin states identifies predominant association 
of the Phantom Peaks to active housekeeping chromatin (69%) followed by active chromatin delineated 
by tissue specific genes (12%) and polycomb chromatin (12%), corroborating previous observation.  
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Figure 4.34: Several DamID profiles show poor overlaps with Phantom Peaks. (A) Background-subtracted tag smoothened 
modENCODE ChIP profiles are juxtaposed to the corresponding DamID profile for the selected factors.DamID profiles 
represents Dam only normalized signal. (B) Peak regions identified on DamID profiles were scored for their overlaps with the 
Phantom Peaks. Percent overlapping peaks at p-value cutoff of 0.05 are plotted against the total numbers of DamID peaks (C) 
Distribution of the Phantom Peaks along the 5-state chromatin model built using DamID profiles. 
 
Moorman et al have defined HOT regions based on DamID profiling of 7 transcription factors where 
several of them co-localize. Unfortunately, the comparison to DamID version of “hotspots” is limited by 
the fact that Moorman et al (243) have used chip hybridization for sequence spanning 2.5 Mio on chr2L. 
Page | 93 
 
This region constitutes only 33 Phantom Peaks and hence interpretation of their differential assignment 
becomes statistically inconclusive. 
FA-mediated crosslinking relies on faithful covalent coupling of the protein to its DNA binding site, 
which may have potential shortcomings. For example, Kasinathan et al have shown that the use of 
crosslinking-free ChIP approach for GAGA factor (GAF) reduced its enrichment along HOT-spots, while 
increasing the numbers of peaks containing the sequence motif (244). However, GAGA factor ChIP from 
the crosslinked chromatin shows poor overlap with the Phantom Peaks (1.7% overlap, p-value <0.05). 
Hence, an assessment of whether organic method from Kasinathan et al reduces Phantom Peak incidences 
is not possible.  
4.5.7 MNase-digested chromatin gives noisy ACF1 profiles 
Although, chromatin shearing by Adaptive Focused Acoustic (Covaris) can yield functionally meaningful 
ChIP-seq profiles (207), it is possible that this shearing method precludes the identification of bona fide 
remodeler-chromatin interactions. To circumvent potential biases caused by sonication, an alternate 
MNase-based chromatin shearing approach was used. ISWI served as a positive control, where 
localization of ISWI using MNase-digested chromatin has been described in larval tissue previously 
(186).  
A single ChIP-seq replicate of ACF1, ISWI and RSF-1 were analyzed using Rb2, P14 and αRSF-1 
antibodies respectively (Appendix A1.3). Cross-correlation analyses suggest overall good quality of the 
profiles and the correlation curves follow MNase digestion pattern. Background-subtracted tag density 
profiles show that the overall signal-to-noise ratio in the MNase-digested profiles is poor. Nonetheless, a 
clear enrichment around the Phantom Peak regions in all 3 profiles is visible (Figure 4.35A). Peaks were 
identified in these profiles using HOMER and subsequently filtered for Phantom Peaks to obtain 2758, 
1037 and 147 peaks for ACF1, RSF-1 and ISWI respectively. Visual inspection of the profiles reveals 
that ChIP signal along the Phantom Peaks is shifted. Since MNase preferentially cleaves accessible DNA, 
it is likely that the resistant nucleosomes around such sites are enriched in this approach. Interestingly, 
inactive regions are associated with the ACF1 and ISWI peaks unlike RSF-1 (Figure 4.35 B-C). However 
the regions where effects of ACF1 deletion are strongest on the nucleosome organizations (the rRoRs) 
show poor enrichment of MNase ChIP-signal for any of the three remodeling factors (blue line, Figure 
4.35 D).  
 RSF-1 profile showed overall good signal-to-noise and hence to gain further confidence, a similar MNase 
ChIP-seq profile was repeated in the mutant background by Dr. Baldi and Fr. Zabel. However, nearly 
identical peak pattern was identified in the mutant suggesting a false positive enrichment (not shown). It 
is therefore likely that both ACF1 and ISWI profiles also show artifact enrichment.   
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Figure 4.35: MNase ChIP-seq mapping of ACF1. MNase-digested chromatin, containing ~80% mono-nucleosomes, were 
subjected to ACF1, RSF-1 and ISWI ChIP. (A) Background-subtracted tag density shows poor signal-to-noise profiles for ACF1 
and ISWI, unlike moderately better RSF-1 profile. (B, C) Distribution of the peaks across genome or 9 state chromatin models. 
(D) ChIP signal along exclusive MNase peaks, Phantom Peak or rRoRs.  
 
4.5.8 GFP tagged ACF1 shows active promoter localization 
ACF1-specific antibody-mediated ChIPs result in identification of false positives. Hence, completely 
independent antibodies raised against GFP tag were employed in ACF1-cGFP transgenic flies to 
identifying genomic targets of ACF1. ACF1-cGFP flies that compensate acf1
7
 deletion were used. ChIP 
performed on Covaris-sheared chromatin gives discernable signal, and hence was used as a method to 
prepare chromatin. GFP tagged ACF1 was pulled down using affinity purified goat αGFP antibody (230). 
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In total, two biological replicates were assessed that show good agreement with each other. Another high 
affinity αGFP reagent (GFP-trap, Chromotek, GmbH) was used to perform a single test ChIP. These VH 
fragments of the αGFP Alpaca antibodies exceed the affinity ranges of conventional antibodies and were 
used to further substantiate the results.  
 
Figure 4.36: GFP epitope ChIP of the recombinant ACF1-cGFP protein in transgenic-deficiency complemented 
background. (A) Two biological replicates were analyzed. Background-subtracted tag densities were plotted for one of the 
replicates. Peaks obtained after subtracting WT-GFP peaks were compared against (B) Phantom Peaks and annotated for their (C) 
genomic localization or 9-state chromatin association. (D) Overall cumulative density plots and (E) corresponding heat-maps 
were obtained along the Phantom Peaks. Quantized signals in heat map appear due to the use of SPP-generated low resolution 
wiggle tracks.  
 
Cross-correlation analyses suggest excellent quality of profiles obtained using goat αGFP antibody, while 
the GFP-trap profile appears to be of a substantially poorer quality. Therefore subsequent analyses were 
carried out on the former profiles. Background-subtracted tag density calculation using SPP package 
reveals a close similarity between the αGFP and αACF1 ChIPs. Anti-GFP ChIP in WT background 
appears to have poor signal-to-noise but distinct active promoter localization. HOMER identifies 
exclusive 423 consensus regions of potential GFP enrichment in the transgenic embryos that were not 
found in WT control (110 regions). Surprisingly, 81% of the peaks show overlap with the Phantom Peaks 
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and a majority follow the same annotation pattern as that of Phantom Peaks, namely active promoters 
from state1 chromatin (harboring H3K4me3, H3K9ac marks) (Figure 4.36A-D).  
In order to investigate the nature of enrichment in GFP-ChIP, Background-subtracted tag density profiles 
were subjected to cumulative and descriptive analyses. Average ChIP-seq signal were calculated in a 2 kb 
window centered at peak summit position. Despite the strength of overall signal is stronger in transgenic 
fly background, WT GFP control shows persistent remnant signal along the same 423 sites (not shown) 
and the Phantom Peaks (Figure 4.36E). The observation suggests that GFP antibody also enriches 
Phantom Peaks. 
This may suggest that the true chromatin binding sites of nucleosome remodelers are actually in fact 
nucleosomes and not in nucleosome free regions as Phantom Peak profiles erroneously suggest. However, 
the fact that even MNase derived profiles are similar in the mutant embryos argues against true positive 
binding sites.  
4.6. Protein interactions of ACF1 
Remodeling factors are targeted to the genomic sites via their interactions with range of chromatin 
proteins or via the affinity interactions of their domains with variety of histone modifications (30, 245). 
ACF1 harbors two C-terminal PHD fingers and a bromodomain. Studies from related remodeling factors 
suggest that these domains play an important role in interactions with methylated or unmodified histones 
and acetylated histone residues respectively [summarized in(30)]. To address the potential molecular 
interactions of CHRAC/ACF, experiments were initiated to identify interacting proteins. The 
investigation is still ongoing and needs further follow up experiments. Following part documents 
preliminary results. 
Rat monoclonal antibodies 8E3 and 3F1 raised against ACF1 were used for analytical pull-down of ACF1 
from either low salt (150 mM KCl) or high salt nuclear extracts [TRAX, modified from (246), Sections 
3.3.1, 3.3.2, 3.3.6, 3.3.7]. In addition to WT embryos, ACF1-cGFP transgenic fly strain was further 
employed in the tag-specific pull-downs (Section 3.3.7). Three embryonic developmental stages, namely 
0-12 hr, 0-4 hr and 8-12 hr after egg laying, were selected for pull-down experiments in three stringency 
buffers (RIPA, RIPA+LiCl and Buffer NXIII) and retrieved proteins were analyzed in seven mass 
spectrometric runs. First four mass spectrometric assessments were carried out on bands excised from the 
analytical SDS-PAGE gel (SID999, 1061, 1066 and 1143), while the remaining three (SID1192, 1361 and 
1830) were subjected to full lane analyses. Downstream analysis of the mass spectrometry (MS) data was 
carried out using MaxQuant software package (247) and the proteins identified with at least two unique 
peptides in IP condition and at-least three times less such peptides in antibody-minus bead control were 
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considered for subsequent analysis. The identified protein hits were further filtered for consistently 
identified contaminants in the lab (Appendix A5, Table A5.2). List of all potential verified or non-
verified interactions is displayed as a wordcloud (Figure 4.37A).   
 
Figure 4.37: Potential interactions for ACF1 during embryogenesis. (A) ACF1 interactions were identified from 7 
independent experiments with stringent detection criteria (see text). The interactions are displayed as word-cloud by pulling them 
together. Size of the word represents occurrences. (B) Based on antibodies used and extracts, experiments were grouped into 4 
categories. Venn representation displays numbers of identified overlapping proteins. (C) A representative list of probable 
interaction proteins, their names and experiments in which they were identified is summarized. Numbers in bracket represent 
unique peptides observed in IP/control experiments.  
 
The analyses identify a number of potential interactions for ACF1. For example, the ATPase subunit of 
CHRAC/ACF complex, ISWI, is always detected in the pull down either by Western Blotting or MS-MS 
and hence serves as a positive control for the IP. Also, Chrac14 and Chrac16 are identified as stable 
interactions of ACF1, assuring reliable pull down of the CHRAC complex in all seven experiments. To 
further classify interactions, all 7 experiments were grouped into 4 categories: 8E3 (High salt), 3F1 (High 
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salt), 3F1 (Low salt) and GFP-IP (Low salt) (Appendix A5, Table A5.1). Potential interactions were 
further assumed high confidence if they are reproduced in at least two categories. In total, 55 and 7 such 
interactions were retrieved that were found in at least 2 or 3 categories, respectively (Figure 4.37B). 
Alternately, 78 potential interactions were identified in at least 2 MS runs (Figure 4.37C, Table A5.2). 
Amongst others, interactions for Hyx, Cdc6, Pita and CG1675 (dNTMT) were tested subsequently in WB 
analysis.  
Hyrax (Hyx) interaction was retrieved in three MS experiments from the low salt extract under the most 
stringent IP conditions using 3F1 antibody. Hyrax is a member of PAF complex that associates with 
elongating polymerase to facilitate its passage by assisting recruitment of histone modification factors. It 
further helps recruit the 3’end processing factors for accurately terminating the transcription process (248, 
249). The Drosophila PAF complex consists of 5 subunits, homologs of yeast PAF members – Hyx 
(yCdc73), Atu (yLeo1), Atms (yPaf1), CG10955 (yRtf1), CG2469 (yCtr9). All these members are 
identified in the MS screen for ACF1, albeit with different peptide coverage such that peptide coverage 
for Hyx, Atu and Atms are stronger in the IP conditions. To validate the interaction of ACF1 with PAF 
complex, two-pronged approach was used. The reciprocal IP and WB validation was performed after 
procuring αHyx antibody from John Lis lab (Appendix A1.3). Indeed, Hyx signal was detected after 
probing the 3F1 antibody-mediated IP (performed in presence of either DNase or Benzonase) on the WB. 
However, the reciprocal analysis did not confirm the interaction (now shown). In subsequent validation 
step, recombinant Hyx protein was translated in vitro using rabbit reticulocyte extract and labeled with 
35
S 
methionine. Recombinant full length ACF1 was purified after expressing the C-terminal flag-tagged 
protein in Sf21 cells followed by flag IP and elution (Appendix A1.10). Co-immunoprecipitation 
experiments were carried out for 3 hour at 4°C. However, the autoradiogram did not show any specific 
interaction of ACF1 with Hyx after incubating both proteins (not shown). It is possible that a functional 
ACF complex provides an interaction surface for the Hyx protein which is not available with ACF1 alone. 
To test this hypothesis, appropriately titrated amounts of recombinant ISWI protein (kind gift from Dr. H. 
Klinker) was added to the co-immunoprecipitation reaction. Nevertheless, the interaction between the 
recombinant proteins was not observed (not shown). These preliminary results still do not rule out 
potential ACF1-Hyx interaction, which may be further explored in the future.   
CG1675, a 30 kDa protein, was observed as a potential hit [3F1 (High salt) category, single experiment, > 
50% sequence coverage, no peptides in bead control] from stringent IPing conditions (RIPA+LiCl). 
CG1675 or dNTMT is a H2B proline methyl transferase that is observed to form a bi-functional complex 
with dART8 (an H3R2 methyl transferase) where they regulate activities of each other in age- and stress-
dependent manner (250). Rat monoclonal antibodies for CG1675 were available from Imhof lab, where 
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the protein had been previously characterized. Subsequent WB validation and reciprocal-IP experiments 
failed to detect ACF1-CG1675 interactions (not shown).     
Several replication related proteins such as RfC3, RfC4 and Cdc6 were abundantly observed in the MS-
MS experiment. Cdc6 is an important player in licensing of the origins of replication, where it interacts 
with regulators such as Dup (human) to promote loading of MCM complex along the poised ORC 
complex (251). Cdc6 was identified in the MS screen [3F1 (Low salt), 3F1 (High salt) categories, 3 
experiments] with ~50% peptide coverage for the protein and therefore warranted closer inspection. 
Antibodies against Drosophila Cdc6, Orc complex members (Orc2, 5) and MCM complex members 
(MCM 2, 5, 7) were obtained from S. Cotterill lab, St. Georges University, London, UK. The interaction 
between ACF1 and Cdc6 was validated in presence of DNase and Benzonase only upon IP with 3F1 
antibody. Reciprocal IP using Cdc6 antibody failed to detect ACF1 signal on WB (not shown). Earlier, it 
had been suggested that ACF1 facilitates DNA replication process (146, 159). To assess whether removal 
of ACF1 from cells bring about changes in ploidy or DNA content, FACS experiments were carried out 
upon ACF1 RNAi in L2-4 cells. Unfortunately, subsequent quantitation did not show alterations in 
overall DNA content of cells (not shown). 
Pita is a zinc finger protein previously described as a potential transcription factor regulating expression 
of 30 selected genes by Glover lab (252). However, recent study identifies that it is a novel CP190-
interacting insulator protein (253). Both CP190 and Pita were identified in the MS-MS screen for ACF1, 
where the latter was found in 3F1 (High salt) category and in two experiments, with astonishingly high 
peptide coverage. Pita antibodies, procured from both Glover lab and Renkawitz lab, validated ACF1-Pita 
interaction under stringent IP conditions and in presence of DNase, when only 3F1 antibody was used 
(not shown). This interaction was characterized further after observing strong co-localization of ACF1 
and Pita ChIP-seq profile generated in S2 cells (253) and by generating a new Pita ChIP-seq profile from 
embryos. However, in the follow up experiment, Pita was further enriched by 3F1 antibody in acf1
7
 
background. Therefore, it is likely that ACF1-Pita interaction is an artifact of antibody cross-reactivity 
(not shown).   
In conclusion, potential interaction partners for ACF1 are observed in a comprehensive mass-
spectrometric screen speculating its roles in replication and/or transcription. However, many of the 
interactions could not be validated. 
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5. Discussion and Conclusions 
5.1 Novel ACF1 allele for functional analyses 
The genes encoding the ATP-dependent chromatin remodeling factor, ACF1, and the signature subunit of 
CHRAC complex, Chrac16, were tagged in this study using fly-fos recombineering method (195). The 
main advantage of this gene tagging approach is that it allows manipulation of the gene locus in its 
genomic context keeping a large surrounding DNA sequence on both ends of the gene. This increases the 
likelihood of retaining the necessary regulatory elements to regulate the recombinant protein expression. 
It is known that unscheduled expression of ACF1 can be deleterious. Observations in the lab suggest that 
ubiquitous expression of ACF1 under constitutive tubulin promoter leads to lethality while the ectopic 
overexpression in eye imaginal discs lead to severe deformation of the adult eyes [unpublished,(160)]. 
Furthermore, recent work from the lab (Bönner K, Jain D et al, manuscript submitted) suggests that 
increase in overall dose of ACF1 has deleterious effects on oogenesis, namely packaging defects in egg 
chambers and increased incidents of apoptosis. These effects may be due to direct involvement of ACF1 
in developmental processes, mistargeting of the protein or indirect effects via deranged chromatin 
organization. Expression of protein under its native regulatory structure should minimize such defects. 
Both N- and C-terminal tagging of ACF1 show faithful expression pattern during embryogenesis, as 
described previously (160). However, ACF1-nGFP seems to undergo some degradation. N-terminus 
region of ACF1 bears a DNA-binding WAC domain and DDT domain for protein interactions. In silico 
structure prediction suggests that this region is largely unstructured compared to C-terminus PHD-bromo 
containing region. Recent studies also suggest that WAC acts as a molecular ruler in ACF1 that senses 
linker length and negatively regulate remodeling activity (77). GFP is a fairly structured protein that folds 
in a defined 3-D structure (254). It is possible that the unstructured domain of ACF1 acquires a stabilized 
structure upon its molecular interactions. ACF1-nGFP may perturb these interactions preventing the 
folding and rendering the protein unstable. Incidentally, the N-terminus tagging further does not rescue 
egg maturation into larvae – a phenotype of acf17 allele, suggesting functional impairment. Furthermore, 
it has been suggested that Chrac14-16 dimer interacts with the N-terminus region of ACF1 (155). 
Addition of a bulky 33 kDa adduct at ACF1 N-terminus may interfere this interaction, leading to 
manifestation of its effects on partial rescue of acf1
7
 mutant phenotype.  
Like ACF1, Chrac16 has been tagged with a mCherry fluorophore domain. IFM analyses show a poor 
signal for mCherry protein in tag specific or live detection of the fluorophore. WB analysis does not show 
protein degradation, suggesting either the recombinant protein expression levels are reduced or the 
fluorophore is not stably folded when added to Chrac16.  
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ACF1-cGFP flies were extensively used in current work to map protein and DNA interactions of ACF1 
(Section 4.5, 4.6). The recombineering protocol was further modified in this study to explore domain 
deletions and to generate new combinatorial tags. As a result, ACF1 N- and C-terminal domain deletion 
flies were generated during the work and extensively used by K. Bönner. Deletion of N-terminus domain 
(aa 1-1065) does not affect nuclear localization, suggesting that the nuclear localization signal (NRS) for 
ACF1 resides in its C-terminal PHD-PHD-Bromo module. Interestingly, NRS prediction for ACF1 
further suggests that the sequence localizes close to the PHD domains.   
5.2 Generation of novel tools to study the diversity of CHRAC related complexes 
The appearance of ACF1 on gels as two bands has been a matter of curiosity, as no differential splice 
junctions are identified for the gene in comprehensive EST or RNA-seq experiments by modENCODE 
consortium. Furthermore, a full length cDNA of ACF1 gives rise to both 185 and 170 kDa band even if 
expressed in a heterologous baculovirus system, suggesting potential RNA-editing or proteolysis. The 
molecular weight (MW) difference between the two bands theoretically corresponds to a clipping of C-
terminus bromodomain from the full length protein. Monoclonal antibodies were raised against two 
peptides from bromodomain which in principle work in WB (Appendix A2.2) albeit with substantial 
cross-reactivity to other nuclear extract proteins. Using purified C-terminus flag-tagged recombinant 
protein or immunoprecipitation samples, it was observed that the bromo-specific antibodies only detect 
large ACF1 isoform. Additionally, preliminary observation after subjecting both the bands to mass-
spectrometric analysis identify abundant bromo-specific peptides from the band of the long isoform that 
are absent in the short isoform. Interestingly, the two molecular weight bands show differential abundance 
in different tissues, such that in ovaries, short isoform is prominent as compared to the large isoform in 
neuronal tissues (unpublished). Tissue-specific functional remodeler complexes have been described for 
SWI/SNF2 family in mammalian cells (66). Also, in Drosophila different Brm complexes show different 
the localization patterns and subunit composition (133). We currently assume that ISWI-containing 
complexes display similar variety in composition and function. For instance, Nurf301, the largest subunit 
of NURF complex, undergoes distinct splicing events to generate several isoforms and the remodeling 
complexes (255–257). Likewise, in Toutatis or TorC complexes, Tau shows clipping at the C-terminus 
which leads to distinct remodeling complexes with non-overlapping genomic localizations using IFM 
(148). Removal of C-terminus bromodomain can potentially have functional implications. Bromodomains 
have propensity to bind acetylated histones (258, 259). Several chromatin factors such as KAP1, P300, 
BPTF and Tip5 have adjacent PHD and Bromo modules that cooperate in binding to nucleosomes and 
specifically identify cognate methylated and acetylated residues on histone tails (260–263). For example, 
in case of P300, it is suggested that PHD-Bromo module can engage nucleosomes more efficiently than 
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each individual domain. Such domain combinations can further have novel regulatory activities, as in case 
of KAP1 corepressor where PHD domain facilitates sumoylation of adjacent bromodomain (264). The 
tissue-specific enrichment of bromo-containing and bromo-less ACF1 isoforms suggests that distinct 
functional molecular assemblies are possible. If validated, such complexes should not only increase the 
intricate compositions of the remodeling factors but also their fine-tuned regulatory roles.  
Recombinant proteins expressed under their native genomic regulatory environment using fly 
recombineering method add a 33 kD tag to the protein. It is possible that such adduct may functionally 
occlude relevant interaction surfaces. Hence, additional polyclonal and monoclonal antibodies for ACF1, 
Chrac16 and ISWI were generated to explore these proteins during fly development (Appendix 2). To 
generate highly specific rat and mouse monoclonal antibodies against Chrac16, peptides from the N- and 
C-terminal were selected. Mainly the clones obtained with latter epitope showed specificities in WB. 
However, the antibodies were not successful in immunoprecipitating the protein from nuclear extracts or 
in IFM. Previous attempts to raise rat monoclonal or polyclonal antibodies in diverse species against 
Chrac16 were only partially successful. Two explanations are likely. As large fraction of Chrac16 is 
conserved across evolutionary phyla, it is possible the protein is only weakly immunogenic. Alternatively, 
due to small size of the protein, immunogenic epitopes on Chrac16 subunits are occluded by its 
interactions with associating factors. Hence, though the protein is specifically detected on WB under 
denaturing conditions, the epitope remains inaccessible under native conditions. 
5.3 Considerations on changes in genomic organization in acf1
7 
mutant embryos  
In this work, the statistical approaches routinely used in complex analog signal processing have been 
employed to analyze the periodicity in nucleosome mapping data. The results suggest profound and 
quantifiable effects of ACF1 deletion on nucleosome regularity at the sites distant from TSS or 
conventionally identified well-positioned nucleosome sites (like insulator binding sites, enhancers). 
Spectral analysis identifies regions of regularly spaced nucleosomes (RoRs) in wild-type embryos. These 
regions maximally encompass 20 well-positioned nucleosomes and are preferentially enriched in the TSS 
and silent chromatin. The RoRs identified in current work further suggest that nucleosomes are not 
homogenously distributed along the genome. However, there are patches of regularly phased nucleosomes 
that remain consistent across the embryo population. On a different note, an observation was reported 
using STORM live imaging of the H2B core histone in mouse cell nuclei, where discontinuous and 
heterogeneous nucleosome clustering was observed on a single cell level. However, it is not clear whether 
these clusters represent well-phased or well-spaced nucleosomes (97). The regularity of a subset of the 
RoRs is diminished upon deletion of ACF1. Majority of the affected sites carry a novel sequence motif. 
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Genome-wide prediction of this motif site show very homogenous nucleosome distribution that appears to 
get fuzzier in mutant background.  
Both spectral and autocorrelation functions are dependent on nucleosome occupancy, where the absolute 
or transformed occupancy values are taken as a measure to assess periodicity in the data. Nucleosome 
occupancies are obtained after sequencing the MNase-digested chromatin. Hence, the degrees of digestion 
can potentially affect the outcome of current analyses. It has been suggested that over-digestion risks 
fuzzier organization of the nucleosomes due to partial intra-nucleosome DNA digestion or destabilization 
and thereby leading to a loss of ‘fragile’ nucleosomes (265, 266). However, nucleosome positions are not 
largely affected unlike their occupancies (266). The differences in the degrees of digestion are purely 
technical and depend on amount of starting material, enzyme concentration and time of digestion etc. 
Such operational parameters potentially affect all analyzed samples equally and hence must be considered 
random. The observed effects in this work do not arise due to over-digestion of mutant samples for 
following reasons. First, multiple biological replicates were performed for each of the analyzed genotypes 
in a completely independent manner (different date of sample collection and preparation). In such case, 
the stochasticity would average out any bias. However, all biological replicates for WT genotypes behave 
in the same manner while the same trend is observed for mutants, suggesting that the observed effects are 
systematic and due to loss of ACF1. And second, these effects are robust and can further be observed in 
BG3 cells upon depletion of ACF1 (but not ISWI or RSF-1) for which the chromatin were prepared with 
similar protocols (Jain, D., Baldi, A., manuscript in preparation).
 
It has been suggested that library size (or sequencing depths) does not affect the nucleosome fuzziness, 
per se, and correlate well with replicates with lower numbers of reads (266). However, to exclude any 
potential effects of library size or different data normalization procedures, random subsampling was 
performed on all the libraries. It appears that spectral analyses remain unchanged. However, 
autocorrelation function (Acf) analyses show decrease in Acf peak amplitudes as a function of library 
size, without affecting the peak shifts or dampening. In order to match the effect sizes observed in acf1
7
, 
the sizes of WT libraries would need to be reduced by more than 67%. However, none of the sequenced 
libraries in the WT has such a small effective size. Furthermore, the Acf peak shift, which is a proxy 
measure for altered linker length, remains unaltered upon changes in library sizes. Current nucleosome 
mapping experiments generate paired-end data and can allow computational size selection of the 
fragments for identifying their contribution in the occupancy or shift effects. However, no effects of the 
fragment sizes were observed.  
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As the embryos develop, overall chromatin organization changes, leading to a heterochromatin formation 
in the nuclei of later stages on embryogenesis (160). It is possible that regions with homogenous 
nucleosome organization change over the course of development. Preliminary exploratory imaging 
analysis in acf1
7
 mutant embryos suggests that there may be a slight delay in mutant embryonic 
development. If valid, then it is possible that effects on nucleosome organization actually stem from the 
delayed development and not due to loss of ACF1. However, a comparison of Acf in 0-12 hr and 2-8 hr 
embryos do not support this assertion. For both time points, the Acf peak shift differences are 
comparatively small (4-8 bp alteration in linker) and may be a consequence of development. If this is a 
biological variation within two time points, then observed linker length difference of ~15 bp between 
acf1
7
 and WT is likely due to the underlying deficiency of ACF1.  
Deletion of the ACF1 gene shows reduced fraction of embryos transiting to the larval stage. If the 
phenotype results from embryonic lethality then the nucleosome organization differences may be 
explained by fragmentation of the genome in mutant as a consequence of apoptosis. However, that seems 
not to be the case due to following reasons. First, microscopic observation identifies large numbers of pre-
blastoderm embryos which persists throughout later stages of embryo development (until 8-10 hr) and 
start to disintegrate. Starting from their deposition, these early embryonic stages do not show well-defined 
DAPI staining suggesting that either they are unfertilized eggs or these eggs die at very early stage of 
embryogenesis. Overall the number of nuclei contributed by earlier (pre-blastoderm) stages is 
insignificant as compared to subsequent stages. Hence, the lethality or apoptosis would not generate 
major nucleosome organization changes in 2-8 hr old tissue. And second, RNA-seq expression data do 
not identify induction of apoptosis-related transcripts in mutants. Taken together, the effects on 
nucleosome organization are arising are most likely due to ACF1 depletion.   
The spectral analysis leads to identification of a novel motif sequence that resides in the center of well-
phased nucleosomes. This regularity is perturbed in acf1
7
 mutant. Such effect is extremely robust across 
the genome for all identified 3457 sites that are predominantly located in transcriptionally silent 
chromatin. Hence, I wondered whether loss of regularity would affect the activity state of these sites. To 
assess the issue, the motif sites were extended to 500 bp on both direction and RNA-seq tag counts were 
compared in these intervals in WT and mutant. It appears that these sites do not show altered RNA-tag 
counts. Furthermore, along these sites, the total RNA-pol-II ChIP signal obtained from modENCODE 
profiles appears weak. In an ensemble of cell types across embryonic population the homogeneity may 
represent a pristine chromatin conformation, generally not perturbed by transcriptional machinery. In vivo 
studies in yeast, by knocking out individual remodeling factors, have established that several remodeling 
factors play a concerted role at the TSS to position +1 nucleosomes and phase downstream array in an 
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ATP-dependent manner [summarized in (111–113, 126, 188)]. ACF1 containing complexes, 
CHRAC/ACF, have been shown to space nucleosomes on in vitro reconstituted chromatinized. As early 
stage embryos are enriched for ISWI containing complexes; it is tempting to suggest that CHRAC/ACF is 
involved in general spacing of nucleosomes across the genome. However, its generalized role may be 
overridden at TSS by the known remodeling factor, but may be revealed along transcriptionally silent 
sites. Given the unusual ability of ACF1 to model ‘chromatosomes’ (nucleosome + linker H1), 
enrichment of H1 histone along the spectral motif sites is not surprising, further suggesting a potential 
ACF1-mediated effect.   
According to the statistical positioning theory of nucleosome organization and repeated observations from 
nucleosome sequencing experiments, nucleosomes are phased against barriers –which can be an NFR or 
an insulator or strong DNA binding factor. In case of NFRs, the barriers have larger footprint on the 
DNA, or in case of insulators, such footprints are accommodated within the linker region (101). Do DNA 
binding factors contribute to the nucleosome organization along the spectral motif? The pull-down 
experiments identify several transcription factors, repressors and gypsy insulator protein, besides few 
unknown. Comparison of the identified hits against the protein interaction database does not identify any 
potential complex. Furthermore, immediate high confidence interaction partners of these hits do not 
support any possibility of a super molecular assembly. Therefore, it is likely that some of these binding 
instances may be false positives. Alternatively, there may be potentially, yet unknown, complex 
formation between some of them.  
Data available from the literature for identified potential motif-binding proteins do not fit well to the 
spectral motif site. Mod(mdg4) shows poor ChIP enrichments along the motif regions. Its functional 
interaction with CP190 or Su(Hw) are reported in the context of gypsy insulator complexes (267–269). 
However, neither of the previously characterized insulator proteins (CP190, SuHw, CTCF) shows ChIP 
signal enrichment along the spectral motif regions. In case of largely uncharacterized putative 
transcription factor Q9VQ77, the localization identified by DamID experiments does not overlap with the 
motif regions (224). Furthermore, Kay-Jra transcription factor complex (homolog of mammalian Fos-Jun 
system) (270–272) has been observed to interact with the spectral motif. However, the principle function 
of this complex is in the transcriptional activation, which is not manifested along the spectral sites.  
However, there are additional hints warranting further investigation. For instance, A) Mod(mdg4) is 
enriched in ACF1-specific IP reactions in mass-spectrometric screens. B) Homologs of Q9VQ77 are 
widespread in phylum arthropoda as compared to other phyla. Preliminary analysis of nucleosome 
organization along the predicted spectral motif sites in non-arthropods like mouse and yeast shows a lack 
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of nucleosome phasing. C) Kay-Jra have been shown to bind TGA[CG]TCA heptad motifs, which 
overlaps well with the 5’end of the spectral motif with two degenerate positions. Furthermore, role for 
Kay is suggested in transcriptional repression that involves its DNA binding to a sequence (270). Taken 
together, mod(mdg4), Q9VQ77 and Kay-Jra interactions can be explored further to assess their 
contribution in either recruiting ACF1 to spectral sites or simply acting as a barrierfor ATP-dependent 
nucleosome phasing. 
5.4 Changing linker lengths in acf1
7 
mutant embryos  
Linker lengths can be estimated by identifying the Nucleosome Repeat Lengths (NRLs) in the genome. In 
current work, Acf is used to compute correlation coefficient with regards to the step sizes across selected 
genomic regions, such as the first 4 nucleosomes downstream of TSS, gene bodies, intergenic regions or 
entire chromosomes. It appears that nucleosomes around TSS are not largely affected in the mutant 
background, but phased nucleosomes at other places show increased linker lengths in the mutant 
background. ACF1 is suggested to carry a molecular ruler that senses linker length via its DNA binding 
WAC module (77). For shorter linker lengths, the module folds back and competes with ISWI for the H4 
tails (77, 157). Such auto-inhibitory feedback is presumed to prevent non-productive engagement of ACF. 
If the linker length-sensing ACF1 is absent, nucleosomes remain fuzzier to begin with after the DNA 
transaction processes such as replication or transcription.  
Overall increase in the linker length may further suggest reduced nucleosome occupancies. At present, 
assessing occupancy changes genome-wide is beyond the scope of this study. Occupancy at the position 
can be estimated by nucleosome fragment density (fragment counts/ library size).  Such density analyses 
along the entire genome identifies that relative fragment counts across 500 bp bins spanning the genome 
remain more or less unchanged. However, it is difficult to assess overall low levels of nucleosomes on the 
genome. If there are low amounts of nucleosomes to start with, ACF1 can be perceived to function as a 
molecular clamp for nucleosomes, as suggested for ISWI previously (90). In addition to spacing, earlier 
studies demonstrate that ACF assembles nucleosomes in presence of histone chaperon NAP-1 (83, 93). It 
is possible that the effects observed here are composite of spacing and assembly functions of ACF1.  
Current work identifies ACF1 dependent fuzzier regions that encompass a fraction of the genome. Earlier 
work that characterized spacing activity of ACF1 in the deletion background had suggested that overall 
linker length is affected in a bulk chromatin (159). Both findings suggest that genome organization 
becomes sloppy in absence of ACF1. How would such fuzzier or sloppy organization of nucleosome 
affect the underlying DNA? The genomic DNA is protected by nucleosomes and packaged into higher 
order chromatin structures that not only limit the access to the DNA but shield the polymer from potential 
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sources of damage. Well-spaced nucleosome arrays are presumed to be a starting point for higher order 
folding where linker histones bind to the array and help its further compaction. In absence of such higher 
order folds, elements or genes may show variegated expression due to their improper silencing. Indeed, 
for acf1
1
 mutation, such position-effect-variegations are documented (159). Furthermore, studies in the 
lab suggest perturbation in heterochromatin organization in developing embryos by following repressive 
marks in IFM (160). If DNA is not folded efficiently, it may remain at risk of UV-induced damage or 
DNA damage in general. It has been indeed observed that deletion of ACF1 leads to susceptibility 
towards double strand breaks in human cell culture system  (165, 166). Moreover, unpublished 
observations from the lab suggest that acf1
7
 allele is susceptible to gamma- or UV- induced DNA 
damages. It is possible that ACF1 has direct involvement in these processes. For instance, interactions of 
ACF1 (or ISWI) with repair proteins have been described earlier (166, 176). However, it is also possible 
that underlying chromatin plays an additive (if not definitive) role in manifestation of above phenotypes.   
5.5 Characterization of the transcriptome in the acf1
7 
embryos  
RNA-seq experiments were performed in 2-8 hr old embryos to assess the transcriptional effects of 
ACF1. The protocol enriches > 200 nt long RNA fragments; hence potentially interesting small RNAs 
like miRNA or piwi RNAs and could not be assessed. The analyses suggest no major difference of 
transcripts upon deletion of ACF1. Only a minor fraction of genes was observed to be mis-regulated 
without any coherent enrichment of gene ontology terms. Amongst the downregulated genes, many enrich 
for developmental processes such as embryonic segmentation, neurogenesis or muscle development. It is 
possible that mutant embryos undergo delayed development and assessing such delays with high temporal 
resolution is non-trivial. In light of such scenario, down-regulated genes may be due to developmental 
asynchrony between WT and mutant.  
Nucleosomes constrain DNA supercoiling locally and their eviction leads to generation of unconstrained 
plectonemic supercoils which promote partial DNA strand separation. Lack of nucleosomes may lead to 
activation of cryptic promoters. In yeast, cryptic unstable transcripts originate predominantly from NFRs 
(273, 274). These transcripts usually escape detection as the RNA surveillance machinery rapidly 
degrades them. Often, mutants of exosome or RNA degradation pathway are needed to stabilize short 
cryptic RNAs (275). Do nucleosome remodelers show alterations in the cryptic transcripts? It had been 
suggested that remodelers play key role in organizing NFRs by actively mobilizing the nucleosomes. 
Widening of NFRs, as observed for yeast Isw2, can potentially lead to manifestation of antisense 
transcription (158). Though the alteration in the chromatin organization in acf1
7
 mutant are subtle, 
whether they affect cryptic or antisense transcription remains beyond the scope of this study due to 
following reasons. First, genetic crosses to combine RNA degradation pathway mutant to acf1
7
deficiency 
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involves sophisticated genetics. And second, the adopted RNA-seq library preparation protocol did not 
include Actinomycin-D, a potent inhibitor of the RNA-polymerase function of reverse transcriptase 
during reverse transcription step (226).  
PAF complex facilitates transcriptional elongation by recruiting histone acetyltransferases and factors 
important for polyadenylation (248). Members of PAF complex are strongly enriched from nuclear 
extracts in ACF1 co-immunoprecipitation experiment (Section 4.6). Transcription does not lead to 
complete eviction of nucleosomes for moderately expressed genes, however strongly expressed genes 
experience nucleosome disassembly and reassembly in the wake of transcription (276–279). ACF1 has 
been shown to assemble nucleosomes by stabilizing the transient DNA-histone intermediates in an ATP-
dependent manner (83). Furthermore, such assembly activities are coupled with spacing of nucleosome 
arrays. Considering the biochemical activities of ACF1 and the observed linker length extensions 
downstream of the TSS upon its deletion, the following can be speculated. ACF1 is recruited to the gene 
bodies via PAF complex where it contributes in nucleosomal assembly and spacing presumably in the 
wake of transcription. However, poor effects on nucleosome positions along such arrays in ACF1 mutant 
may suggest that its functions along these sites are presumably redundant and hence compensated.  
Transposons are mobile genetic elements that can laterally integrate in the genome. Such translocations 
are reported to bring about DNA double strand breaks (DSB) leading to genomic instability and instances 
of mutations [summarized in (227)]. Drosophila germ line is a well-studied system where retro-
transposable elements must be silenced for genome stability, by piwi RNA system (280). The DNA DSB 
loci are earmarked by the phosphorylated form of H2A.V (γH2A.V) in Drosophila and increased 
instances of DSB can be scored by following their counts in IFM. The RNA-seq experiment revealed at 
least 2 fold up-regulation of transcripts of LTR (long terminal repeat) class of retrotransposons (total 10) 
without corresponding increase in the DNA copy numbers. Preliminary unpublished and semi-
quantitative findings in the lab suggest that γH2A.V signals are comparable in WT and acf17 mutant 
embryos as well as ovaries, implying no associated instances of increased DSB.  
What consequences may the upregulated LTR transposons have? Earlier studies in Drosophila suggested 
that an age dependent upregulation of transposable element in neuronal tissue leads to memory 
impairments and shorter lifespan (281). Upregulation of transposons of LINEs, SINEs, and LTR class 
have been further observed in several neurodegenerative diseases (282, 283). ACF1 is strongly expressed 
in neuronal lineages during Drosophila development. Though the mechanistic details of transposon 
upregulation and subsequent pathologies or neuronal impairments are not clearly established, it is 
tempting to speculate potential memory impairment in ACF1 mutants.  
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5.6 Considerations on manifestation of Phantom Peaks 
Comprehensive genomic projects like ENCODE and modENCODE impose strict guidelines for 
generating ChIP profiles for chromatin binding factors. For instance, the guidelines demand validation of 
the antibodies by WB and/or IFM. Additionally, a strong overlap between the profiles generated by two 
independent antibodies (or using a tag-specific ChIP) is expected. Profiles generated in accordance with 
such standards are usually considered valid (284). ChIP profiles described in the current work meet all 
these requirements, where 3 protein-specific antibodies and a tag-specific antibody give strongly 
overlapping ChIP profiles for ACF1. However, a thorough analysis using mutant background or a GFP 
antibody in WT background suggest that observed peaks for ACF1 (and for RSF-1) are in fact false 
positive enrichments. The robust set of 3090 peaks here leads to identification of consistent false-positive 
signals (irrespective of the factor being ChIPped) and are collectively referred to as Phantom Peaks. 
The observed false positive regions are not randomly distributed across the genome, but localized along 
the strongly transcribing loci. Similar observations in yeast suggest hyper-ChIPpable regions across 
strongly transcribing regions or the t-RNA loci (285). Moreover, localization of completely unrelated 
non-chromatin proteins have been observed to ChIP at highly transcribing genes (231, 285). These 
authors suggest that ChIP signal should be normalized against preimmune serum control. In a ChIP 
experiment, actively transcribing regions tend to release DNA fragments that bias sequencing. Input 
correction can mitigate this bias during peak calling (234). However, neither input nor preimmune control 
reduces instances of Phantom Peaks.  
A large fraction of Phantom Peaks further coincides with previously mapped HOT regions, where 8 to 24 
transcription factors (TFs) have been found co-localizing (modENCODE, BDTNP). Several studies 
suggest that HOT sites serve as potential transcriptional enhancers (286–288). However, the functional 
relevance of many such interactions is not been shown. For instance, comparing expression patterns of 
TFs during development and their observed localizations along the reporter HOT sites suggest a poor 
overlap concluding many TFs bound at HOT sites have no activity (286). Concomitantly, HOT regions in 
C. elegans are described as CG-rich domains that have natural propensity to remain nucleosome-free 
thereby facilitating non-specific and non-functional interactions with  DNA binding proteins (289). On 
the other hand, experiments studying ecdysone signaling (EcR) suggest that a multifunctional, large 
molecular weight TF complex is required to drive broad transcriptional program upon signaling. (287). It 
is not clear whether the co-occupying TFs at HOT regions in Drosophila are functional molecular 
complexes like described for EcR or localized aggregation of the abundant nuclear factors.  
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It is important to note that only specific immune-sera (rose against ACF1 or RSF-1) lead to identification 
of Phantom Peaks. These false positive enrichments may be due to poor ChIP specificity of the antibodies 
or highly mobile nature of the remodeling factors in the nuclei or the combinations of both. Earlier studies 
in the lab using highly specific polyclonal antibodies against MSL proteins have identified their high 
signal-to-noise localizations that are distinct from Phantom Peaks (207). Likewise, antibodies against 
ACF1 and RSF-1 are highly specific when analyzed on WB or IFM. However, fluorescence-based 
measurements have shown that only a minor fraction (<3%) of hSNF2H binds to the genomic DNA. It’s 
only during the DNA transaction processes like replication / repair, where nucleosome substrates are 
available, SNF2H localization on the genomic DNA increases (167, 182, 183). Therefore, it is likely that 
formaldehyde based crosslinking traps highly mobile remodelers at the most accessible sites in the 
genome. However, this likely scenario does not explain presence of peaks in the absence of an antigen.  
Why should regions with high transcription rates or high density of co-localizing factors get non-
specifically enriched in the ChIP assays upon protein specific immune-sera? Perhaps availability of 
‘sticky’ surfaces along these sites may explain the enrichments. It is possible that these regions contain 
proteins carrying unstructured domains or motifs that are poised for interactions with other proteins via 
molten globule interactions. Localized high charge density, low complexity of the protein sequences can 
potentially drive induced fit interactions for proteins (290–293). It has been suggested that low 
complexity domains present in certain transcription factors can recruit RNA polymerase II via their 
interactions with equally unstructured CTD (294). Conceivably, shearing protocols lead to fragmentation 
of molecular assemblies and exposing the sticky surfaces that can non-specifically interact with 
antibodies. If such scenario is assumed correct, then preferential enrichment along actively transcribing 
genes with or without presence of an antigen can be well explained. Similar local amassing of factors can 
be envisaged during DNA repair or replication processes where localized crosslinking of large assemblies 
can provide non-specific interaction surfaces after their fragmentations.  
GFP tagged ACF1 mapping shows strong enrichment along the actively transcribing Phantom Peaks. The 
observation can be explained using previously outlined reasoning in which, the highly mobile remodeling 
factors preferentially get trapped along the accessible sites in the genome. Moreover, GFP ChIP 
performed in the WT background - this resembles a scenario where ChIP is performed in the mutant 
background. In line with earlier observations, GFP ChIP signal remains detectable in WT albeit with poor 
signal strength and without being identified as peak in most instances by different peak callers. 
Surprisingly, MNase based digestion of chromatin leads to identification of a considerable fraction of 
peaks that do not belong to the Phantom Peaks. Though, in case of RSF-1, further scrutiny identifies all 
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these peaks as false positives. It is therefore likely that most of the ACF1-specific peaks observed upon 
MNase -ChIP are in fact erroneous.  
Comparison of Phantom Peaks with ChIP-seq profiles deposited in the modENCODE identify roughly 
1/3
rd
 of the profiles carrying 20% or more Phantom Peaks (p-value <0.05). These overlaps do not 
necessarily mean that the modENCODE profiles are erroneous. However, some of the following 
observations are bewildering. First, in case of insulators, many identified sites of enrichment do not 
contain the respective insulator motifs, perhaps suggesting indirect binding or false enrichments. Second, 
in case of HDACs and many repressors, a strong enrichment along actively transcribing genes is observed 
which is not in line with their known function as repressors. And third, preferential enrichment occurs 
along the HOT sites, where several recruitments have been suggested as neutral or non-functional. It is 
possible that two profiles have significant overlap due to a chance event, technical reasons or due to 
potential biological function of the proteins along these sites. It is possible that amongst the compared 
modENCODE profiles, the peaks represent a combination of bona fide binding sites and Phantom Peaks 
with varying contributions. The actively transcribing regions are strongly regulated in the genome and 
instances of regulatory factor binding along them may indeed have biological functions.  
Phantom Peak artifacts are not limited to Drosophila model system. Hyper-ChIPable regions have been 
described in yeast, actively transcribing regions in bacteria and accessible DNA regions in mouse model. 
Furthermore, antisera raised against non-nuclear or non-chromatin proteins have also been shown to 
retrieve these regions (285, 295–297). It is possible to limit the scope of Phantom Peaks by filtering out 
peaks identified in non-related protein control, such as GFP. However, due to poor enrichment not all of 
these regions are identified as peaks by peak-calling software. For example, in current case, only 19 
Phantom Peaks are identified in GFP-WT ChIP out of 3090. It is possible that GFP antibodies have rather 
poor non-specific interactions with the ‘sticky’ surfaces available at active promoters, largely due to their 
strong affinity to the cognate antigen, like those observed for MSL antibodies. It has been suggested 
earlier that crosslinking artifacts can be avoided if ChIPs are performed under the native conditions in 
case of GAGA factor (GAF) (244). Alternatively, Calling-card or DamID methods have also been 
suggested (298, 299). These methods offer alternative viewpoints on factor localization, but have their 
own technical or method-specific drawbacks.  
There is an increasing awareness in the research community about shortcomings of antibody-based 
assays, such as cross-reactivity or relaxed affinities towards the target. The efforts have lead to initiatives 
towards increased standardization and stringent quality control measures for all research grade immuno-
affinity reagents (300). For all antibody-based ChIP methods, a knockout control is essential to identify 
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false positives. However, running such control is not always possible due to the unavailability of mutant 
cells. RNA interference reduces RNA levels however often complete loss of protein is not achieved. 
Moreover, current technical limitations restrict routine use of non-ChIP methods in variety of tissue types. 
In all such instances, a list of Phantom Peaks may serve as a catalog of ‘potential false positive’ sites akin 
to the cRAP contaminant catalog for Drosophila in mass spectrometry experiments (301). Noticeable 
enrichment of Phantom Peaks along the identified peak list should be considered as a red flag and 
additional confirmatory experiments should be performed before drawing functional inferences.  
5.7 Evaluation of the potential ACF1 interactions 
Several transient potential interactions for ACF1 are identified during using mass-spectrometric screen. 
Some of these interactions were not validated subsequently in WB analysis from native embryonic 
nuclear extracts, for example dNTMT or replication licensing-related MCM complex or the 
armadillo/pygopus complex. However, several of the interactions were subsequently validated using 
WBs, but remained inconclusive in reciprocal IP experiments –for instance Cdc6, Hyx, Pita.  
Potential interaction with PAF complex member Hyrax was further examined using in vitro translation 
followed by co-IP experiment, but was not validated in the current assay settings. The result still does not 
completely rule out this potential interaction. ACF1 is largely unstructured at its N-terminus region, 
which plays an important role during linker length sensing in ACF1 mediated remodeling reaction. It is 
possible that interactions of ACF1 with additional factors are further stabilized in the context either or 
both CHRAC/ACF and PAF complex. In such hypothetical scenario, co-localization in ChIP and further 
examination of the co-occupied loci for functional link may be a reasonable approach. However, ACF1 
cannot be mapped on the genome under crosslinking conditions. And attempts to map Hyrax using rabbit 
polyclonal antibody (Section A1.3) from 0-12 hr old embryos were unsuccessful. Importantly, the ACF1–
Hyrax interaction was only identified using 3F1 monoclonal antibody but not by pulling down the longer 
isoform of ACF1 (i.e. ACF1-cGFP) or by another highly specific 8E3 monoclonal antibody.  
Proteins involved in replication licensing are further identified in ACF1 pull-down. Striking enrichment 
of Cdc6 in ACF1 IPs is in agreement with previously described interaction of SNF2H with replication 
licensing protein (162). If ACF1 shows strong effects on replication cultured cell of Drosophila, such as 
Pita or hACF1, a change in DNA content after S-phase should be detected in FACS analyses (146, 252). 
Knockdown of ACF1 in cultured L2-4 cells (S2 sub-clone) does not lead to accumulation of DNA and 
change of cell ploidy in the nucleus, when assessed by FACS. It is possible that L2-4 cells are not ideal to 
study replication related effects of ACF1, where perhaps abundance of another remodeling factor may 
have redundant role. Detecting the roles of ACF1 in replication may require sensitizing the system as is 
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frequently done in yeast. It is equally likely that the ACF1 mediated effects on DNA-replication program 
are subtle and cannot be readily quantified at normal physiological state.  
Interestingly, several signaling proteins are identified in ACF1-specific interaction screen. Reports in the 
field suggest that roles of remodeling factors in signaling-mediated gene activation or repression at its 
wake (142, 302–305) presumably by altering the chromatin at the promoter or over the gene body. 
Ecdysone and MAPK signaling pathways play important roles in development and growth activities 
respectively by activating broad sets of genes. In fact, several genes that overlap the spectral motifs tend 
to show moderate enrichment of growth-signaling related transcripts. RNA-seq experiments do not 
support transcriptional role for ACF1, however its redundant role as a facilitator cannot be ruled out.  
Potential interaction of ACF1 with mod(mdg4) is not validated in current study yet. However, its 
observed interactions with spectral motif warrant closer inspection. Interestingly, RSF-1 has also been 
observed to interact with mod(mdg4) (S. Baldi, unpublished observation). It is possible that mod(mdg4) 
may interact with multiple remodelers in context-specific manner. If real, whether these interactions bring 
about regular nucleosome phasing along the binding sites or destabilize nucleosome interactions would be 
interesting to assess.   
Intriguingly, several remodelers of distinct ATPase class are identified in the ACF1 interaction screen -
such as Mi2, Bap55, Moira (Bap155) or Nurf-38. These interactions are not likely mediated by DNA as 
all the immuno-precipitation reactions were performed in presence of excess amounts of DNase-1. 
Nevertheless, RNA-mediated non-specific interactions can’t be ruled out. All Mi2, NURF and SWI/SNF 
have been shown to play a role during transcription. At the normal physiological state, transcription is by 
far the most prevalent chromatin disruptive force, which recruits variety of protein complexes including 
remodelers to facilitate the process. Local amassing of the proteins and high concentrations of localized 
RNA can potentially drive non-specific interactions. For example, many a times splicing factors are 
identified as toggle contaminants in the mass-spectrometry approaches (306). Remodelers are usually 
present as multi-subunit complexes. Identifying isolated subunits in the interaction screen further suggest 
them as false positive. 
5.8 Outlooks 
It has been suggested that recruitment of remodelers, if not always then often, is brought about by their 
interactions with sequence-specific factors (30). Spectral motif sites offer a homogenous system along 
which nucleosome occupancies and phasing are altered in absence of functional ACF1 in the embryos. 
The same observation can be reproduced from cultured Drosophila neuronal lineage cells, where 
depletion of ACF1 (but not ISWI or RSF-1) robustly affect the nucleosome phasing along motif sites. 
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Moreover, label-free quantitation using mass spectrometric approach has identified several potential 
factors that bind the spectral motif. If either of these factors facilitates recruitment of ACF1, then their 
deletion should have an effect on nucleosome organization along the spectral motif sites. As it is difficult 
to ChIP ACF1, corroborating experiment would look for genome-wide mapping of the identified motif 
binding factor, its potential enrichment along the rRoRs and changes in nucleosome phasing upon their 
depletion. 
Recombineering approach has been used to tag both termini of ACF1 using Gal4 DNA binding domain 
(Gal4-DBD). These flies are already made homozygous and can be potentially crossed to any engineered 
line carrying UAS elements. A collection of UAS elements can potentially be tested for tethering of the 
ACF1-containing complexes and addressing following. Whether these recruitments alter underlying 
nucleosome architecture; if so, do these alterations depend on underlying chromatin environment 
(transcriptionally active, repressive etc)? Is transcription (cryptic, divergent, antisense) affected along the 
UAS sites in different chromatin environment? Earlier studies in the lab have shown interactions between 
ACF1 and another remodeling ATPase, Domino in early embryo extracts. The tethering system can 
potentially be used to study recruitment of ACF1 interacting factors to the UAS sites by ChIP. A step 
further, DNA-pull down of UAS elements and identifying proteins associated with them can also reveal 
range of molecular compositions getting recruited to UAS sites.  
Genome-wide mapping of ACF1 still remains elusive, when ChIP-based assays are attempted. However, 
localizations of ACF1 can be studied using DamID method, albeit with poorer resolution. Preliminary 
work has already established a system of transiently transfecting Drosophila L2-4 cells (S2 sub-clone) 
with Dam fused ACF1. Successive optimization steps can be used to infer meaningful localization 
patterns of ACF1 by performing DNA methylation using the fusion constructs and correcting it for 
methyl background control by Dam-only control. Modular design of the used constructs further offers 
ease of cloning different domain deletion mutants of ACF1 and studying their effects on targeting of 
ACF1. If successful, this study should nicely corroborate nucleosome fuzziness phenotype.  
Preliminary peptide-chip experiments suggest that C-terminal PHD-PHD-Bromo module of ACF1 binds 
to unmodified H3 and subsequent H3 modification by methylation reduce the affinity. Conceivably, 
bromodomain may interact with acetylated lysine. However, regions with altered nucleosome 
organization tend to have silent chromatin marks, such as H3K27me3. It is possible that affinity of ACF1 
towards unmodified histones is altered or overridden in presence of dominant functional domains 
contributed by interacting factors. If so, whether PHD and bromodoains of ACF1 play a role in targeting 
it across unmodified (poised) or actively transcribing chromatin domains would be further interesting to 
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investigate. The experiments would benefit from characterization of modified histone-ACF1 interaction 
using peptide pulldown or microscale thermopheresis experiments (307). It is equally likely that the 
targets for PHD-PHD-Bromo module of ACF1 do not reside on histones but they interact and regulate 
other nuclear regulatory proteins.    
ACF1 complete knockouts are not available. The acf1
7
 allele shows expression of leftover RNA with a 
promiscuous gain of in-frame 3 amino acids, starting with methionine (predicted protein would be 805aa 
long from aa952 onwards). Using range of antibodies the leftover protein was not identified by WB or 
IFM, suggesting a complete null scenario. However, even if the protein is absent, leftover RNA can itself 
have toxic effects that can be realized upon its mistargeting or titrating out other RNA binding factors. 
Recently, it has been suggested that leftover RNA from RNAi experiments can have deleterious effects 
(308). To assess complete null phenotype of ACF1, a new null allele was generated using CRISPR 
technology (Appendix A2.5). Preliminary analyses suggest absence of protein in WB and IFM from 
Drosophila tissues. The mutant would prove useful in assessing double knockout phenotypes of 
remodelers (such as ACF1/ RSF-1 or ACF1/Tou or ACF1/Mi2) to score synthetic phenotypes. Full extent 
of severity upon ACF1 deletion can be further assessed a) during oogenesis where the acf1
7
 allele shows 
pronounced egg chamber defects; b) on developmental transcriptome in embryogenesis or oogenesis and 
c) in functional assays such as radiation sensitivity of the mutants.   
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6. Abbreviations 
aa  amino acid 
Acf Autocorrelation function 
ACF ATP-utilizing chromatin assembly and remodeling factor 
ACF1-cGFP 2XTY1-GFP-3XFLAG- ACF1 (C-terminus) 
ACF1-nGFP 2XTY1-GFP-3XFLAG- ACF1 (N-terminus) 
ATP Adinosine triphosphate 
bp Base pair 
ChIP Chromatin immunoprecipitation 
CHRAC  Chromatin accessibility complex 
Chrac16-nmCherry 2XTY1-mCherry-3XFLAG- Chrac16 (N-terminus) 
DBD DNA binding domain 
DNA  Deoxyribonucleic acid 
DNase1 Deoxyribonuclease 1 
DSB Double strand break 
HOT High occupancy target 
IFM Immuno-fluorescence microscopy  
IP Immunoprecipitation 
ISW1a, ISW1b, 
ISW2 Imitation Switch (S.cerevisiae) 
ISWI Imitation Switch (D. melanogaster) 
kb kilobase 
LTR Long terminal repeat 
mAb monoclonal antibody 
Mio Million 
MS Mass spectrometry 
NDR Nucleosome depleted region 
NFR Nucleosome free region 
NRL Nucleosme repeat lenght 
nt Nucleotide 
pAb polyclonal antibody 
PCR Polymerase chain reaction 
qPCR quantitative PCR 
RNA Ribonucleic acid 
RNase1 Ribonuclease 1 
RoR Regions of Regularly spaced nucleosomes 
rRNA ribosomal RNA 
rRoRs Reduced regions of regularly spaced nucleosomes 
SD  spectral density 
SDE spectral density estimation  
TF Transcription factor 
TSS Transcription start site 
UCSC University of California, Santa cruz 
WB Wstern blot 
WT Wild-type 
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8. Appendix  
Appendix 1: Supporting materials and methods 
A1.1 Sources of chemicals 
Acrylamide (Rotiphorese Gel® 30) Roth, Karlsruhe  L-Arabinose Sigma, Taufkirchen 
Agar-Agar  Probio, Eggenstein Leupeptin Genaxxon, Ulm 




L-Rhamnose Monohydrate Sigma, Taufkirchen 
Ampicillin  Roth, Karlruhe Nipagin  Sigma, Taufkirchen 
Aprotinin  Genaxxon, Ulm Normal goat serum Dianova, Hamburg 
Bacto Agar BD, France NP40 (Igepal CA-630)  Sigma, Taufkirchen 
Brewer´s yeast Leiber, Bramsche Orange G Sigma, Taufkirchen 
BSA (Bovine serum albumin), 98% 
pure  
Sigma, Taufkirchen Paraformaldehyde  Sigma, Taufkirchen 
BSA, purified NEB, Frankfurt/Main Pepstatin  Genaxxon, Ulm 
Chloramphenicol Roth, Karlsruhe Phenol  Roth, Karlsruhe 
Coomassie G250  Serva, Heidelberg PMSF  Sigma, Taufkirchen 
Corn meal  Bäko, Nürnberg Raisins Ökoring, Mammendorf 
dNTP-Mix  NEB, Frankfurt/Main SDS (Sodium dodecyl sulfate)  Serva, Heidelberg 
DTT  Roth, Karlsruhe Semolina  Tengelmann KG, 
Germany 
EDTA  Sigma, Taufkirchen Sf-900II medium  (Gibco) Invitrogen, 
Karlsruhe 
EGTA  Sigma, Taufkirchen Spectinomycin Dihydrochloride 
Gamma 
Sigma, Taufkirchen 
Ethidium bromide Sigma, Taufkirchen Streptomycin Sulfate Sigma, Taufkirchen 
Fetal bovine serum  Sigma, Taufkirchen Sugar beet molasses  Ökoring, Mammendorf 
HEPES  Roth, Karlsruhe Temed (N,N,N’,N’-
Tetramethylethylenediamine) 
Roth, Karlsruhe 
Hygromycin B solution Sigma, Taufkirchen Tris Invitrogen, Karlsruhe 
IPTG Roth, Karlsruhe Triton X-100  Sigma, Taufkirchen 
Kanamycin  Sigma, Taufkirchen β-Mercaptoethanol Sigma, Taufkirchen 
 (All other chemicals were purchased in analytical grade from Merck, Darmstadt) 
A1.2 Kits 
1 kb DNA marker NEB, Frankfurt/Main  Nitrocellulose membrane Amersham, GE 
Healthcare, Munich 
BaculoDirect™ Baculovirus 
Expression System kit  
Invitrogen, Karlsruhe Plasmid Mini or Maxi Kit QIAGEN, Hilden 
ECL detection system  GE Healthcare, Munich Ribo-Zero Magnetic Gold Kit 
(Human/Mouse/Rat) 
Biozyme, Hessisch 
Gel Extraction Kit QIAGEN, Hilden RNA-seq library preparation 
kits 
NEB, Frankfurt/Main 
GenElute PCR Clean-Up Kit Sigma, Taufkirchen RNeasy Mini Kit QIAGEN, Hilden 
Glutathion-Sepharose beads 4B GE Healthcare, Munich SERVAGel TG PRiME precast 
and gradient gels  
SERVA Electrophoresis, 
Heidelberg 
Immobilon-PVDF membrane Millipore, Massachusetts, 
USA 
Super RX Fuji medical X-ray 
film  
Fuji, Düsseldorf 
MicroPlex Library Preparation™ 
kit 
Diagenode, Belgium TNT sp6 high-yield wheat 
germ protein kit  
Promega, Salzburg 
Miracloth (Calbiochem) Merck, 
Darmstadt 
miRNeasy Mini Kit QIAGEN, Hilden αFLAG M2 agarose  Sigma, Taufkirchen 
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A1.3 Antibodies 
Antibody Description Usage Dilution 
3F1 Rat monoclonal αACF1 WB 1:20 
3F1 Rat monoclonal αACF1 IP 700 µl, presorbed to 35 µl beads 
8E3 Rat monoclonal αACF1 WB 1:20 
8E3 Rat monoclonal αACF1 IF 1:2 
8E3 Rat monoclonal αACF1 IP 700 µl, presorbed to 35 µl beads 
Rb1 Rabbit polyclonal αACF1 WB 1:7500 
Rb1 Rabbit polyclonal αACF1 IP 1:250 
Rb1 Rabbit polyclonal αACF1 ChIP 1:100 
Rb2 Rabbit polyclonal αACF1 WB 1:7500 
Rb2 Rabbit polyclonal αACF1 IP 1:250 
Rb2 Rabbit polyclonal αACF1 ChIP 1:100 
GFP Goat polyclonal αGFP ChIP 1:100 
P14 Rabbit polyclonal αISWI (Peter Verrijzer lab) ChIP 1:100 
Hyrax Rabbit polyclonal αHyx WB 1:1000 
Hyrax Rabbit polyclonal αHyx ChIP 1:100 
Cdc6 Rabbit polyclonal αCdc6 WB 1:1000 
Cdc6 Rabbit polyclonal αCdc6 ChIP 1:100 
Pita Rabbit polyclonal αPita (David Glover lab) WB 1:2000 
Pita Rabbit polyclonal αPita (Pavel Georgiev lab) WB 1:2000 
Pita Rat polyclonal αPita (Pavel Georgiev lab) ChIP 1:100 
CTCF Rabbit polyclonal αCTCF (Ranckawitz lab) WB 1:1000 
CTCF Rabbit polyclonal αCTCF (Ranckawitz lab) ChIP 1:100 
CP190 Mouse monoclonal αCP190 (Ranckawitz lab, BX63 clone) WB 1:1000 
CP190 Mouse monoclonal αCP190 (Ranckawitz lab, BX63 clone) ChIP 1:100 
For WB detection using ECL system, all secondary HRP-conjugated antibodies (i.e. goat α mouse, rat or rabbit) 
were procured from Promega, Mannheim. 
For WB detection using LiCOR system, all secondary iRDye-conjugated antibodies (i.e. α mouse/ α rat/ α rabbit) 
were procured from Biomol, Hamburg. 
For IF detection, all secondary Alexa fluorophore-conjugated antibodies were obtained from Invitrogen, Karlsruhe. 
Cy3 conjugated secondary antibodies were procured from Dianova, Hamburg. 
A1.4 Primer sequences 
Primer-name Purpose Sequence (5'-3') 
Chrac16-Rec-N-F Recombineering ccaaaaaaattcccaagccatagtttgcttgggaattaagtaaacaaatggaagtgcataccaatcaggac 
Chrac16-Rec-N-R Recombineering gtttccgcggtcggtggacgctccacgggtggttggctccttggttcgcccttgtcgtcgtcatccttgta 
Acf1_Rec_NF Recombineering gccatttaaacttaaggacattcaagagcaaaaggaaaacaccaaacatggaagtgcataccaatcaggac 
Acf1_Rec_NR Recombineering ttcttgccctccttctgattcaggtcgaatccttcccgcttgcaaatgggcttgtcgtcgtcatccttgta 
Acf1_Rec_CF Recombineering tgcagctaccgtttaggcctagcgatatgaacggggaagtcaaagcttgcgaagtgcataccaatcaggac 
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Acf1_Rec_CR Recombineering gtagactaactaatttacacgatagctggtggagatcagcgtccggctcacttgtcgtcgtcatccttgta 
Acf1_Rec_deltaC_F Recombineering gctttgctcaagtctttctgcacctaaacatcttgcacgactgtattcaggaagtgcataccaatcaggac 
Acf1_Rec_deltaN_R Recombineering gtactttccattagcgaaacttcccactggtgcaaacgcgagtcgcaggccttgtcgtcgtcatccttgta 
ACF1-WAC-F ACF1 quantification gatagtggccaagtttctgc 
ACF1-WAC-R ACF1 quantification tccaacttgacacccaacac 
ACF1-DDT-F ACF1 quantification gatgacacgtgcactgactg 
ACF1-DDT-R ACF1 quantification gatcgaaaacagtgccaagc 
ACF1-PHD1-F ACF1 quantification gcaggcgacaaagaagaaac 
ACF1-PHD1-R ACF1 quantification catcctcatcggtcatatcg 
ACF1-Bromo-F ACF1 quantification gcagatcatgaagcacaagg 
ACF1-Bromo-R ACF1 quantification tgatggtagtcgggaacctc 
Intron9, Timeout_F ACF1-ChIP qPCR agtcatgtgcgacatttgg 
Intron9, Timeout_R ACF1-ChIP qPCR acgcaacaagaatggagagg 
3' of Fz2_F ACF1-ChIP qPCR Cgtactgtcaactgcttg 
3' of Fz2_R ACF1-ChIP qPCR cagttctggaataccatgtc 
Intron3, Spn_F ACF1-ChIP qPCR ctgttgttgggcagacttagc 
Intron3, Spn_R ACF1-ChIP qPCR attggttcagctggttcgtg 
3' of CG6465_F ACF1-ChIP qPCR tgtcctcgctttagcttagcc 
3' of CG6465_R ACF1-ChIP qPCR tggtgcgcgtcactactatg 
5' T48 and Ro_F ACF1-ChIP qPCR gtcttcatacaagcagtgtgtgc 
5' T48 and Ro_R ACF1-ChIP qPCR aggttgttgtcctcgcaaag 
Acf1-cGST-F  gtcccctatactaggacagtggaggcgttcc 
Acf1-cGST-R  ataacctagtataggggacatgcaagctttgac 
Pita_1RNAi_F Pita-ACF1 interaction taatacgactcactatagggtggccgcgaaactgga 
Pita_1RNAi_R Pita-ACF1 interaction taatacgactcactatagggcaactaattgggctgtaacct 
Pita_2RNAi_F Pita-ACF1 interaction taatacgactcactatagggcctcctgcgccagtatccg 
Pita_2RNAi_R Pita-ACF1 interaction taatacgactcactatagggtgcgcgagcgagtgtgatt 
Acf1_crispr_LHS6 ACF1-CRISPR ttagcgcagcgtccacctaa 
Acf1_crispr_RHS2 ACF1-CRISPR gggcgcctaccagctaaacg 
 
Key for recombineering primer use for ACF1 tagging  
 Forward Reverse Tag 
N' tagging of ACF1 Acf1_Rec_NF Acf1_Rec_NR N' 
C' tagging of ACF1 Acf1_Rec_CF Acf1_Rec_CR C' 
N' ACF1 domain deletion Acf1_Rec_deltaC_F Acf1_Rec_CR N' 
C' ACF1 domain deletion Acf1_Rec_NF Acf1_Rec_deltaN_R C' 
N' tagging of Chrac16 Chrac16-Rec-N-F Chrac16-Rec-N-R N' 
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A1.5 Plasmids  
Name Purpose  Name Purpose 
pRedFlp4 Recombineering  pFF-C'Gal4-DBD-ACF1 Recombineering 
pTagNG-EGFP Recombineering pFF-N'Gal4-DBD-ACF1 Recombineering 
pTAGNG-mCherry Recombineering pOT2-LD9043 cDNA clone 
pTagNG-TBPVF Recombineering pOT2-LD32807 cDNA clone 
pTagNG-TPVBF Recombineering pOT2-LD47989 cDNA clone 
pTagNG-Gal4-DBD Recombineering pCR8TOPO-Acf1-FlagR ACF1 cDNA 
pFF-C'EGFP-ACF1 Recombineering pCR8TOPO-Acf1-FlagF ACF1 cDNA 










A1.6 Fly lines 
Stock 
number 
Genotype Background Descriptions Genomic 
Insertion 
PB_334 yw;nEGFP-Acf1/nEGFP-Acf1 yw[1118] N' terminus 2XTY1-EGFP-3XFLAG tag on fosmid pFlyfos21945. 




yw[1118]  25C7 
PB_336 yw;nEGFP-Acf1/nEGFP-
Acf1;MKRS,Sb/TM3,Tb 
yw[1118]  25C7 
PB_337 yw;∆Acf1-EGFP/∆Acf1-EGFP yw[1118]  25C7 
PB_338 yw;cEGFP-Acf1/cEGFP-
Acf1;acf1[1]c/acf1[1]c 
yw[1118] acf1[1] (Alexander Konev) complementation 25C7 
PB_339 yw;nEGFP-Acf1/nEGFP-
Acf1;acf1[1]c/acf1[1]c 
yw[1118]  25C7 
PB_340 yw;cEGFP-Acf1/cEGFP-
Acf1;acf1[7]c/acf1[7]c 
yw[1118] acf1[1] (Alexander Konev) complementation 25C7 
PB_341 yw;nEGFP-Acf1/nEGFP-
Acf1;acf1[7]c/acf1[7]c 
yw[1118]  25C7 
PB_342 yw;nmCherry-
Chrac16/nmCherry-Chrac16 
yw[1118] N'-terminal 2XTY1-mCherry-3XFLAG tag on fosmid 
pFlyfos16131.  









yw[1118] Second chromosome is balanced for both the copies. Stock143 -
second chromosome balancer by Matthias Prestle was used for 





yw[1118] Generated for double colour imaging and colocalization studies for 





yw[1118]   




yw[1118] Generated for live imaging of Acf1. BL30562 was used for 




yw[1118]   
PB_457 yw;nGal4DBD-Acf1/nGal4DBD-
Acf1 
yw[1118] Acf1 is tagged in its endogenous locus at N' end by 2XTY1-
Gal4DBD-3XFLAG. Fosmid clone 21945 from Dr. Pavel 
Tomancak's Drosophila melanogaster genomic library was used 





yw[1118]  25C7 
PB_459 yw;∆Acf1-Gal4DBD/∆Acf1-
Gal4DBD 
yw[1118]  25C7 
 
A1.7 Buffers 
Embryo fixing solution  
10 ml, 0.1 M NaCl, 0.05 M HEPES pH 8.0, 1 mM 
EDTA, 0.5 mM EGTA, 3.7% Formaldehyde (Sigma, 
Cat. No F1635) added to 30 ml n-Heptane (VWR, 
Cat. No. 8.22332.1000) 
Cell fixing solution (10X) 
0.1 M NaCl, 0.05 M HEPES pH 8.0, 1 mM EDTA, 
0.5 mM EGTA, 3.7% Formaldehyde (Sigma, Cat. No 
F1635) 
RIPA 
1% Triton X-100, 0.1% Sodium deoxycholate, 140 
mM NaCl, 10 mM Tris pH 8.0, 1 mM EDTA, 0.1% 
SDS, 1 mM PMSF 
MNase digestion buffer 
10 mM Tris-HCl pH 7.5, 15 mM NaCl, 60 mM KCl, 
0.15 mM spermine, 0.5 mM spermidine, 2 mM CaCl2 
NX-1 
15 mM HEPES pH 7.6, 10 mM KCl, 2 mM MgCl2, 
0.5 mM EGTA, 0.1 mM EDTA, 350 mM sucrose, 1 
mM DTT, 0.2 mM PMSF, Protease inhibitors 
Leupeptin, Pepstatin and Aprotinin (10 µg/ml) 
NX-2 
15 mM HEPES-KOH pH 7.6, 110 mM KCl, 2 mM 
MgCl2, 0.1 mM EDTA pH 8.0, 1 mM Sodium 
metabisulphate, 0.2 mM PMSF, 1 mM DTT (just 
before use), Protease inhibitors Leupeptin, Pepstatin 
and Aprotinin (10 µg/ml) 
NX-3 
25 mM HEPES-KOH pH 7.6, 100 mM KCl, 2 mM 
MgCl2, 0.1 mM EDTA pH 8.0, 1 mM DTT (just 
before use), 20% v/v Glycerol, 1 mM Sodium 
metabisulfite, 0.2 mM PMSF, Protease inhibitors 
Leupeptin, Pepstatin and Aprotinin (10 µg/ml) 
NX-4 
25 mM HEPES-KOH pH 7.6, 100 mM KCl, 12.5 
mM MgCl2, 0.1 mM EDTA pH 8.0, 20% v/v 
Glycerol, 1 mM DTT (just before use), 1 mM 
Sodium metabisulfite, 0.2 mM PMSF, Protease 
inhibitors Leupeptin, Pepstatin and Aprotinin (10 
µg/ml) 
Laemmli buffer (5X) 
250 mM Tris-HCl pH 6.8, 10% w/v SDS, 50% v/v 
Glycerol, 0.1% w/v Bromophenol blue, 10% β-
mercaptoethanol 
PBS (10X) 
1.54 M NaCl, 15 mM KH2PO4, 27 mM 
Na2HPO4*12H2O 
Agar plates for collecting Drosophila embryos 
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1.8% Bacto-agar, 2% Sucrose, 0.1% Acetic acid 
Fly food 
13.3% w/v Brewer’s yeast, 26% w/v Semolina, 
13.3% w/v Corn meal, 50% v/v Sugar beet molasses, 
9.5% w/v Agar-agar, 40% w/v Raisins, 1.6% v/v 
Propionic acid, 24% v/v Nipagin 
GST elution buffer 
20 mM HEPES-KOH pH 7.6, 100 mM NaCl, 0.5 
mM EDTA, 1.5 mM MgCl2, 10% Glycerol, 33mM 
Glutathion-Tris-HCl pH 9.5, Protease inhibitors 



























LB agar plates 
1.5% w/v bacto-agar in ddH2O water 
LB medium 
1.0% w/v Tryptone, 0.5% w/v Yeast extract, 1.0% 
w/v NaCl 
TAE 
40 mM Tris-acetate, 1 mM EDTA pH 8.0 
Transfer buffer 
48 mM Tris base, 39 mM Glycine 
HEMG 200/500  
20 mM HEPES-KOH pH 7.6, 200/500 mM KCl, 0.5 
mM EDTA, 1.5 mM MgCl2, 10% Glycerol, 0.05% 
NP40
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A1.8 General methods for DNA analyses 
A1.8.1 Agarose gel electrophoresis  
Depending on the sizes of DNA to be assessed, 0.7% to 1.5% gels (w/v agarose) were prepared in 1X 
TAE buffer. The gels contained 0.5 μg/ml ethidium bromide. One sixth volume of loading dye (NEB, 
B7024S) was added to DNA samples and loaded on the gel. Electrophoresis was performed applying ~10 
V/cm gel length. After separation, DNA was examined on UV light (254-366 nm) in a gel documentation 
system (Peqlab, Erlangen). 
A1.8.2 Cloning and plasmid preparation  
Restriction cloning was performed for constructs using suitable restriction enzymes (NEB, Frankfurt am 
Main) in pGEX-4T3 vectors (for αACF1, ISWI polyclonal antibody production), pGEX-6P1 (for ACF1 
domain expression) and pOT2 (for assembling ACF1 cDNA clones).  
For expression constructs, chemically competent 50 µl E. coli BL21 (DE3) cells were thawed on ice and 
incubated with 10 ng – 100 ng plasmid DNA for 5 min. Heat shock was given for 90 sec at 42°C and LB 
medium without antibiotic was added to the suspension with subsequent incubation at 37°C for 60 min. 
Transformed bacteria were plated on agar plates containing appropriate antibiotics. Plates were incubated 
overnight at 37°C. Plasmids were prepared from the cells grown in liquid medium overnight using 
QIAGEN Plasmid Mini or Maxi kits (QIAGEN, Hilden) following the manufacturer’s instructions. For 
general cloning purpose, E.coli DH5α strain was used. 
A1.9 General methods for protein analyses 
A1.9.1 SDS-PAGE 
SDS-PAGE - consisting of 8-15% separation and 5% stacking gel were casted in the lab. In addition, 
SERVAGel TG PRiME precast and gradient gels (4-20%) were used according to manufacturer’s 
guidelines. Protein samples prepared in 1X Laemmli buffer were heated to 95°C for 5 min, spun down at 
3000 rpm 2 min and loaded on the gels with protein gold marker (no. 4 or 5). After separation, the gel was 
further processed for Coomassie staining (Colloidal Blue staining kit, NOVEX, according to the specified 
guidelines) or for Western blotting.  
A1.9.2 Western Blot 
Proteins from the polyacrylamide gels were transferred to a methanol-activated Immobilon-PVDF 
membrane or on nitrocellulose membrane (Amersham-Protran, GE healthcare) using a Mini Trans-Blot 
cell wet chambers (Biorad, Munich). Western blotting was carried out as described previously (309) with 
following modifications: Protein transfer was conducted at 4°C for 1.5 hr at 400 mA. For protein 
detection, the membrane was blocked in blocking buffer [1 x PBS, 0.1% Tween20, 5% (w/v) milk 
Page | 137 
 
powder] for 30 min on rocking platform. Subsequently, the membrane was incubated with the primary 
antibody prepared in blocking buffer overnight at 4°C and washed 3 times for 10 min at RT with 1 x PBS 
[+ 0.1% Tween20]. HRP (horse radish peroxidase) conjugated secondary antibodies were incubated with 
the membrane in blocking buffer for 1 hr at RT. Subsequent 3 washes with 1 x PBS-T [+ 0.1% Tweeen 
20] were given. Secondary antibodies were diluted to 1:10,000. Proteins were later detected using ECL 
detection system according to the manufacturer’s instructions (GE Healthcare, Munich). Signals were 
exposed to X-ray films (medical X-ray Super RX, Fuji, USA) for 10 sec – 5 min and developed in a 
developing machine (AGFA curix 60, Mortsel, Belgium). 
A1.9.3 Recombinant protein expression for antibody preparation 
GST-tagged recombinant ACF1 (aa 1065 - 1463) and ISWI (aa 691 – 1027) expression constructs in 
pGEX 4T-3 were inoculated in 200 ml started culture at 37°C, 400 rpm, overnight. The saturated cultures 
were used as inoculum for 2 L expression culture. The cultures were inoculated and OD was monitored 
spectrophotometriacally. At OD = 0.8 units, the cultures were induced with 0.3 mM IPTG for 3 hr at 
30°C. Cells were harvested and sheared by repeated freeze-thawing in 15 ml 1X PBS [with inhibitors] /L 
culture. The cells were further sheared using Branson sonifier 250 D (Branson, Danbury, USA) at 6 times 
20 sec ON cycles with 45% amplitude. The lysate was spun down at 15k rpm, 10 min at 4°C in GSA rotor 
tubes (Sorvall). The cleared lysate was used for GST pull down. Briefly, 1 ml pre-equilibrated Glutathion-
Sepharose beads (GE Healthcare, Munich) slurry per liter of culture was used for pull down at 4°C on 
wheel for 2 hr. The beads were subsequently washed in 10 bead volumes of 1X PBS, 10 min, 4°C for 
each wash. After first PBS wash, two washes of 1X PBS [+ 0.5% Tween 20], two washes of  1X PBS [+ 
0.1% Tween 20], and two washes of 1X PBS were given for ACF1 while 0.5 M NaCl and 0.1 M NaCl 
stringency washes were given for ISWI. Finally the protein was eluted using GST elution buffer in 1X 
bead bed volume for 30 min [centrifugation at 3000 rpm, 2 min at 4°C]. The elution was repeated and 
both eluents were combined. Protein was estimated using Bradford assay and Coomassie stained gels. 
Purified protein was stored at -80°C until further use. 
A1.10 Recombinant ACF1 production in SF21 cells 
ACF1 cDNA was prepared from two partial cDNA clones LD9043 and LD 32807 by restriction cloning 
using PciI enzyme (NEB, R0655S) in pOT2 plasmid. The cDNA was verified by sequencing before use 
and cloned into modified Gateway entry clone (310) of BaculoDirect™ expression system (Invitrogen, 
Karlsruhe) by restriction digestion. The Gateway entry clone allows expression under Cu
++
 inducible 
metallothionein promoter and has additional N-terminal BLRP (biotin ligase recognition peptide) epitope 
tag. The entry clone was recombined with N-terminal-linearized baculovirus genome and transfected into 
SF21 cells following manufacturer’s guidelines. The virus titre was monitored by protein expression after 
induction and to obtain a stock. Handling was done as outlined in (310).   
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Spodoptera frugiperda (SF21) cells were cultured in Sf-900 II medium (Gibco, Invitrogen, Karlsruhe) 
supplemented with 10 mg/ml Penicillin & A and 10% (v/v) fetal bovine serum. Cells were cultured in a 
density range of 0.5 x 10
6
 and 4 x 10
6
 cells/ml. For protein expression, cells were grown in 1 l shaking 
flask with 200-300 ml medium at 27°C and were not cultured for more than 3 months.  
200 ml SF21 cells at 10
6
 / ml were infected with 50-70 µl of virus P4 stock for 72 hr at 27°C in a shaking 
flask in presence of 0.5 mM CuSO4 [protein can still be expressed without inducing agent, final cell 
density 4-5 X 10
6
 /ml]. The cells were spun down washed in 5 ml ice cold PBS and stored in 5 ml 
HEMG500 and stored at -80°C.    
For protein purification, cells were rapidly thawed in luke-warm water and immediately sonicated on ice 
using in a 15 ml falcon tube (5 times 10 sec on, 30% amplitude, Digital Sonifier 250D, Branson, 
Danbury, USA) and centrifuged (10 min, 12000 rpm, at 4°C in SS34 tubes in Sorvall centrifuge). The 
lysate was transferred to fresh tube and flag tagged protein was immunoprecipitated using 200 µl flag 
beads (Sigma, A2220) for 2 hr at 4°C on rotating wheel. The beads were washed 3 times for 10 min with 
1.5 ml HEMG500 and 2 times with HEMG200. The protein was eluted in two times in 2 bed volumes of 
HEMG200 containing 0.5 mg/ml FLAG-peptide and the fractions were combined. The eluted protein was 
aliquoted and stored at -80°C. 
A1.11 In vitro translation and protein-protein interaction validation for ACF1 
cDNA clone for Hyrax (LD47989 in pOT2, DGRC) was ordered and high quality plasmid was prepared 
using QIAGEN Mini plasmid prep kit. C-terminal flag tagged ACF1 was expressed in SF21 insect cells 
and purified as described in A1.9. The cDNA clone was used to prepare 
35
S-Methionine radiolabelled 
Hyrax using in vitro transcription and translation system (TNT® Quick Coupled 
Transcription/Translation Systems, Promega, L3261). The 50 µl labelled reaction was used for flag- co-
immunoprecipitatiopn using 1 µg recombinant flag-ACF1 (full length) protein in 400 µl reaction. The co-
immunoprecipitation was carried out for 3 hr at 4°C on wheel in RIPA [-SDS] buffer and the immune-
complexes were purified using flag-beads (Sigma, A2220) for 1 hr at 4°C. The beads were washed with 
1ml RIPA [-SDS] for 3 times, 10 min at 4°C. The immunoprecipitated protein complexes were analyzed 
on 8% SDS-PAGE gel. Further, equimolar amounts of ACF1 and ISWI (kind gift from Henrike Klinker) 
were used in the reaction to assess complex formation.  
A1.12 Fly Maintenance 
Transgenic flies were maintained at ~18°C and ambient humidity and flipped every 3-4 weeks in small 
vials (Buddeberg, Mannhein) or larger bottles (Greiner Bio-one, Frickenhausen). After January 2015, fly 
food vials were purchased from Nikolaus Gomel lab, Martinsreid were used. Crosses were set up at 25°C. 
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For large numbers of embryos, vials were supplemented with yeast paste, in addition to the regular food 
in the vials. 
Appendix 2: Novel tools established during the course of the work 
A2.1: ACF1 rabbit polyclonal antibodies  
Recombinant GST tagged PHD-PHD-Bromo module of ACF1 was expressed in E.coli BL21 (DE3) 
(Appendix A1.9.3). Purified protein was sent to PSL, Heidelberg, Germany for injection into two rabbits, 
to obtain antibody Rb1 and Rb2 (Appendix A1.3). The antibodies were characterized for WB (Appendix 
A1.9.2), IP and ChIP. ChIP-seq profiles were obtained from both these antibodies.   Rb1 does not work in 
IFM when tested using slow-formaldehyde fixation and heat fixation protocol on overnight embryos 
(Section 3.5.1). Rb2 gives non-specific signal in IF when heat fixation protocol was used in wild-type and 
acf1
7 
overnight embryos. Rb2 shows cross-reactivity to the muscular tissue in the embryos (Figure A2.1). 
 
Figure A2.1: Embryo immunostaining analysis of Rb2-ACF1 polyclonal antibody. Rb2 antibody recognizes nuclear antigen 




A2.2: ACF1 bromodomain-specific monoclonal antibodies  
Antigen:  
Acf1 1-2: LNSAALYDLLEQI aa1361-1373 
Acf1 1-3: DAGCQLERFVIDR aa 1445-1457 
IF tests: 
IF protocol described in Section 3.5.1 was used to test immunofluorescence of ACF1 antibodies on 
overnight embryos. However, different methods of fixation can be used for optimal staining. 




Antigen Class Clone WB IP 
111 Acf1 1-3 R-G1 3B8 ok - 
11111 Acf1 1-3 R-G1 9E10 good - 
11 Acf1 1-3 R-G1 19F12 ok - 
11 Acf1 1-3 R-G1 14D7 weak - 
111 Acf1 1-2 R-2B 10B8 ok Maybe? 
111 Acf1 1-3   14H1 ok - 
11 Acf1 1-3   7A7 ok - 
Table A2.2: New antibodies rose against bromo-domain of ACF1 
 
WB tests suggest Bromo domain is lacking in low molecular weight band: 
WB analysis was carried out on ACF1-specific IP from embryo extract (using 8E3 mAb that purifies both 
bands, lane1) and C-terminal flag-purified ACF1 (i.e. long MW band, lane 2) (Figure A2.2). Preliminary 
observations suggest that low MW band is not detected by Bromo-specific antibodies, hence lacks 
bromodomain.  
 
Figure A2.2: Bromodomain antibody only recognizes long MW form, suggesting that the short MW band lacks bromodomain  
A2.3: ISWI rabbit polyclonal antibodies  
GST tagged recombinant ISWI protein was expressed in E.coli BL21 (DE3) cells and affinity purified on 
GST beads (Appendix A1.9.3). The protein was immunized in two rabbits yielding Rb1 and Rb2 
antibodies. These antibodies were tested in WB and ChIP experiments (not shown). For ChIP, P14 (Peter 
Verrijzer lab,(133)) rabbit polyclonal antibody was used as a control. Apparently, the enrichment on 
model loci obtained from modENCODE ISWI profile (modE3030) was poor with Rb1 and Rb2 
antibodies compared to P14. Besides, these antibodies show cross reactivity in Western blot when tested 
using S2 whole cell extracts after ISWI and GFP RNAi. Based on these preliminary observations, the 
antibodies were not further characterized.   
A2.4: Chrac16 monoclonal antibodies  
   Antigen Clone Antibody name Subclone Species WB (1:20) IP  
(pre-sorbed Protein G beads) 
P16B 2a+2b 1G4   Rat     
P16B 2b 3B2 11 Rat Excellent No 
P16B 2a 7F1 111 Rat poor No 
P16 2b 9H6 111 Rat good No 
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P16B 2b 12A10   Rat     
P16B 2b 6C11 111 Rat good No 
P16A+B 2a 4G9   Rat     
P16B 2a 8E4   Rat     
P16B 2a 4C5   Rat     
P16B 2b 11A9 111 Rat   No 
P16A+B 2a+2b 4H9 111 Rat Excellent No 
Table A2.1: New antibodies rose against Chrac16 
Antigen:  
P16: pMaJo (rec.Chrac14-16 prepared in large quantities by Felix Hartlepp) 
P16A: Peptide A (ETFLPLSRVRTIMKSSMDT, aa 17-35) 
P16B: Peptide B (EFLLQIVPQKIRVHQFQ, aa 90-106) 
P16A+B: Peptide A+B 
 
IF tests: 
These final subclones of the antibodies were tested in IF (1:2 dilution) using 0-12 hour old embryos and 
using previously published protocol for IF (160). However, nuclear signal was not obtained when imaged 
on epifluorescence microscope. It is possible, that some of the antibodies may work if another fixation 
method or antibody dilution schemes are used.  
A2.5: Generation of novel and complete-ACF1 null allele using CRISPR  
CRISPR-mediated ACF1 deletion was generated to assess clear null phenotypes of ACF1. Currently 




show varied phenotypes during oogenesis. For 
example, studies by Kenneth Börner in the lab shows that acf1
1
 predominantly shows egg chamber 
packaging phenotype while, acf1
7
 shows largely apoptotic phenotype. Both these alleles express leftover 
RNA however the protein is only detected in the former. To establish clear deletion phenotype of ACF1 
and study both embryogenesis and oogenesis processes at molecular levels in isolation or in combination 
with the deletion of other remodeler mutants, a complete null allele was generated during the studies 
(Section 3.2.2). However, as the mutant was generated towards the end of the thesis work, it could not be 
analyzed by me.  
The CRISPR sgRNAs in presence of Cas9 make double stranded break at 5’ and 3’ end of the genes. 
Presence of dsRed cassette carrying 1.5 kB flanking homologous regions of next to the cut sites lead to 
recombination and gene replacement by the cassette provided by pJET1.1 vector. The mosaic progeny is 
crossed with WT w1118 and the subsequent F1 progeny is screened for recombination event using dsRed 
cassette. Recombination clone and sgRNA for the method were generated in the lab and microinjection 
followed by first level fly screening was performed in Frank Schnorrer lab (MPI biochemistry, 82152 
Martinsried, Germany). Two transgenic male flies from F1 progeny were backcrossed initially in w1118 
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genotype to retrieve 5 male F2 progeny flies from each of the crosses (1A-1E, 2A-2E). The F2 flies were 
backcrossed in the same w1118 genotype and established as stocks. The flies so obtained were subjected 
to PCR screening and outcrossed into yw progeny. Briefly, 2 -3 F3 male flies from the obtained 10 stocks 
were crossed to yw females and sacrificed for PCR analysis after enough eggs were laid in the tubes. PCR 
screening was performed by amplifying a 3.5 kb region where one end of the amplicon lies on the dsRed 
cassette and another end occupies 2 kb upstream or downstream regions of the ACF1 allele, to score 
correct recombination. The analysis identifies integration events in 7 lines, for the remaining 3 the 
analysis was inconclusive.  To ascertain the loss of ACF1 protein, flies were rendered homozygous by 
following the eye fluorescence. Presence of ACF1 protein was assessed in ovarian tissues by 
confirmatory Western blot experiment (Figure A2.3). Lines 1B, 1C and 2B were established. 
 
Figure A2.3: Western blot analysis of new ACF1 null allele. Western blot performed in 3-5 days old adult homozygous 
females of 7 independent lines. The lane position indicates their identifier.  





 shows enhanced developmental arrest at the end of embryogenesis (Figure 4.5). To assess strongly 
affected developmental stage, staging experiments were performed. Briefly, the embryos were collected 
after every 3 hr until 12 hr and staged to obtain developmental stages corresponding to 0-3 hr, 3-6 hr, 6-9 
hr and 9-12 hr. The embryos were subsequently dechorinated and DAPI counterstained to visualize the 
developmental stages under bright filed microscope. The stages were counted into 3 conspicuous 
morphological features, a) bag like structures without notch (~0-3 hr, until blastoderm stage) b) notched 
embryos without segmentation (~3 -7 hr, stage with germ band elongation) c) segmented embryos (7 hr 
onwards). Total 250 - 650 embryos were counted along each staged interval into above 3 morphological 
classes. The percent of embryos in each of such morphological class are represented in Figure A3.1. 
Persistent appearance of bag shaped embryos was noted in the later developmental stages in acf1
7
 mutant, 
albeit many of them are disintegrated. The observation suggests following possible scenarios. First, the 
embryos die at very early stage of development (in cleavage or preblastoderm stage, characterized by few 
nuclei without cell membranes). Second, the mutant flies produce large numbers of unfertilized eggs due 
to defects in female germline (this scenario supports apoptotic egg chamber phenotype during oogenesis, 
as seen for the mutant). Third, the unfertilized eggs may manifest due to defects in male germline. 
Recently it has been suggested that mouse Baz1A (ACF1 homolog) is essential for mouse 
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spermatogenesis (161).  Fourth, the phenotype is a combination of all or some of the above three. Of note, 
notched embryos (without segmentation) are present in later stages of development in the mutant 
background. The fraction constituting such embryos is only 5 – 6% of total counted embryos in 6 - 9 hour 
and 9 – 12 hour embryos, but apparently higher than observed for wild-type. This may suggest that 
mutant embryos have a slightly delayed developmental plan or that the embryos show lethality during 
different stages of development. Comparative staining of embryos for apoptotic markers in wild-type/ 
mutant backgrounds can be tricky as embryogenesis inherently employs apoptosis process during 
morphogenesis. However, it may be further interesting to assess effects of ACF1 deletion on testes 
structures 
 
Figure A3.1: Morphological investigation of embryogenesis in acf17. Staged embryos in 0-3h until 9-12h are counted for their 
morphological features such as bags, presence of notch and presence of segments. The relative fractions are depicted for each 
developmental stage in w1118 (wild type) and acf17.   
Appendix 4: Profile conversion key for Figure 4.24 
Legend File name (without adapter sequence) 
ACF1-3F1 WT rep1 B40-3F1Acf1ChIP_LOct13_DJ 
ACF1-3F1 WT rep2 B41_3F1Acf1ChIP_LNov13_DJ 
ACF1-3F1 WT rep3 B41-3F1Acf1-RIPA_LOct13_DJ 
ACF1 -Rb1 acf1 rep1 B70_Rb1Acf1_LMarch14_DJ 
ACF1 -Rb2 acf1 rep1 B70_Rb2Acf1_LMarch14_DJ 
ACF1 -Rb2 acf1 rep2 B75_Rb2ACF1_LJuly14_DJ 
ACF1-Rb1 WT rep1 B40_Rb1Acf1ChIP_LJan14_DJ 
ACF1-Rb2 WT rep1 B40_Rb2Acf1ChIP_LJan14_DJ 
ACF1-Rb2 WT rep2 B41_Rb2ACF1_LJuly14_DJ 
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ACF1-Rb2 WT rep3 B62-Acf1Rb2ChIP_LJune14_DJ 
Preimmune WT rep1 B40_Rb2PPI_ATCACG_LSep14 
Preimmune WT rep2 B41_Rb2PPI_TGACCA_LSep14 
Preimmune WT rep3 B41_RbMSL2PPI_ACAGTG_LSep14 
RSF1-Rb rsf1 rep1 0-12hEmb_rsf1[1]_Rsf1ChIP_LAug14_AZ 
RSF1-Rb WT rep1 0-12hEmb_W1118_Rsf1ChIP_LAug14_AZ 
RSF1-Rb WT rep2 B40_Rsf1ChIP_LJune14_DJ 
Input WT Chromatin1 B40-RIPAInput_LOct13_DJ 
Input WT Chromatin2 B41_Input_RIPASDS_LNov13_DJ 
Input WT Chromatin3 B41-RIPA-Input_LOct13_DJ 
Input acf1 Chromatin1 B70_Inp_LMarch14_DJ 
Input acf1 Chromatin2 B75_Input_LJuly14_DJ 
Input WT Chromatin4 B40_Input_LJan14_DJ 
Input WT Chromatin5 B41_Inp_LJuly14_DJ 
Input WT Chromatin6 B62-Input_LJune14_DJ 
Input rsf1 Chromatin1 0-12hEmb_rsf1[1]_Inp_LAug14_AZ 
Input WT Chromatin7 0-12hEmb_W1118_Inp_LAug14_AZ 
(*All raw sequencing files are located on ~/ColdStorage/Dhawal) 
Appendix 5: ACF1 protein interactions  
Total seven MS experiments were carried out that can be grouped into 4 categories. Table A5.1 
summarizes experimental details while Table A5.2 lists all potential interactions identified in at least two 
of the seven experiments.  
SID Extract Antibody Buffer Stage 
999 Low salt 3F1 RPIA+ LiCl 0-12h 
1061 High salt 3F1 RPIA+ LiCl 0-12 h 
1066 Low salt 3F1 RPIA+ LiCl 0-12h 
1143 Low salt 3F1 RIPA 0-12 h 
1143 High salt 3F1 RIPA 0-12 h 
1192 Low salt 3F1 RIPA 0-12 h 
1361 Low salt ACF1-cEGFP, GFP Buffer NXIII 0-12 h 
1830 High salt 3F1 Buffer NXIII 8-12 h 
1830 High salt 3F1 Buffer NXIII 0-4 h 
1830 High salt 8-E3 Buffer NXIII 8-12 h 
1830 High salt 8-E3 Buffer NXIII 0-4 h 
Table A5.1. Description of the MS experiments. 
Protein Description Experiment (Observed peptides in 
IP/Bead control) 
Prp8 pre-mRNA processing factor 8 1192(46/4) 1361(10/4) 1830(2/0)  
CG4747 - 1143(6/0) 1830(3/0) 1830(2/0)  
Ranbp9 Ranbp9 1192(23/3) 1830(22/7) 1830(20/9)  
Klp10A Kinesin-like protein at 10A 1830(27/0) 1830(19/0) 1192(2/0)  
CG10306 - 1830(3/1) 1830(3/0)  
CG9769 - 1361(6/1) 1830(3/0) 1830(2/0)  
Rpn7 Regulatory particle non-ATPase 7 1830(4/1) 1830(3/1) 1830(2/0)  
CG11920 - 1830(9/0) 1830(7/2)  
CG12253 - 1830(10/0) 1830(3/0)  
CG12320 - 1830(2/0) 1830(2/0)  
CG1703 - 1361(3/0) 1192(2/0)  
CG2091 - 1830(8/0) 1830(6/0)  
CG31712 - 1830(8/0) 1830(7/1)  
CG32708 - 1830(11/2) 1830(11/0)  
CG3542 - 1830(15/1) 1830(14/1)  
CG4119 - 1830(24/4) 1830(19/5)  
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CG4849 - 1192(10/1) 1830(9/4)  
CG6340 - 1830(3/0) 1830(2/0)  
CG7839 - 1830(23/5) 1830(21/0)  
CG7967 - 1830(9/0) 1830(7/0)  
CG8036 - 1830(9/2) 1830(5/1)  
CkIIalpha casein kinase IIalpha 1192(10/0) 1361(3/0)  
dre4 dre4 1192(15/6) 1830(2/0)  
Droj2 DnaJ-like-2 1830(10/5) 1830(8/4)  
eEF1delta eukaryotic translation Elongation Factor 1 delta 1830(19/0) 1830(15/0)  
Ef1gamma eukaryotic translation Elongation factor 1 gamma 1830(21/1) 1830(19/0)  
EF2 Elongation factor 2 1830(3/1) 1830(3/0)  
eIF-2alpha eukaryotic translation Initiation Factor 2alpha 1830(4/0) 1830(3/0)  
eIF3-S9 eIF3-S9 1361(8/3) 1830(3/1)  
Hel25E Helicase at 25E 1830(4/0) 1830(2/0)  
hoip hoi-polloi 1830(2/0) 1830(2/0)  
l(3)72Ab lethal (3) 72Ab 1361(13/6) 1830(2/0)  
mdlc midlife crisis 1830(13/0) 1830(12/0)  
qkr58E-1 quaking related 58E-1 1830(6/1) 1830(3/1)  
Rab1 Rab1 1361(6/0) 1830(2/0)  
rod rough deal 1192(3/0) 1830(2/0)  
RpL23 Ribosomal protein L23 1830(4/1) 1830(4/1)  
RpL23A Ribosomal protein L23A 1361(5/2) 1192(2/0)  
RpLP2 Ribosomal protein LP2 1830(2/0) 1830(2/0)  
Rpn12 Regulatory particle non-ATPase 12 1361(8/0) 1830(2/0)  
Rpn13 Regulatory particle non-ATPase 13 1830(2/0) 1830(2/0)  
RpS3 Ribosomal protein S3 1361(14/6) 1192(2/0)  
RpS3A Ribosomal protein S3A 1830(11/5) 1830(10/5)  
Rpt1 Regulatory particle triple-A ATPase 1 1830(5/0) 1830(2/0)  
Rpt3 Regulatory particle triple-A ATPase 3 1361(12/5) 1830(5/1)  
Rpt6 Regulatory particle triple-A ATPase 6 1830(6/2) 1830(3/0)  
TER94 TER94 1830(5/0) 1830(4/0)  
U2af38 U2 small nuclear riboprotein auxiliary factor 38 1830(4/0) 1192(2/1)  
Uba1 Ubiquitin activating enzyme 1 1830(2/0) 1830(2/0)  
Uch-L5 Ubiquitin carboxy-terminal hydrolase L5 ortholog 1830(2/0) 1192(2/0)  
Wwox WW domain containing oxidoreductase 1830(17/0) 1830(10/0)  
Table A5.2. Additional proteins identified in the MS run 
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